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ABSTRACT 
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The chaetoglobins are a structurally unique class of azaphilone alkaloid dimers with 
reported anticancer activity.1 They are also a potential platform for the development of 
antibacterial2 and botulinum antitoxin.3 Notably, this class of compounds has not been 
synthesized to date. Chaetoglobin A (1) and B (2) were originally isolated from the 
endophytic fungus Chaetomium globosum.1 Chaetoglobin A has been shown to be 
potentially active against human colon and breast cancer. However, the bioactivity of 
chaetoglobin B has not been studied due lack of material, suggesting the need of further 
research. The main goal of this project is the design and optimization of a synthetic route 
for chaetoglobin natural products. 
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SELECTIVE OXIDATIVE HOMO- AND CROSS-COUPLING OF PHENOLS USING 
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Achiral phenol coupling has been studied for many years; however, the regioselective 
methods reported to date are substrate-dependent and limited in scope.4-5 Previously, we 
developed a regio- and enantioselective method for oxidative phenol coupling applying a 
series of bimetallic and monomeric vanadium catalysts. The aim of this project is to 
develop a new complementary method for regioselective oxidative phenol coupling. In 
collaboration with Trung Cao and Young Lee, 84 catalysts were synthesized and 
screened against a collection of phenolic substrates using High-Throughput 
Experimentation (HTE). We successfully identified catalysts that give high reactivity 
toward different substrates, and upon scale-up isolated the products in good yields. 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 Armstrong, A. A.; Cameron, C.; Nonhebel, D. C.; Perkins, P. “Oxidative Coupling of Phenols” 10 Part 
Series, J. Chem. Soc. Perkin. Trans. II, 1983, 562-589. 
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CHAPTER 1 
 
 
PROGRESS TOWARD THE ASYMMETRIC TOTAL SYNTHESIS OF 
CHAETOGLOBIN A 
 
 
1.1. Background: Isolation, Structure Elucidation and Biological Activity 
Figure 1.1.0 Chaetoglobins 
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Chaetoglobin A (1) and B (2, Figure 1.1.0) were originally isolated from the 
endophytic fungus Chaetomium globosum living inside of the stem of Imperata 
cylindical. 1  Chaetoglobin’s structural skeleton contains a 2H-isoquinolone-6,8-dione 
moiety, two quaternary centers, and a chiral axis that connects two identical motifs. 
Chaetoglobin B contains an alkyl chain attached to the nitrogen in one of the units. 
 To elucidate the absolute stereochemistry of metabolites 1 and 2, Tan and co-
workers used Mosher’s method and circular dichroism spectroscopy. The 12S-
configuration was determined using Mosher’s method. However, Mosher’s method failed 
for the assignment of the absolute configuration of the quaternary center at C7. The 7S-
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  Ge, H. M.; Zhang, W. Y.; Ding, G.; Saparpakon, P.; Song, Y. C.; Hannongbua, S.; Tan, R. 
X. “Chaetoglobins A and B, Two Unusual Alkaloids from Endophytic Chaetomium Globosum Culture” 
Chem. Commun. 2008, 45, 5978–5980.	  
	   2	  
configuration for 1 and 2 was assigned according with the CD absorption bands at 249 
nm, 354 nm and 302 nm (Figure 1.1.1 and 1.1.2) that matched with CD absorptions for 
(7S)-7-acetoxy-3,5,7-trimethyl-2-benzopyrane-6,8-dione and rubiginosin C (3 and 4, 
Figure 1.1.3). The axial chirality around C-5 and C-5’ was identified to be the 5R-
configuration based on a negative exciton split (395nm and 354nm) shown in the CD 
spectrum. 
 
Figure 1.1.1 CD Spectrum of Chaetoglobin A 
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Figure 1.1.2 CD Spectrum of Chaetoglobin B 
	  
 
 
Figure 1.1.3 Strandard Azaphilones Used for Absolute Stereochemistry Elucidation of 
Chaetoglobins A and B. 
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Chaetoglobins are a potential platform for the development of antibacterial2–3 and 
botulinum antitoxin.4 Chaetoglobin A has been shown to be potentially active against 
human colon and breast cancer.  It inhibits the tumor-related genes bcl-2, c-myc and β-
catenin, which are common in human and animal cancers. Gene bcl-2 is a proto-
oncogene that produces a protein responsible for apoptosis inhibition. Excess of β-catenin 
protein promotes the production of bcl-2 protein. However, the bioactivity of 
chaetoglobin B has not been studied due to lack of material, suggesting the need of 
further research.  
 
1.1.1  Proposed Biosynthesis 
Tan postulated a possible biosynthetic pathway for Chaetoglobins A and B (shown 
in Figure 1.1.1.0)1 based on reported studies on azaphilones monomers using 13C labeled 
acetate sodium tracer experiments. 5 , 6 , 7 , 8  The proposed biosynthesis starts from a 
polyketide, which cyclizes, dimerizes, and undergoes amide condensation, which would 
leads to chaetoglobins A and B. 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2 Ayer, W. A.; Craw, P.A.; Nozawa, K. “Two 1H-naphtho[2,3-clpyran-1-onemetabolites From the Fungus 
Paecilomyces Variotii” Can. J. Chem. 1991, 69,189–191.  
3 Mukhopadhyay, T.; Roy, K.; Coutinho, L.; Rupp, R. H.; Ganguli, B. N. “Fumifungin, a new antifungal 
antibiotic from Aspergillus Fumigatus Fresenius 1863 ” J. Antibiot. 1987, XL, 1050–1052. 
4  Hemaiswarya, S.; Soudaminikkutty, R.; Narasumani, L. M.; Doble, M. “Phenylpropanoids Inhibit 
Protofilament Formation of Escherichia Coli Cell Division Protein FtsZ” J. Med. Microbiol. 2011, 60, 
1317–1325. 
5  Seto, H.; Tanabe, T. “Utilization of 13C-13C Coupling in Structural and Biosynthetic Studies III. 
Ochrephilone - a New Fungal Metabolite” Tetrahedron Lett. 1974, 15, 651–654.  
6 Ryan, A.; Birth, A. J.; Whalley, W. B. “Studies in relation to biosynthesis. Part XVII. Sclerotiorin, 
citrinin, and citromycetin” J. Chem. Soc. 1958, 0, 4576–4581. 
7 Kurini, M.; Nakanishi, K.; Shindo, K.; Tada, M. “Biosyntheses of Monascorubrin and Monascoflavin.” 
Chem. Pharm. Bull. 1963, 11, 359–362. 
8 Masanao, T.; Kiyotaka, K.; Shinsaku, N. “Four New Azaphilones from Chaetomium globosum var. flavo-
viridae” Chem.  Pharm. Bull. 1990, 38, 625–628. 
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Figure 1.1.1.0 First Postulated Biosynthesis. 
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Recently, Watanabe et al. identified the gene cluster involved in the production of 
azaphilones isolated from Chaetomium Globosum including chaetoglobins  A and B and 
proposed a more plausible biosynthetic pathway (Figure 1.1.1.1  and Figure 1.1.1.2).9, 10 
This study reports that the starter unit: ACP transacylase (SAT) in gene CHGG_10027 is 
capable of accepting acetyl-CoA as a substrate and extending it with four malonyl-CoA 
units. SAT also accepts heptanoyl-CoA or 5-hydroxylheptanoyl-CoA as a substrate. The 
emerging chain cyclizes through an aldol condenzation, followed by aromatization and 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
9 Winter, J. W.; Sato, M.; Sugimoto, S.; Chiou, G.; Garg, N. K.; Tang Y.; Watanabe K. “Identification and 
Characterization of the Chaetoviridin and Chaetimuglin Gene Cluster in  Chaetomium globosum Reveal 
Dual Functions of an Iterative Highly-reducting Polyketide Synthetase” J. Am. Chem. Soc. 2012, 134, 
17900–17903. 
10 Makazawa, T.; Ishiuchi, K.; Sato, M.; Tsunematsu, Y.; Sugimoto, S.; Gotanda, Y.; Noguchi, H.; Hotta, 
K.; Watanabe, K. “Targeted Disruption of Transcriptional Regulators in Chaetomoim globosum Activates 
Biosynthetic Pathway and Reveal Transcriptional Regulator-like Behavior of Aureonitol”  J. Am. Chem. 
Soc. 2013, 135, 13446–13455. 
	   6	  
release from its terminal reductase domains to form a benzaldehyde. 9, 11, 12 Oxidative 
dearomatization and enolization of the benzaldehyde followed by cyclization produces 
monomeric azaphilones. Acetylation of the hydroxyl group in the ring system, by O-
acetytransferase (CHGG_10028), and dimerization (CHGG_10025) forms dimeric 
azaphilone 7. Precursor 7 converts in to chaetoglobins A (1) and B (2) via non-enzymatic 
amination and cyclization of the alkyl chain will produce cochliodone A (9). 
 
Figure 1.1.1.1 
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11 Crawford, J. M.; Thomas, P. M.; Scheerer, J. R.; Vagstad, A. L.; Kelleher, N. L.; Towsend, C. A.; 
“Deconstruction of Iterative Multidomain Polyketide Synthase Function” Science  2008, 320, 243. 
12 Bailey, A. M.; Cox, R. J.; Haly, K.; Lazarus, C. M.; Simpson, T. J.; Skellam, E. “Characterization of 1-
methylorcinaldehyde Synthetase (MOS) in Acremonium strictum: First Observation of a Reductive Release 
Mechanism During Polyketide Biosynthesis” Chem. Commun. 2007, 4053–4055. 
	   7	  
Figure 1.1.1.2 Second  Proposed Biosynthesis 
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1.1.2 Related Azaphilone Natural Products and Previous Synthetic Studies 
 
Azaphilones alkaloids are a family of natural products characterized by a highly 
oxygenated bicyclic structure and an asymmetric quaternary center (Figure 1.1.2.0, 
1.1.2.1). These alkaloids differentiate from one another though modifications to the 
bicyclic pyranoquinone scaffold (10-11, 14-15, 20-22),13, 14,15,16,17 reduction (35-36),18 
attachment of acetyl groups to the oxygenated quaternary center (12-16, 37),18,19, 20,21 
halogenation (17-19, 34)14,20,22,, annulation (17-29, 34)17,23, modifications of the alkyl 
chain (24-29),24 spirocyles (30-32),21,25,26 amination (33-34),20 aromatization (35-36),18 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
13 Muroga, Y.; Yamada, T.; Numata, A.; Tanaka, R. “:Chaetomugilins I–O, New Potent Cytotoxic 
Metabolites from a Marine-fish-derived Chaetomium Species. Stereochemistry and Biological Activities” 
Tetrahedron 2009, 65, 7580–7586. 
14 Winter, J. M.; Sato, M.; Sugimoto, S.; Chiou, G.; Garg, N. K.; Tang, Y.; Watanabe, K. “Identification 
and Characterization of the Chaetoviridin and Chaetomugilin Gene Cluster in Chaetomium globosum 
Reveal DualFunctions of an Iterative Highly-Reducing Polyketide Synthase” J. Am. Chem. Soc. 2012, 134, 
17900−17903 
15 Stierle, A. A.; Stierle, D. B.; Girtsman, T. “Caspase-1 Inhibitors from an Estremophilic Fungus that 
Target Specific Leukemia Cell Lines” J. Nat. Prod. 2012, 75, 344–350. 
16 Myobatake, Y.; Tskeuchi, T.; Kuramochi, K.; Kuriyama, I.; Ishido, T.; Hirano, K.; Sugawaa, F.; 
Yoshida, H.; Mizushina, Y. ”Phinophilins A and B, Inhibitosr of Mammalian A-,B- and Y-family DNA 
Polymerases and Human Cancer Cell Proliferation” J. Nat. Prod. 2012, 75, 135–141. 
17 Kanomedahkul, S.; Kanomedahkul, K.; Nasomjai, P.; Louangsysouphanh, S.; Soytong, K.; Isobe, M.; 
Palangpon, K.; Pranpai, S.; Suksararn, A. “Antifungal Azaphilones from Fungus Chaetomium Cupreum  
CC3003” J. Nat. Prod. 2006, 69, 891–895. 
18 Gao, J. M.; Yang, S. X.; Qin, J. Q. “Azaphilones: Chemistry and biology” Chem. Rev. 2013, 113, 4755–
4811. 
19 Wang, H.; Wang, Y.; Wang, W.; Fu, P.; Liu, P.; Zhu, W. “Anti-influenza Virus Polyketides from the 
Acid-Tolerant Fungus Penicillium purpurogenum JS03-21” J. Nat. Prod. 2011, 74, 2014–2018. 
20	  McMullin, D. R.; Sumarah, M. W.; Blackwell, B. A.; Miller, J. D. “New azaphilones from Chaetomium 
Globosum Isolated from the Built Environment” Tetrahedron Lett. 2013, 54, 568–572.  	  
21 Quang, D. N.; Hashimoto, T.; Stadler, M.; Asakawa, Y. “New azaphilones from the inedible mushroom 
Hypoxylon rubiginosum” J. Nat. Prod. 2004, 67, 1152–1155. 
22 Mancilla, W. S. G.; Guimaras, D. O.; Duran-Patrn, R.; Collado, I. G.; Pupo, M. T. “Azaphilones from the 
Endophyte Chaetomium Globosum” J. Nat. Prod. 2011, 74, 1182–1187. 
23 Huang, H.; Feng, X.; Xiao, Z.; Lui, L.; Li, H.; Ma, L.; Lu, Y.; Ju, J.; She, Z.; Lin, Y. “Azaphilones and p-
terphenyl from the Mangrove Endophytic Fungus Penillium Shermesium (ZHE4-E2) Isolated from the 
South China Sea”  J. Nat. Prod. 2011, 74, 997–1002. 
24 Panthama, N.; Kanokmedhakul, S.; Kanokmedhakul, K.; Soytong, K. “Cytotoxic and Antimalarial 
Azaphilones from Chaetomium Iongirostre” J. Nat. Prod. 2011, 74, 2395 
25 Romero-Ariza, M.; Larsen, T.; Petersen, B. O.; Duus, J.; Christophersen, C.; Barrero, A. F.  “A Novel 
Alkaloid Serantrypinone and the Spiro Azaphilones Daldinin D from PenicilliumTthymicola ” J. Nat. Prod. 
2001, 64, 1590–1595. 
26 Che, Y.; Gloer, J. B.; Koster, B.; Malloch, D. “Decipinin A and Decipienolides A and B: New bioactive 
Metabolites from the Coprophilous Fungus Podospora Decipiens”  J. Nat. Prod.  2002, 65, 916–919. 
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fused rings to 4H-pyran ring (37)18 and dimerization (Figure 1.1.2.1, 1-2, 8, 38-
41).1,18,27,28,29 Many azaphilone natural products have been reported with an extended 
range of biological applications such as: cytotoxicity against leukemia cells, human 
prostate cancer,30 other cancer cells lines,13,15,31,32 activity against M. tuberculosis,29 
antimalarial activity against plasmodium falciparum,24 antiviral activity against influenza 
A,19 antibacterial activity,2–3,26,33 anti-fungal activity,14,34 and anti-inflammatory. 35 
 
 
 
 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
27 Andrioly, W.; Conti, R.; Araujo, M. J.; Zanasi, R.; Cavalcanti, B. C. “Mycoleptones A-C and Poliketides 
from the Endophyte Mycoleptodiscus Indicus” J. Nat. Prod. 2014, 77, 70–78. 
28	  Peng, W.; Lei, G.; Zheng, C. J.; Zhang, Q. Y.; Jia, M.; Jiang, Y. P.; Han, T.; Qin, L. P. “Two new 
Azaphilone Alkaloids Dimers from Endophyte Chaetomium Fusiforme of the Liverwort Scapania 
Verrucosa Heeg” Biochem. Syst. and Ecol. 2012, 45, 124–126	  
29	  Phonkerd, N.; Kanokmedhakul, S.; Kanokmedhakul, K.; Soytong, K.; Prabpai, S.; Kongsearee, P., “Bis-
Spiro-azaphilones and Azaphilones from the Fungi Chaetomium Cochliodes VTh01 and C. Cochliodes 
CTh05” Tetrahedron 2008, 64, 9636-9646.	  
30	  Chen, R. J.; Hung, C. M.; Chen, Y. L.; Vu, M. D.; Yuan, G. F.; Wang, Y. J. “Monascuspiloin Induces 
Apoptosis and Autophagic Cell Death in Human Prostate Cancer Cells via the Ark and AMPK Signaling 
Pathways” J. Agric. Food. Chem. 2012, 60, 7185–7193.	  
31  Yasukawa, K.; Takahashi, M.; Natori, S.; Kawai, K.; Yamazaki, M.; Takeuchi, M.; Takido, M. 
“Azaphilones Inhibit Tumor Promotion by 12-O-Tetradecanoylphorbol-13-Acetate in Two-Stage 
Carcinogenesis in Mice” Oncology  1994, 51, 108-112 
32 Takeuchi, T.; Mizushina, Y.; Takaichi, S.; Inoue, N.; Kuramochi, K.; Shimura, S.; Myobatake, Y; 
Katayama, Y.; Takemoto, K.; Endo, S.; Kamisuki, S.; Sugaware, F. “Total Synthesis of (+)-Sch 725680: 
Inhibitor of Mammaliam A–,B–, and Y– family DNA Polymerases” Org. Lett. 2012, 14, 4303–4305. 
33 Borges W. S., Mancilla G., Guimaras D. O., Duran-Patrn R., Collado I. G.,  Pupo M. T., “Azaphilones 
from the endophyte Chaetomium globosum” 2011, 74, 1182–1187. 
34 Brase, S; Encinas, A.; Keck, J.; Nising, C. F. “Chemistry and Biology of Mycotoxins and Related Fungal 
Metabolites” Chem. Rev. 2009, 109, 3903-3990. 
35 Hsu, L. C.; Liang, Y. H.; Hsu, Y. W; Kuo, Y. H.; Pan, T. M. “Anti-inflammatory Properties of Yellow 
and Orange Pigments from Monascus Purpureus NTU 568”  J. Agric. Food. Chem. 2013, 61, 2796–2802. 
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Figure 1.1.2.0 Azaphilone Natural Products 
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Figure 1.1.2.1 Dimeric Azaphilones 
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These structurally interesting and challenging molecules gave arise to a number of 
synthetic studies. In 1986, Stauton et al. published the synthesis of racemic (±)-citrinin, 
an azaphilones monomer with antibiotic activity against gram-positive bacteria and a 
potential insecticide.34 Acetylation of ethyl 2-ethyl-4,6-dimethoxybenzoate 42 afforded 
43, follow by reduction to yield lactone 44. Reduction of the carbonyl and palladium 
catalyzed hydrogenolysis to install the methyl group at the arene provided 46. 
Deprotection of the methyl ethers and successive carboxylation, formylation, and 
cyclization yielded (±)-citrinin 
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Scheme 1.1.2.0 Total Synthesis of (±)-Citrinin 
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Yao and coworkers reported the synthesis and study of a series of 
chloroazaphilones and vinylogous γ-pyridone. 36  The synthetic route started with 
commercially available benzyl alcohol 49. Chlorination followed by aromatic 
nucleophilic substitution afforded compound 50. Generation of the dithiane anion of (3-
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
36 Wei, W. G.; Yao, Z. J. “Synthesis Studies Toward Chloroazaphilones and Vinylogous Pyridines: Two 
Common Natural Product Core Structures” J. Org. Chem. 2005, 70, 4585–4590. 
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(1,3-dithian-2-yl)propoxy)(tert-butyl)dimethylsilane followed by condensation with the 
benzyl chloride 50 yielded intermediate 51. Metalation of the arene at the C3 position and 
subsequent treatment with methyl iodide to introduce a methyl group was followed by a 
nonselective deprotection of the dimethyl acetal and silyl ether group to afford 
benzaldeldehyde 52. After the selective reprotection of compound 52 as acetate 53, the 
dithiane moiety was cleaved. Methyl ether deprotection and chlorination afforded formyl 
ktone 55. Acid-catalyzed cyclization followed by oxidation yielded chloroazaphilone 56. 
Finally, Yao investigated the reaction of cloroazaphilone 56 with several primary amines 
to afford their corresponding γ-pyridones. 
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Scheme 1.1.2.1 Synthesis Chloroazaphilones and Vinilogous γ-Pyridone.  
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Scheme 1.1.2.2 Cycloisomerization-oxidation of Alkynylbenzaldehydes. 
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Within the same timeframe, Porco and coworkers reported a method for the 
synthesis of the azaphilones using a cycloisomerization of alkynylbenzaldehydes to 2-
benzopyrylium salts followed by oxidation to the 2H-isoquinolone-6,8-dione system 
(Scheme 1.1.2.2).37, 38 The synthesis of azaphilones starts with nitration of the readily 
available benzaldehyde 60 and aldehyde protection to afford geminal diacetate 61. 
Reduction of the nitro substituent and bromination yield compound 62. Deamination and 
deprotection of o-bromoniline 62 followed by deprotection of the methyl ethers yielded 
54. Finally, Sonogashira cross-coupling yielded o-alkynylbenzaldehyde 58 which was 
used for oxidative dearomatization.  Porco investigated a number of Lewis acid catalysts 
for the cycloisomerization and found that gold(III) acetate was optimal at room 
temperature and short reaction time.  After screening a number of oxidants, Porco found 
that subsequent o-iodoxybenzoic acid (IBX) treatment afforded the desired azaphilones 
59 in excellent yields. 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
37 Zhu, J.; Germain, R.; Porco, J. A. “Synthesis of Azaphilones and Related Molecules by Employing 
Cycloisomerization of o-Alkynylbenzaldehydes” Angew. Chem. Int. Ed. 2004, 43, 1239 –1243 
38	  Zhu, J. “Studies Toward the Synthesis of Azaphilone Natural Products” Ph.D. Dissertation, Boston 
University, Boston, MA, 2005.	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Scheme 1.1.2.3 Cycloisomerization-oxidation sequence 
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The proposed mechanism for the cycloisomerization and oxidation is shown in 
Figure 1.1.2.2. The formation of 2-benzopyrilium salt V was proposed through two 
possible pathways. Activation of the alkyne in o-alkynylbenzaldehyde I by a Lewis acid 
would afford complex III, which is later protonated to provide V (Path A). On the other 
hand, the triple bond can be activated by a protic acid, then attacked by the aldehyde to 
provide intermediate V. Addition of o-iodoxybenzoic acid oxidizes the phenol at C6 and 
simultaneously inserts an oxygen at C7 yielding intermediate VIII after a reductive 
workup. Enolization of 2-benzopyrylum complex VIII affords the desired 2H-
isoquinolone-6,8-dione moiety IX. 
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Figure 1.1.2.2 Proposed Mechanism for Cycloisomerization and Oxidation  
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The cycloisomerization-oxidation approach was successfully applied to several 
natural and unnatural azaphilones shown in Figure 1.1.2.3. S-15183a (66) is a 
sphingosine kinase inhibitor isolated from Zopfiella inermis, which was synthesized by 
Porco and used as a model system for the optimization of cycloisomerization-oxidation 
method. 
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Pettus et al. successfully utilized Porco’s method for the synthesis of (±)-
mitorubrinic acid (65) in 12 steps and 31% overall yield.39  Yang and coworkers also 
employed oxidative dearomatization method for the synthesis of an azaphilone library 
with antifungal activity.40 
 
Figure 1.1.2.3 
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In 2005, Porco reported an enantioselective method for the synthesis of azaphilones 
using a copper-mediated asymmetric oxidation of phenolic substrates.41 This method 
consists in the oxidative dearomatization of an o-alkynylbenzaldehyde using a [(–)-
sparteine]2Cu2O2 complex, followed by a phosphate-buffered cyclization to afford the 
bicyclic pyranquinone core (Figure 1.1.2.4). Porco performed mechanistic studies for the 
enantioselective oxidative dearomatization and proposed a possible pathway for this 
transformation (see Figure 1.1.2.4).38 The complex produced from the mix of 
Cu(CH3CN)4PF6 and (–)-sparteine  under an inert atmosphere is oxidized by purging with 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
39 Marsini, M. A.;  Gowin, K. M.; Pettus, T. R. R. “Total synthesis of (+)-Mitorubric Acid ” Org. Lett. 
2006, 8, 3481–3483. 
40 Lin, L.; Mulholland, N.; Wu, Q. Y.; Beattie, D.; Huang, S. W.; Irwin, D.; Clough, J.; Gu, Y. G.; Yang, G. 
F. “Synthesis and Antigungal Activity of Novel Sclerotiorin Analoges” J. Agric. Food. Chem. 2012, 60, 
4480–4491. 
41 Zhu, J.; Grigoriadis, N. P.; Lee, J. P.; Porco, J. A. “Synthesis of the Azaphilones Using Copper-Mediated 
Enantioselective Oxidative Dearomatization” J. Am. Chem. Soc. 2005, 127, 9342-9343 
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oxygen to afford the oxo-dimeric complex I.  Phenolic alkynylbenzaldehyde binds to one 
of the copper centers as shown in complex II. Oxidation of the phenol and electrophilic 
aromatic substitution occur simultaneously to afford complex III in which the phenol is 
converted to a carbonyl, an oxygen is inserted and one of the coppers is reduced to 
Cu(II).  A second alkynylbenzaldehyde can bind to complex III to form intermediate IV. 
Yet this second phenolate bound to complex IV cannot be further oxidized and may not 
be able to bind to different [(–)-sparteine]2Cu2O2 complex. This phenomenon may 
explain the low conversion early in the investigation. However, addition of strong 
nitrogen-donor bases such as DMAP either avoids phenolate binding or promotes 
dissociation of phenolate by binding to the copper  (complex V).  This additive leaves the 
alkynylbenzaldehyde free to bind to a new [(–)-sparteine]2Cu2O2 complex and undergoes 
oxidative dearomatization. Acidic workup hydrolizes complex V to produce enol VII, 
that is later cyclized to afford azaphilones 59. 
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Figure 1.1.2.4 Proposed Mechanism of Oxidatve Dearomatization Reaction. 
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Figure 1.1.2.5 
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As a result of this method, Porco reported the asymmetric syntheses of bioactive 
natural azaphilones such  (-)-Miturobin(68)42 and (-)-S-15183a (69)Error! Bookmark not defined. 
in good yields and high enantioselectivities.  
In 2008, Boger et al. successfully applied both Porco’s method for the synthesis 
the azaphilone-derived chromophore (75) as part of their approach towards for the 
MDM2-p53 inhibitor chlorofusin (76, Scheme 1.1.2.4).43,44, 45, 46, 47 Boger synthesized o-
alkynylbenzanzaldehyde precursor 64 in a different fashion that involves protection of 
benzaldehyde 60 to form aminal 70. An ortho-directed lithiation of aminal 70 followed 
by bromination and deprotection of the aminal via an acidic work up afforded 
bromobenzaldehyde 63. The methylenes were removed and a Sonogoshira cross coupling 
was undertaken to afford o-alkynylbenzaldehyde 58a. Cycloisomerization-oxidation of 
58a produce the racemic azaphilones 59a in a 72% yield. The enantiopure azaphilone 59a 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
42 Zhu, J.; Germain, A. R.; Porco, J. A., Jr “Asymmetric Syntheses of (-)-Mitorubrin and Related 
Azaphilone Natural Products” Angew. Chem., Int. Ed. 2004, 43, 1239. 
43 Clark, R. C.; Lee, S. Y.; Boger D. L. “Total Synthesis of Chlorofusin, Its Seven Chromophore 
Diastereomers, and Key Partial Structures” J. Am. Chem. Soc. 2008, 130, 12355–12369.  
44 Clark, R. C.; Lee S. Y.; Searcey, M.; Boger D. L “The Isolation, Total Synthesis and Structure 
Elucidation of Chlorofusin, a Natural Product Inhibitor of the p53–MDM2 Protein–protein Interaction” 
Nat. Prod. Rep. 2009, 26, 465477. 
45 Qian, W. J.; Wei, W. G.; Zhang, Y. X.; Yao, Z. J. “Total Synthesis, Assignment of Absolute 
Stereochemistry, and Structural Revision of Chlorofusin” J. Am. Chem. Soc. 2007, 129, 6400–6401. 
46 Lee, S. Y.; Clark, R. C.; Boger, D. L. “Total synthesis, Stereochemical Assignment and Absolute 
Configuration of Chlorofusin” J. Am. Chem. Soc. 2007, 129, 9860–9861. 
47 Woon, E. C. Y.; Arcieri, M.; Wilderspin, A. F.; Malkinson, J. P.; Searcey, M. “Solid-phase Synthesis of 
Chlorofusin Analoges” J. Org. Chem. 2007, 72, 5146–5151.	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was obtained via asymmetric oxidative dearomatization with up to 98% ee. Due to the 
unavailability of (+)-sparteine at that moment, this route provided the unnatural 
enantiomer. Borger proceeded to undertake a chromatographic separation of a racemic 
sample of azaphilone 59a to obtain the natural enantiomer. Acetylation of 59 with butyric 
anhydride followed by chlorination and silyl ether deprotection provided chloro-
azaphilones 74.  Condensation of (R)-74 with dipeptide Fmoc-L-Orn-L-Thr-OBn yielded 
74. Finally, oxidative spiro cyclization of 74 provided the chlorofusin chromophore 75. 
Chlorofusin 76 was afforded after the enlongation of the peptide chain in a number of 
steps. 
Like chlorofusin, a number of azaphilones natural products possess the opposite 
stereochemistry to that investigated produced with Cu2L2O2[(–)-spartiene]. Due the 
unavailability of (+)-sparteine, Porco developed a series of (+)-sparteine surrogate 
mimics for the asymmetric oxidative dearomatization (Scheme 1.1.2.5).48  Porco was 
able to identify N-ethyl-(+)-sparteine mimic 79  to be optimal ligand to provide 
azaphilones with excellent yield and ee. This allowed the synthesis of (+)-sclerotiorin 
(Figure 1.1.2.6, 82)49 and (+)-8-O-methylsclerotiorinamine (83). 43, 50  (+)-Sclerotiorin is 
a lipoxygenase inhibitor with applications in food processing and free radical 
scavenger.49   (+)-8-O-methylsclerotiorinamine inhibited protein-protein interactions of 
Grb2-Shc.50 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
48	  Germain, A. R.; Bruggemeyer, D. M.; Zhu, J.; Genet, C.; O’Brien, P.; Porco, J. A. “Synthesis of the 
Azaphilones (+)-Sclerotiorin and (+)-8-OMethylsclerotiorinamine Utilizing (–)-Sparteine Surrogates in 
Copper-Mediated Oxidative Dearomatization” J. Org. Chem. 2011, 76, 2577–2584.	  
49	  Chindananda, C.; Sattur, A. P. “Sclerotiorin, a Novel of Lipoxygenase from  Penicillium Frequentans” 
J. Agric. Food. Chem. 2007, 55, 2879–2883.	  
50  Nam, J.; Kim, H.; Kwon, J.; Han, M. Y.; Son, K.; Lee, C. U.; Choi, J.; Kwon, B. “8-O-
Methylsclerotioramine, Antagonist of the Grb2-SH2 Domain, Isolated from Penicillium Multicolor” J. Nat. 
Prod. 2000, 63, 1303–1305. 
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Scheme 1.1.2.4 Total Synthesis of Chlorofusin 
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Scheme 1.1.2.5 (+)-Sparteine Surrogate Mimics 
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Figure 1.1.2.6 
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Recently, Porco reported the synthesis of an azaphilone-based library, utilizing 
cycloisomerization-oxidation and buffer-mediated cycloisomerization methodologies. 
This approach starts with a Sonogashira cross-coupling of bromobenzaldehyde 64 to 
insert R1 diversity. Cycloisomerization, oxidation, bromination, and Stille coupling the 
afforded azaphilones in Chemset 1.  This set was expanded through acetylation of the 
hydroxyl group at C7 to provide a number of azaphilones esters (Chemset 2).  Selected 
azaphilones from Chemset 2 were condensed with a number of amines to provide 
vinilogous 4-pyridones is Chemset 3.  In summary, three azaphilones sublibraries were 
created with a total of 32 azaphilones. 
 
Scheme 1.1.2.6 Synthesis of an Azaphilone-based Library 
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1.1.3 Conclusion 
A series of studies towards the synthesis of monomeric azaphilone natural products 
has been reported. The two most relevant methodologies were developed by Porco and 
coworkers, which consist of cycloisomerization followed by IBX mediated oxidation and 
copper-mediated oxidation followed by cyclization of the resulting vinylogous acid. As a 
result, Porco reported the syntheses of the azaphilone natural products (-)-S-15183a, (+)-
sclerotiorin and (+)-8-O-methylsclerotiorinamine.  Also, Boger et al. synthesized the 
azaphilone-derived chromophore as part of their synthetic plan for the MDM2-p53 
inhibitor chlorofusin. To date, no one has synthesized the more difficult azaphilones 
dimers, chaetoglobin A and B.  Chaetoglobins represent a potential platform for the 
development of anticancer and antibacterial drugs. Therefore, the design of an efficient 
synthetic route for these natural products is key to achieving its complete biological 
characterization and optimization via analog preparation.  
In the next section we describe the design and optimization of a synthetic route for 
the preparation of chaetoglobin natural products. 
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1.2 Studies Towards the Total Synthesis of Chaetoglobin A. 
 
1.2.1 Retrosynthetic Analysis 
 The chaetoglobins are a structurally unique class of azaphilone alkaloid dimers with 
reported anticancer activity. Notably, this class of compounds has not been synthesized to 
date.  These azaphilone dimers present several structurally interesting features, such as 
2H-isoquinolone-6,8-dione moiety, a quaternary center at C7 on the core and another 
stereocenter on the alkyl chain. However, the major challenge inherent in these structures 
lies in the enantioselective formation of the axial chiral bond between the two units. 
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Key disconnections targeted for the construction of chaetoglobin A, include 
oxidative dearomatization of alkynylbenzaldehyde (3) to form the 2H-isoquinolone-6,8-
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dione moiety. We have previously demonstrated phenols can be coupled 
enantioselectively by means of a chiral vanadium catalyst. Based on these studies, we 
propose the asymmetric oxidative phenol coupling of an arylalkyne (4, 5) to provide the 
C5-C5’ axial stereochemistry followed by formylation of the resulting biaryl.  An 
alternative pathway includes asymmetric phenol coupling of phenol (7), formylation of 
the produced biaryl and a Sonogashira cross-coupling to give biaryl (3).   
 
1.2.2 Design and Optimization of Synthetic Route Using a Model System 
  The synthetic strategy proposed for the construction of the chaetoglobin natural 
products consists of three key steps: (1) Sonogashira cross-coupling, (2) asymmetric 
phenol coupling, (3) oxidative dearomatization and amination. To optimize the proposed 
synthetic route, a model diphenol with an achiral alkynyl group (n = 2, R = H, 5) was 
prepared. The optimized synthetic pathway was applied to the  synthesis of chaetoglobin 
A using a siloxy-derived (n = 1, R=OTBS and R=OTBDPS, 4) alkyne. 
 
1.2.2.1 Studies Towards Asymmetric Phenol Coupling.  
  Asymmetric oxidative phenol coupling is a critical step for the enantioselective 
synthesis of chaetoglobin natural products. This step is responsible for generating the 
stereochemistry in the axial portion of the molecule.  
  Achiral phenol coupling has been studied for many years with a variety of 
stoichiometric oxidants; however, there are no reports in the literature of 
enantioselective oxidative phenol coupling. Our research group has been studying 
asymmetric phenol coupling for years. Scott Allen (in collaboration with Dr. Sangeeta 
	   30	  
Dey) developed an asymmetric and regioselective method for oxidative phenol 
employing the bimetallic vanadium catalyst V2 made from R-BINOL and L-tert-leucine 
with oxygen as the terminal oxidant obtaining up to 100% conversion and 77% ee of 
ortho-ortho coupled biphenols (V1 and V2, Scheme 1.2.2.1.0).51  Recently, Young Lee 
developed a new monomeric vanadium catalyst (V3) that enhanced the reactivity and 
enantioselectivity for the phenol coupling reactions (Scheme 1.2.2.1.0).52 
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51	  Allen, S. E. “Part I: The Confluence of Steric and Electronic Effects in N-heterocyclic Carbene-
Catalyzed Processes. Part II: Studies Toward the Asymmetric Oxidative Coupling of Phenols” Ph.D. 
Dissertation, University of Pennsylvania, Philadelphia, PA, 2013. 
52 Torruellas, C.; Lee, Y.; Kozlowski, M. C. unpublished results. 
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 Previous studies on the enantioselective phenol coupling revealed that a free phenol 
ortho to the C-C coupling site is essential.51 Also, it is necessary to have an alkyl group 
ortho to the phenol in order to get high enantioselectivities.  Scheme 1.2.2.1.1shows the 
oxidative phenol coupling of 2,3,5-trimethylphenol.  The ortho-ortho coupling product 
was obtained in up to 77% ee while the para-para coupling product was racemic.  
 
Scheme 1.2.2.1.1Asymmetric Phenol Coupling 
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 The proposed catalytic cycle for phenol coupling (using bimetallic and 
monometallic vanadium catalysts) is shown in Figure 1.2.2.1.0. First, the phenol 
coordinates to a vanadium complex and becomes oxidized to phenoxide B via simple 
electron transfer.  The produced radical can give two possible products (ortho–ortho and 
para-para), but our studies have shown that the ortho-ortho product is favored in C. The 
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produced dimer dissociates and rearomatizes to yield the corresponding biphenol. Finally, 
oxygen reoxidizes the vanadium catalyst. 
 
Figure 1.2.2.1.0 Proposed Mechanism for Asymmetric Phenol Coupling 
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1.2.2.1.1  Synthesis of Coupling Substrates 
Asymmetric oxidative phenol coupling is a key step in the synthesis of chaetoglobin 
A, since it provides the C5-C5’ axial stereochemistry. In order to identify a highly 
selective phenolic substrate that could serve as a precursor to chaetoglobin, several 
phenolic substrates (Figure 1.2.2.1.1.0) were designed based on the following pre-
requisites; (1) A free phenol ortho to the C-C coupling site is essential to obtain 
enantioselectivity and (2) electron-widrowing substituents prevent the oxidative coupling.  
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Substrate 8 posses a masked aldehyde in the form of an acetal, and only one phenol ortho 
to the desired C-C coupling site.  Substrates 5 and 10 through 13 provide two C-C 
coupling sites with only one possible dimeric product. 
 
Figure 1.2.2.1.1.0 Proposed phenol coupling substrates 
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A highly functionalized arybromide is required as an intermediate in the synthesis 
of chaetoglobin A.  Initially, test phenols 8 and 9 (Scheme 1.2.2.1.1.0) were synthesized 
from the commercially available 2,6-methoxytoluene (14).  Substrate 9 had not been 
reported in the literature; however, Diederich and co-workers reported the synthesis of 
the corresponding diphenol 10 in a 94% yield.53  
Bromination of 14 successfully produced 15 in 95 % yield.  The next step 
involved a “benzyne-type” reaction, in which arylbromide 15 was converted in a para-
substituted aniline 16 (Scheme 1.2.2.1.1.0).  Potassium was used instead of sodium based 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
53 Weyermann, P.; Gisselbrecht, J. P.; Boudon, C.; Diederich, F.; Gross, M. “Dendritic Iron Porphyrins 
with Tethered Axial Ligands: New Model Compounds for Cytochromes” Angew. Chem. Int. Ed. 1999, 38, 
3215–3219. 
	   34	  
on previous experiments published by Roth et al. in which produced 16 in up 80% yield 
(60% higher than sodium).54 However, our efforts to produce 16 through aromatic 
nucleophilic substitution to a benzyne were not successful even with new iron nitrate and 
larger amounts of liquid ammonia; only starting material (15) was recovered. Due the 
difficulties encountered in this reaction and the undesirable conditions for large-scale use, 
we turned our attention to alternative precursors 19 and 21 (Scheme 1.2.2.1.1.1).  
 
Scheme 1.2.2.1.1.0 Proposed synthesis of 5-bromo-3-methoxy-2-methylphenol 
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Initially, the route to compound 19 in Scheme 1.2.2.1.1.1 was undertake.  The 
three-step sequence involves a Vismeier-Haack formylation, 55  protection of the 
aldehyde56 and ortho-directed bromination.43  Formylation of 2,6-methoxytoluene 14 
produced 17 in a 55% yield.  Aldehyde 15 was protected as the ketal 18 in 90% yield.  A 
directed ortho-lithiation of the ketal 18 was attempted, followed by bromination with 
dibromotetrachloroethane; however, this attempt failed. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
54 Roth, B.; Aig, E.;.Rauckman, B. S.; Strelitz J,. Z.; Phillips, A. P. “2,4-Diamino-5-benzylpyrimidinesand 
Analogues as Antibacterial Agents. 5.3’,5’-Dimethoxy-4’-substituted-benzAylnalogues of Trimethoprim” 
J. Med. Chem. 1981, 24, 933–941. 
55 Wu, Y. C.; Zhu, J.  “Asymmetric Total Syntheses of (−)-Renieramycin M and G and (−)-Jorumycin 
Using Aziridine as a Lynchpin” Org. Lett. 2009, 11, 5558–5561. 
56 Meng, C. Q.; Ni, L.; Worsencroft, K. J.; Ye, Z.; Weingarten, D.; Simpson, J. E.; Skudlarek, J. W.; 
Marino, E. M.; Suen, K. L.; Kunsch, C.; Souder, A.; Howard, R. B.; Sundell, C. L.; Wasserman, M. A.; 
Sikorski, J. A. “Carboxylated, Heteroaryl-Substituted Chalcones as Inhibitors of Vascular Cell Adhesion 
Molecule-1 Expression for Use in Chronic Inflammatory Diseases” J. Med. Chem. 2007, 50, 1304–1315. 
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Finally, aldehyde 17 was protected as the aminal (20). At first, directed ortho-
litiation/bromination produced a mixture of brominated and chlorinated product 
(identified by GC-MS). In order to solve this problem, slow addition of the 
dibromotetrachloroethane solution over one hour was necessary. As a result, directed 
ortho-lithiation/bromination successfully produced aryl bromide 21 in 99% yield.37,44,57 
 
Scheme 1.2.2.1.1.1 Proposed synthesis of brominated ketal 
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  To obtain the requisite target 22, required selective deprotection of the less 
hindered methoxy group. Several conditions where screened (Table 1.2.2.1.1.0). BBr3 
and BCl3 both provided the undesired regioisomer 23, which was secured by an HMBC 
experiment.  This regioisomer was favored because BBr3 and BCl3 Lewis acids that to the 
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nitrogen of the aminal and deprotect the neighboring methyl ether.  Phenylthioate 
provided the desired product, but with poor yield and the formation of byproducts.58 A 
less nucleophilic reagent, phenylselenide, did not show any reactivity.59 
 
Table 1.2.2.1.1.0 Selective methyl ether deprotection 
Me
MeO
OMe
Br
N
N
Me
Me
Me
HO
CHO
OMe
Br
2320
Me
MeO
OH
Br
22
or
Reaction 
Conditions
Product
23a
23a
22
BBr3 , CH2Cl2 
 –75 – 25 °C, 24 h
Entry % yield
20 
25
7
BCl3 , CH2Cl2 
–75 – 25 °C, 24 h
PhSH, K2CO3, NMP
190 °C, 30 min
CHOConditions
1
2
3
     a Product 22 was identified using HMBC.
PhSeH (1 equiv)
THF-HMPA, 70 ºC 21 h4 - -
 
 
Prior investigations have also show that C-C coupling of substrates with two free 
phenols can be accomplished with high regio- and enantioselectivity.  Scheme 1.2.2.1.1.2 
shows the oxidative phenol coupling of 2,5-dimethylbenzene-1,3-diol to afford the ortho-
ortho coupling product in a 47% yield and 79% ee.  Since the selective deprotection was 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
58 Nayak, M.; Chakraborti, A. K. “Chemoselective Aryl Alkyl Ether Cleavage by Thiophenolate Anion 
Through its in situ Gen” Tetrahedron Lett. 1997, 38, 8749-9752 
59 Sharpless, K. B.; Lauer, R. F.  “Mild Procedure for the Conversion of Epoxides to Allylic Alcohols. First 
Organoselenium Reagent” J. Am. Chem. Soc. 1973, 95, 2697–2699. 
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unsuccessful, both methyl ethers were deprotected to obtain compound 24 in a 28% yield 
(Scheme 1.2.2.1.1.3).  
 
Scheme 1.2.2.1.1.2 Enantioselective Phenol Coupling of 2,5-Dimethylbenzene-1,3-diol 
OH
HO Me
OH
HO Me
HO Me
OH
5 mol% cat. V2
AcOH (6.7 equiv) 
O2,  ClCH2CH2Cl rt
+
47% yield
79% ee
Me
Me
OH
Me
Me OH
Me OH
Me
OH
Me
OH
Me
HO
Me
 
 
Scheme 1.2.2.1.1.3  Methyl Ether Deprotection  
Me
MeO
OMe
Br
N
N
Me
Me
21
BBr3, 
CH2Cl2, –75  to 25 °C , 
24 h
28%
Me
HO
CHO
OH
Br
24  
 
An aldehyde in the phenol would slow down or halt the oxidative coupling 
reaction, so is necessary to protect the aldehyde.  Three different reaction conditions were 
screened (Table 1.2.2.1.1.1).43,56,60 Unfortunately, each produced partial debromination 
of the substrate.  
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
60 Togashi, M.; Ozawa, S.; Abe, S.; Nishimura, T.; Tsuruga, M.; Ando, K.; Tamura, G.; Kuwahara, S; 
Ubukate, M.; Magae J. “Ascochlorin Derivarives as Ligands for Nuclear Hormone Receptors” J. Med. 
Chem. 2003, 45, 4113–4123. 
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Table 1.2.2.1.1.1. Aldehyde Protection 
Me
HO
CHO
OH
Br
24
Me
HO
OH
Br
25
O
O
Reaction Conditions Product
-
-
decomp.
Ethyene glycol, 
PTSA, benzene reflux
Entry % yield
-
-
-
TMSOTf, 3Å MS, –30 ºC, 40 h
1
2
3
Ethyene glycol (10 equiv) 
PPTS, Benzene, reflux
OTMSTMSO
Reaction Conditions
 
 
After several unsuccessful attempts to protect the aldehyde substituent as a ketal, 
aminal 27 was synthesized. The synthesis of compound 27 involves deprotection of the 
methylethers to form 24 followed by reinstallation of the aminal (Scheme 1.2.2.1.1.4).43  
In 2011, Hartwig published a method that allowed an expeditious synthesis of 
compounds 10 and 9. Phenol 9 was generated via a three steps sequence by the 
combination of selective borylation using a sterically hindered iridium catalyst, followed 
by bromination of 28. 61  Subsequent mono-deprotection yielded aryl bromide 9.  
Compound 10 was prepared following the same procedure, but applying 4 equiv of BBr3. 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
61 Liao, X.; Stanley, L. M.; Hartwig, J. F. “Enantioselective Total Syntheses of (-)-Taiwaniaquinone H and 
(-)-Taiwaniaquinol B by Iridium-Catalyzed Borylation and Palladium-Catalyzed Asymmetric R-Arylation” 
J. Am. Chem. Soc. 2011, 133, 2088–2091. 
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Scheme 1.2.2.1.1.4 Synthesis of Coupling Substrates 
Me
OMe
OMeN
N
 BBr3 (4 equiv)
    CH2Cl2, 24 h, rt.
  64% overall yield
Me
OH
OHN
N
Br
21 27
Toluene 110 ºC
97%
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24
N
H
H
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Me
OMe
OMe
Br
Me
OMe
OMe
Me
OR
OH
Br
BBr3 (x equiv) 
CH2Cl2, 24 h, rt.
Me
OMe
OMe
Bpin
B2pin2 (0.85 equiv)
[Ir(COD)(OMe)]2
(0.25 mol %)
tBu-bipy
(0.50 mol %)
THF, 80 ºC
CuBr2 (3.0 equiv)
H2O:MeOH (1:1)
80 ºC
80% two steps, 
one pot14 28 6
       R= H   10  (>99%)    X= 1 
       R= Me 9   (93%)      X= 2  
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1.2.2.1.2  Preparation of Alkyne 5 
 
Scheme 1.2.2.1.2.0 
Me
OMe
OMe
Br
Pd(PPh3)2Cl2 (10 mol%)
CuI (10 mol%),
 Et3N, DMF
49%
OMe
Me
OMe 1-methyl-cyclohexene
BBr3(3 equiv), K2CO3
CH2Cl2, –78 ºC–25 ºC, 7 h
73%
OH
Me
OH
17 29
5  
Also, a model diphenol with an achiral alkynyl chain (5) was prepared through a 
Sonogoshira cross-coupling of arylbromide 17 with octyne followed by deprotection of 
the methyl ethers (Scheme 1.2.2.1.1.0).62 Originally, the aryl alkyne 5 had impurities 
possibly from bromine produced in the reaction. The compound was successfully purified 
through column chromatography.  However, the Sonogashira cross-coupling of 
arylbromide 17 yielded the alkyne in only 49% yield and notable decomposition (Entry 
1, Table 1.2.2.1.2.0). The temperature was decreased to room temperature, minimizing 
decomposition and providing 29 in up to 91% yield (Entry 2). In addition,  different 
solvents, bases and palladium catalysts were tested (Entries 3-5), but no increases in the 
yields were observed. The dihydroxy arylbromide 10 was also tested with two different 
palladium catalysts to afford the desired alkyne 5 with a low conversion. No 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
62 Busch-Petersen, J.; Hill, W. A.; Fan, P.; Khanolkar, A.; Xie, X. Q.; Tius, M. A.; Makriyannis, A. 
“Unsaturated Side Chain β-11-Hydroxyhexahydrocannabinol Analogs” J. Med. Chem. 1996, 39, 3790–
3796. 
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decomposition was observed for the Sonogashira cross-coupling of the dihydroxy aryl 
bromide 10, however the Rf values for both product and starting material were very 
similar and they were impossible to separate through TLC or column chromatography.   
 
Table 1.2.2.1.2.0 Sonogashira cross-coupling 
Me
OR
OR
Br OR
Me
OR
[Pd], CuI 
Base, Solvent
6    R = Me
10  R = H
29    R = Me
5  R = H  
7 6
Catalyst
10 mol%
10 mol%
10 mol%
10 mol%
3 mol%
3 mol%
10 mol%
Yield (%)a
a 1H NMR yield based on produced alkyne, determined using  anthracene as internal standard. b Isolated by column 
chromatography. c 1 H NMR conversion based on recovered starting material
Me
Me
Me
Me
Me
H
H
49b
91b
68
63
49b
0
42c
Pd(PPh3)2Cl2
Pd(PPh3)2Cl2
Pd(PPh3)2Cl2
Pd(PPh3)2Cl2
Pd(PhCN)2Cl2
[HP(tBu)3]BF4
Pd(PhCN)2Cl2
[HP(tBu)3]BF4
Pd(PPh3)2Cl2
Solvent Temperature Time
70 ºC
rt
rt
rt
rt
50 ºC
70 ºC
1 h
31 h
24 h
24 h
3 d
24 h
6 h
Entry
1
2
3
4
5
6
7
R BaseCat. Loading
Et3N
Et3N
Et3N
i-PrNH2
i-PrNH2
i-PrNH2
Et3N
DMF
DMF
THF
DMF
THF
THF
DMF
 
 
The next step for the synthesis of the alkynyl model system is  deprotection of the 
methyl ethers. First the methyl ethers were removed using BBr3 in CH2Cl2 at room 
temperature with 1-methylcyclohexene to trap bromine and a base to neutralize hydro 
bromic acid present in the BBr3 solution (Scheme 1.2.2.1.2.1).62 Unfortunately, yields for 
5 were irreproducible (23–77% yield). Low yields and decomposition possibly occur 
because the alkynyl functional group in 29 is unstable to these reaction conditions. Thus, 
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a second method was examined for the deprotection of the methyl ethers. This method 
consists in the use of TMSI as a Lewis acid, which coordinates to the methyl ethers with 
the iodine attacking and displacing the methyl groups to produce the corresponding TMS 
protected arylalkyne, which is subsequently hydrolized to yield the desired aryl alkyne 
5.63 Unfortunately, this strategy failed and only starting material was recovered.  
 
Scheme 1.2.2.1.2.1 Methyl ether deprotection 
OH
Me
OH
OMe
Me
OMe
1-methyl-cyclohexene
BBr3 (3 equiv), K2CO3
CH2Cl2, –78 ºC–0 ºC, 1.5 h
23%–77%
OH
Me
OH
OMe
Me
OMe
1. TMSI, CDCl3
2. p-TsOH 
CH2Cl2, MeOH
1. TMSI, CDCl3
2. TBAF, THF
29 5
29 5
 
 
At this point, we decided to re-optimize the Sonogashira cross-coupling of aryl 
bromide 10 without the phenol protecting group (Table 1.2.2.1.2.1). Initially, alkyne 5 
was generate with 42% conversion in 6 h. The effect of the solvent was investigated in 
Entries 2 and 3, however, DMF remained the best solvent for the reaction. A base 
screening was carried out in entries 4–7, including primary, secondary, tertiary and 
cyclic amines. Diethylamine gave a conversion of 77% and 66% yield (Entry 7), 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
63 Mitsui, C.; Tanaka, H.; Tsuji, H.; Nakamura, E. “Bis(carbazolyl)benzodifuran has a High Triplet Energy 
Level for Application in Blue Phosphorescent OLED” Chem. A. J. 2011, 6, 2296–2300. 
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however, the reaction did not get to full completion, and the starting material and the 
product could not be separated through conventional purification methods. 
 
Table 1.2.2.1.2.1 Sonogashira crosscoupling of dihydroxyarylbromide 10 
Me
OH
OH
Br OH
Me
OH
PdCl2(PPh3)2, CuI 
Base, Solvent
60 ºC, 18–21 h 510  
10 mol%
10 mol%
10 mol%
20 mol%
20 mol%
20 mol%
20 mol%
Yield (%)c
aThe reaction was run fo 6 h.b 1H NMR conversion based on recovered starting material c 
1H NMR yield based on produced compound 5, determined using  anthracene as internal 
standard.
-
11
27
45
36
52
66
Solvent Conversion (%)b
42
45
55
59
52
58
77
Entry
1a
2
3
4
5
6
7
BaseCat. Loading
Et3N
Et3N
Et3N
i-PrNH2
i-Pr2EtN
Pyrrolidine
Et2NH
DMF
THF
DMF
DMF
DMF
DMF
DMF
 
 
A palladium catalyst screening was also conducted to identify a catalyst that 
would provide complete conversion to the product. With 10 palladium catalysts chosen 
from Sonogashira cross-coupling literature (Table 1.2.2.1.2.2), none afforded complete 
conversion.  
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Table 1.2.2.1.2.2 Palladium catalyst screening 
Me
OH
OH
Br OH
Me
OH
PdCl2(PPh3)2, CuI 
Base, Solvent
60 ºC, 18–21 h 510  
Catalyst
a H NMR conversion based on recovered starting material  
b 1H NMR yield based on produced compound 5, determined 
using  anthracene as internal standard.
Pd(PPh3)2Cl2
Pd(dba)2
PdCl4Na2
Pd(PPh3)4
PdCl2
PdCl2 (COD)
PdCl2(P(o-tolyl)3) 
PdCl2(dppf)
Pd(OAc)2
PdCl2(dppe)
Conversion (%)a
54
0
0
47
0
0
57, 49b 
47
0
0
Entry
1
2
3
4
5
6
7
8
9
10
 
 
Hypothesizing that oxidative addition of the aryl bromide was problematic. Aryl 
iodide 30 was prepared in a 49% yield through a sterically hindred borylation followed 
by direct iodonation in one pot (Scheme 1.2.2.1.2.2)64 using copper iodide and potassium 
iodide under air. A second iodination method using N,N’-dimethylethylenediamine was 
tested, but resulted in even lower conversion. The most efficient process to generate 31 
for the Sonagashira cross-coupling was a longer 3-step sequence via bromide 6 from 
commercially available substrate 14 (Scheme 1.2.2.1.2.2).65 Gratifyingly, Sonogashira 
cross-coupling with the aryl iodide 31 afforded the desired product 5 with full conversion 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
64 Partridge, B. M.; Hartwig, J. F. “Sterically Controlled Iodination of Arenes via Iridium-Catalyzed C–H 
Borylation” Org. Lett., 2013, 15, 140–143. 
65 Jian, H.; Tour, J. M. “Preparatice Fluorous Mixture Synthesis of Diazonium-Functionalized 
Oliglo(pheylene vinylene)s” J. Org. Chem. 2005, 70, 3396–3424. 
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and 88% yield (Scheme 1.2.2.1.2.3). In total, four phenolic substrates were successfully 
synthesized to be applied to asymmetric oxidative phenol coupling (Figure 1.2.2.1.2.0). 
 
Scheme 1.2.2.1.2.2 Synthesis aryl iodide 31. 
Me
OMe
OMe
I
Me
OMe
OMe
Me
OMe
OMe
PinB
B2pin2 = bis(pinacolato)diboron
dtbpy = 4,4'-di-tert-butylbipyridine
B2pin2 (0.85 equiv)
[Ir(COD)(OMe)]2
(0.25 mol%)
tBu-bipy
(0.50 mol %)
THF, 80 ºC
CuI, KI
phen
MeOH:H2O
air 1 h14 28 31
 
Me
OMe
OMe
I
Me
OMe
OMe
PinB
28 30
N
H
H
N
 CuI, NaI
    Dioxane
Me
OMe
OMe
Br
Me
OH
OH
I
N
H
H
N
1. CuI, NaI
    Dioxane, 95% 
2. BBr3, DCM, 
–78 ºC – rt, 24 h,  90%
6 31  
 
Scheme 1.2.2.1.2.3 Synthesis of alkynyl model system thought aryl iodide 31 
OH
Me
OH
88%
Pd(PPh3)2Cl2
CuI, Et2NH
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I
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Figure 1.2.2.1.2.0 Phenol coupling substrates. 
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1.2.2.1.3  Synthesis of Vanadium Catalysts 
Three catalysts were synthesized for the oxidative phenol coupling of the 
substrates prepared in the previous section (Scheme 1.2.2.1.3.0).66,67 First, the binaphthol 
scaffolds was synthesized starting from commercially available BINOL 32. 
Hydrogenation afforded H8-BINOL (33). 68  Protection of the hydroxyl groups with 
MOMCl afforded biaryl 34. 69 , 70  Directed lithiation followed by formylation using 
dimethyl formamide provided the corresponding dialdehyde 35, which was then 
deprotected to yield compound 36.   Condensation of 36 with (L)-tert-leucine, followed 
by addition of VO(OEt)3 provided bimetallic vanadium catalysts V1 and V2, 
respectively. 
Monomeric vanadium catalyst V3 and V4 were synthesized in 3-4 steps. The nitro 
substituded aldehyde was synthesized from the commercially available tert-butylphenol 
37. Formylation of 37 afforded benzaldehyde 38 in up to 33% yield.66 The nitro group 
was incorporated through an electrophilic aromatic substitution with HNO3 to afford 
aldehyde 39.67 Condensation of benzaldehyde 39 with (L)-tert-leucine and rac-
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
66 Gisch, N.; Balzarini, J.; Meier C. “Enzymatically Activated cycloSal-d4T-monophosphates:   The Third 
Generation of cycloSal-Pronucleotides” J. Med. Chem. 2007, 50, 1658–1667. 
67 Chen, C. T.; Kao, J. Q.; Salunke, S. B.; Lin, Y. H. “Enantioselective Aerobic Oxidation of α-Hydroxy-
Ketones Catalyzed by Oxidovanadium(V) Methoxides Bearing Chiral, N-Salicylidene-tert-
butylglycinates”Org. Lett. 2011, 13, 26–29. 
68	  Ouyang, X.; Chen, Z.; Liu, X.; Yang,  Y.; Deng, M.; Weng, Y.; Zhou, Y.; Yu, J. “One-dimensional (1D) 
Helical and 2D Homochiral Metal-Organic Frameworks Built from a New Chiral Octahydrobinaphthalene-
Derived Dicarboxylic Acid” Inorg. Chem. Commun. 2008, 11, 948–950.	  
69	  Li, H.; Da, C.; Xiao, Y.; Li, X.; Su, Y. “Direct Asymmetric Aldol Reaction of Aryl Ketones with Aryl 
Aldehydes Catalyzed by Chiral BINOL-derived Zincate Catalyst ” J. Org. Chem., 2008, 73 , 7398–7401	  
70	  Belokon, Y. N.; Chusov, D. A.; Skupskaya, D.; Bor’kin, D. A.; Yashkina, L. V; Lyssenko ,K. A.; Il’in, 
M. M.; Timofeeva G. I.,  Peregudov, A. S.; North, M. “Synthesis of chiral polydentate ligands and the use 
of their titanium complexes as pre-catalysts for the asymmetric trimethylsilylcyanation of benzaldehyde ” 
Russ. Chem. Bull. 2008, 7, 1981—1988.	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phenylalanine respectively, followed by addition of VO(OEt)3 provided bimetallic 
vanadium catalysts V3 and V4. 
Scheme 1.2.2.1.3.0 Synthesis of Vanadium Catalyst 
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1.2.2.1.4  Optimization of Asymmetric Phenol Coupling 
Oxidative phenol coupling of four substrates (Figure 1.2.2.1.2.0) was carried out 
using the three vanadium synthesized catalysts (Table 1.2.2.1.4.0). The aim of this 
experiment was to access reactivity and enantioselectivity of the substrates. First, the 
phenol coupling of compound 27 was attempted using VO(acac)2 (Table 1.2.2.1.4.0). 
Unfortunately, the aminal hydrolyzes during the reaction producing the respective 
aldehyde. This aldehyde was unreactive because electron-withdrowing groups in the 
phenol destabilize the radical intermediate that lead to the coupling product (Figure 
1.2.2.1.0).  
Bromo-3-methoxy-2-methylphenol (9) exhibited low reactivity and 
enantioselectivity. Diphenol 10 was slightly more reactive and yielded the desired biaryl 
in up to 75% ee by employing catalyst V2. However, with alkyne 5, the corresponding 
biaryl was obtained in up to 89% ee with catalyst V3 (Table 1.2.2.1.4.0).  
Catalyst V4 was used for the preparation of racemic dimer for assay purposes. This 
catalyst showed a similar reactivity  relative to catalyst V3 (Scheme 1.2.2.1.4.0). 
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Table 1.2.2.1.4.0 Oxidative Phenol Coupling  
 catalyst
 AcOH (6.25 equiv), O2
Solvent
OH
R OH
R
OH
R
1
2
3
4
5
6
 
Substrate Catalyst
100 mol% VO(acac)2
20 mol% V1
20 mol% V2
40 mol% V3
20 mol% V1
20 mol% V2
40 mol% V3
20 mol% V2
40 mol% V3
Conversion(%)a Yield (%)b ee(%)c
Me
OH
OMe
Br
Me
OH
OH
Br
OH
Me
OH
Me
OH
OHN
N
Br
5
0
-
-
12
9
-
24
20
76
59
62–67
-
-
-
-
-
28
-
-
-
-
33
-
25
38
47
44
71–75
20
27
40
58
86–89
Solvent Temperature Time
DCE
DCE
DCE
Toluene
DCE
DCE
Toluene
DCE
DCE
DCE
Toluene
25–40 ºC
rt
rt
0 ºC
rt
rt
0 ºC
0 ºC
rt
rt
0 ºC
5 d
24 h
24 h
overnight
24 h
24 h
15 h
2 d
2 d
26 h
15 h
Entry
1
2
3
4
8
9
10
5
a H NMR conversion based on recovered starting material  b  Isolated by column chromatography. c HPLC  
 
Scheme 1.2.2.1.4.0 Oxidative Phenol Coupling Using Catalyst V4 
Me
OH
OH
OH
Me
OH
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Me
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   40 mol% cat. V4
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Table 1.2.2.1.4.1 Optimization of Oxidative phenol Coupling of Alkynyl Phenol 5 
 
Me
OH
OH
OH
Me
OH
OH
Me
OH
Additive,  O2,
Toluene
405
V3
O2N
t-Bu
N
O
t-Bu
O
O
V
EtO O
 
Concentration Yield (%)b
AcOH
AcOH
LiCl
LiCl
LiCl
LiCl
33
50, 52c
62
67
72–99c,d
66–91c,d
0.5 M
0.5 M
0.5 M
0.5 M
0.2 M
0.2 M
Temperature Time
0 ºC
0 ºC
0 ºC
–25 ºC
0 ºC
0 ºC
15 h
15 h
3.5 h
1.5 h
3.5 h
10 h
Entry
1
2
3
4
5
6
Additive ee (%)e
86–89
73
82
66
70–80
74
Cat. loading
40 mol %
40 mol %
40 mol %
40 mol %
40 mol %
20 mol %
Conversion (%)a
62-67b
82
100
93
80
89
a 1H NMR conversion based on recovered starting material.  b 1H NMR yield based on produced dimer, determined using an internal 
standard c Isolated by column chromatography. d Based on recovered starting material. e HPLC  
 
Oxidative phenol coupling of diphenol 5 was further optimized. Originally, Young-
Eun Lee coupled alkyne 5 to generate biaryl 40 in 33% yield and 89% ee (Entry 1, Table 
1.2.2.1.4.1). In a second trial, I found improved yields (52%) using the same reaction 
conditions (Entry 2). Using lithium chloride as an additive enhanced the reactivity, 
producing full conversion in 3.5 h (Entry 3). Surprisingly, reactions at lower 
temperatures produced biaryl 40 with lower ee (Entries 4). Decomposition of both the 
product and starting material was noted during the course of the reaction.  When lithium 
chloride is used with a concentration of 0.2 M this decomposition is highly reduced to 
produce 40 and up to 99% yield and 80% ee (Entry 5). Further optimization of this 
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process in a larger scale by modulating reaction time and catalyst loading yielded up to 
91% yield and 74% ee (Entry 6). Even at this stage (74–80% ee), trituration can provide 
>99% ee material for the completion of the proposed route.71 
 
1.2.2.1.5  Studies Towards the Phenol Coupling Trimeric Product 
Oxidative phenol coupling of alkynyl diphenol 5 using acetic acid as additive 
showed 67% conversion of the substrate, but only 33% yield of dimer 40. The HPLC 
analysis showed two peaks between the peaks corresponding to the enantiomers of 40.  
These peaks were separated through prep-TLC and analyzed by 1H NMR, 13C NMR and 
HRMS, which indicated a trimer. Efforts toward the selective production of this trimer 
were unsuccessful. 
Scheme 1.2.2.1.5.0 
Me
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OH
Me
OH
OH
Me
OH
40 mol %
AcOH (6.25 equiv),  O2, 
overnight, Toluene(0.2 M) 5 ºC
+
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HO
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71 Podlesny, E. E.; Kozlowski, M. C.  “Enantioselective Total Synthesis of (S)-Bisoranjidiol, an Axially 
Chiral Bisanthraquinone” Org. Lett., 2012, 14, 1408–1411. 
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1.2.2.2 Vilsmeier-Haack Formylation 
The next step in the synthesis of chaetoglobin A is a Vilsmeier-Haack formylation 
of alkynyl biaryl 40.  First, three monomeric alkynes were screened, using N,N-
dimethylformamide as solvent. (Table 1.2.2.2.0, Entries 1-3).55 From these three 
alkynes, diphenol alkyne 5 gave the respective benzaldehyde with a 74% conversion and 
24% yield (Entry 1). The formylation reactions were run for 18 h  (Entries 4 and 5) 
yielding up 96% conversion and 77% yield (Entry 7).  The reaction was further 
optimized using dichloroethane as solvent and 10h for reaction time, to obtain to 87% 
yield (Entry 6). 
The dimeric diphenol 40 was formylated using the original reaction conditions 
(DMF as solvent), however, the dimer is unstable under these conditions (Entry 7). With 
DCE, dimeric phenol 40 was found to have higher reactivity than monomer with 
complete consumption of the substrate in 1 h provide the product in 60% NMR yield 
(Entry 8). 
Further solvent screening (Entries 9-12) revealed that dichloromethane provided 
the dimeric benzaldehyde 3a in 58% isolated yield.  This reaction was further optimized 
by decreasing the temperature to 0 ºC to afford 3a with up to 80% yield (Entry 13). 
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Table 1.2.2.2.0  Vilsmeier-Haack Formylation  
 
POCl3, DMF
 25 ºC OR2
Me
OR1
OHC
OR2
Me
OR1
5      R1 =  R2 = H
41    R1 = Me  R1 = H
29    R1 =  R1 = Me
40    R1 = R1 = H (dimer)
42a   R1 =  R2 = H
42b   R1 = Me  R1 = H
42c   R1 =  R1 = Me
3a     R1 = R1 = H (dimer)  
Entry R1 R2 Solvent Time (h) Conversion(%)b
1
2
3a
4
5
6
7
8
9
10
11
12
13
H
Me
Me
H
H
H
H (dimer)
H (dimer)
H (dimer)
H (dimer)
H (dimer)
H (dimer)
H (dimer)
H
H
Me
H
H
H
H
H
H
H
H
H
H
DMF
DMF
DMF
DCE
Toluene
DCE
DMF
DCE
Toluene
CH3CN
THF
CH2Cl2
CH2Cl2
10
10
10
18
18
10
1
1
1
1
1
1
1
 a The reaction was heated to 110 ºC. b a H NMR conversion based on recovered starting material  
 c Isolated by column chromatography. d 1H NMR yield based on produced aldehyde, determined using  an internal 
standard.eThe reaction was run at 0 ºC.
74
49
0
96
94
96
decomp
100
100
100
100
100
100
24
27
-
77
66
87
0
60d
41d
29d
27d
58
80e
Yield (%)cSubstrate
5
41
29
5
5
5
40
40
40
40
40
40
40
 
 
 
 
 
 
 
	   55	  
1.2.2.3 Diasteroselective Oxidative Dearomatization 
With the chiral biaryl in hand, the next step in the synthesis is oxidative 
dearomatization of model system 3a (n=2, R=H) to give the corresponding azaphilone 
dimer 43a (Scheme 1.2.2.3.0). We propose the use of achiral oxidant to afford oxidative 
dearomatization of dimer 3a in a diasteroselective manner. Diastereoselective oxidative 
dearomatization based on the chiral axis at 3a is proposed to control the stereochemical 
outcome. Figure 1.2.2.3.0 presents a 3D structure of benzaldehyde 3a, which shows that 
the alkyl chain could hinder the top face of the aryl, preventing the attack to that face of 
the molecule.  
 
Scheme 1.2.2.3.0.  Oxidative Dearomatization of Dimeric  Alkynyl Benzaldehyde Using 
Cu2O2L2 Catalyst 
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O
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3a 43a  
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Figure 1.2.2.3.0 Diasteroselective Oxidative Dearomatization 
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A series of oxidative methods were evaluated in this transformation. Oxidative 
dearomatization involving a gold-catayzed cyclization followed by IBX was reported in 
2004 by Porco, yielding azaphilone monomers in high yields (see Scheme 1.1.2.2).37,38 
Somoza and co-workers, reported an alternative acid-cataylzed cyclization followed by 
oxidation using lead(IV) acetate to yield the corresponding azaphilone acetate (Scheme 
1.2.2.3.1).72 The first step of this reaction involves heating the benzaldehyde in acetic 
acid, which may contribute to the low yield reported. To avoid that problem, cyclization 
at low temperature using gold (III) acetate as a Lewis acid was proposed followed by 
oxidation with lead (IV) acetate to afford the acetated azaphilone. 
 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
72	  Somoza, A. D.; Lee, K. H.; Chiang, Y. M.; Oakley, B. R.; Wang, C.’ “ Reengineering an Azaphilone 
Biosynthesis Pathway in Aspergilliusnidulans to Create Lopixygenase Inhibitor” Org. Lett. 2012, 14,972–
975.	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Scheme 1.2.2.3.1  Acid-Catalyzed Oxidative Dearomatization 
1. p–TsOH, AcOH
95 – 100 ºC
2. Pb(OAc)4, 18 ºC, 1 h
30%
O
Me
O
O
O
OH
Me
OH
OHC
O
44 45  
 
Initial studies were undertaken using the corresponding monomeric benzaldehyde 
(Table 1.2.2.3.1). Initially, the azaphilones were produced in low yield accompanied by 
decomposition (Entries 2, 4, 6). Lower temperatures did not prevent the decomposition 
(Entries 1 and 5). 
1H NMR monitoring of the gold-catalyzed cyclization step showed full 
conversion.to the corresponding ionic intermediate. This suggests that decomposition is 
occurring in the oxidation step.  Synthesizing fresh IBX73 and purchasing new Pd(OAc)4 
did not improve the yield.  Finally, addition of a second equivalent of oxidant provided 
each product in 95% and 55% respectively (Entries 3 and 7). 
 
 
 
 
 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
73 Frigerio, M.; Santagostino, M.; Sputore, S., “A User-Friendly Entry to 2-Iodoxybenzoic Acid (IBX)” J. 
Org. Chem. 1999, 64, 4537–4538. 
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Table 1.2.2.3.1. Cyclization-Oxidation Reactions 
Conditions
O
Me
O
O
OR
OH
Me
OH
OHC
42a 46a  R = H
46b  R = Ac  
Conditions Yield (%)b
a 1H NMR conversion based on recovered starting material.  b 1H NMR yield based on produced 
azaphilone, determined using an internal standard. c Isolated by column chromatography. 
 d 2 equiv of oxidant added to the reaction
H
Ac
Ac
15
23c
90d
-
16
26c
56d
Au(OAc)3, TFA
IBX, Bu4NI, DCE 
1. p–TsOH, AcOH
100 ºC, 1 h 
2.  Pb(OAc)4, rt 
Au(OAc)3, TFA
Pb(OAc)4, DCE
Entry
1
2
3
4
5
6
7
R Temperature (ºC)
0
25
25
25
0
25
25
Conversion (%)a
54
67
100
decomposition
94
100
100
 
 
Oxidative dearomatization using [(–)-sparteine]2Cu2O2 complex is a well-studied 
rotocol, developed by Porco and co-workers.41 This method consists of the oxidation of 
the benzyldehyde to the meta- quinone follow by a buffer-catalyzed cyclization. Initially, 
we attempted oxidative dearomatization of monomeric benzaldehyde using inexpensive 
tetraethylethenediamine (Table 1.2.2.3.1). When the temperature was increased to 0 ºC, 
the reaction yielded intermediate I with 100% conversion, but low yield and high 
decomposition (Entry 1). Lower reaction times at –10 ºC or –20 ºC yielded intermediate 
I with higher conversion and no decomposition was observed (Entries 2-5).  
Since complex Cu2L2O2 is known to be water sensitive, molecular sieves were added, 
but was a fruitless effort to increase the conversion (Entry 6). Finally, (–)-spartiene 
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yielded intermediate I with 85% conversion (Entry 8).  This method was applied to the 
dimeric benzaldehyde 3a, which was, unfortunately, unreactive.  
 
Table 1.2.2.3.1 Oxidative Dearomatization Using Cu2L2O2 Complex 
i Pr2NEt, DMAP, O2
O
Me
O
O
OH
OH
Me
OH
OHC
42
O
Me
O
CuIII
N
N
EtEt
Et Et
O
O
CuIII
N
N
Et Et
Et Et
2PF6-
OH
OH
K2HPO4/KH2PO4
CH3CN
I
II  
Conversion I (%)a Yield I (%)b
Et diamine
Et diamine
Et diamine
Et diamine
Et diamine
Et diamine
Et diamine
Sparteine
26
-
-
-
-
-
-
45
100
58
77
61
73
43
56
86
Temperature Time (h)
0 ºC
–10 ºC
–10 ºC
–20 ºC
–20 ºC
–10 ºC
–10 ºC
–10 ºC
30
30
60
30
85
30
30
30
Entry
1
2
3
4
5
6 (4Å MS)
7
8
DiamineCu2L2O2
1.1 equiv
1.1 equiv
1.1 equiv
1.1 equiv
1.1 equiv
1.1 equiv
1.8 equiv
1.1 equiv
a 1H NMR conversion based on recovered starting material  b 1H NMR yield based on produced 
intermediate I, determined  using an internal standard  
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Scheme 1.2.2.3.2 Oxidative Dearomatization of Dimer 3a 
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O
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O
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O
O
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+
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 At this point, we decided to apply the cycloisomerization-oxidation method, 
previously explored with the monomer, to the dimer. This method successfully afforded 
dimeric azaphilone 47a in up to 80% yield (Scheme 1.2.2.3.2). Only two of the three 
possible diasteroisomer were identified (1:1 ratio), and were easily separated via column 
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chromatography. 1H NMR analysis indicated the formation of one symmetric isomer 
(SSS or RSR) and one unsymmetrical compound (SSR). An (S)-chiral axis was assigned 
as S based on previous studies on the stereochemical outcome of vanadium catalyst V3. 
Oxidative dearomatization of 3a using Pb(OAc)4 afforded  the acetylated dimeric 
azaphilone 48a with high diasteroselectivity towards the symmetric diasteroisomer, but 
low yield due decomposition. 
  From 47c, the next step in the synthesis is the acetylation hydroxyl groups. This 
acetylation was first optimized using monomer 46a, which was quickly afforded in 94% 
yield (Entry 3, Table 1.2.2.3.2).74 
 
Table 1.2.2.3.2 Acetylation of Monomer 
O
Me
O
O
OH
O
Me
O
O
OAc
46a 46b
Yield (%)a
a Isolated by column chromatography.
decomp.
decomp.
94%
Entry
1
2
3
Temperature (ºC)
25
0
0
Time (min)
40
20
10
Ac2O 
DMAP, Et3N
CH2Cl2
 
 
 The symmetric dimer of 47a was acetylated using different reaction conditions 
(Table 1.2.2.3.3). With conventional conditions (acetic anhydride and acetyl chloride) 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
74	  Lin, L.;  Mulholland N.; Wu, Q.; Beattie, D.; Huang S.; Irwon D.; Clough J.; Gu Y.; Yang G. “Synthesis 
and Antifungal Activity of Novel Sclerotiorin Analogues” J. Agric. Food Chem., 2012, 60, 4480–4491.	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no reaction was observed (Entries 1 and 2).43,38 The hydroxylic group in this molecule 
is highly hindreded. Special reaction conditions for sterically hindred groups were next 
investigated (Entry 3), with no success.75 A stronger base was used to deprotonate the 
hydroxylic group; however, only decomposition was observed (Entry 4). Finally, use of 
acetic anhydride, DMAP, and triethylamine afforded the desired acetylated azaphilone 
46b in 82% yield. 
 
Table 1.2.2.3.3 Acetylation of Dimeric Azaphilone 
OH
O
O
O
Me
O
O
O
OH
Me
OAc
O
O
O
Me
O
O
O
OAc
Me
(S,S,S)- or 
(R,S,R)-47a
(S,S,S)- or 
(R,S,R)-48a
Conditions
 
Yield (%)a
a Isolated by column chromatography.
NR
NR
NR
decompsition
NR
82
Entry
1
2
3
4
5
Reaction
Conditions
Ac2O, DMPA
CH2Cl2
AcCl, i-Pr2NEt
CH2Cl2
AcCl, AgCN
Benzene 80 ºC
AcCl, NaH
THF/DMF
Ac2O, Et3N, DMAP
CH2Cl2, 0 ºC
Time (h)
72
24
overnight
1
10 min
10 min
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
75	  Takimoto, S.; Inanaga, J.; Katsuki, T.; Yamaguchi M. “Preparation of hindered esters for acid chlorides 
and alcohols in the presence of silver cyanide” Bull. Chem. Soc. Jnp.  1976, 49, 2335–2336.	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1.2.2.4.    Amination Studies. 
 
Figure 1.2.2.4.0 Proposed Mechanism 
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The last key step in the proposed synthetic pathway is the amination of dimeric 
azaphilone 48.  Yao and coworkers studied this reaction as part of the synthesis of a 
series of chloroazaphilones and vinilogous γ-pyridone.36 To explain his results, Yao 
proposed a mechanism similar to the one shown in Figure 1.2.2.4.0, in which the oxygen 
is replaced with nitrogen by a primary amine.  The mechanism starts with a conjugate 
addition of a primary amine I to form carbinolamine II, which undergoes C-O bond 
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cleavage, to provide enamine III which exists in equiliblium with enamine IV. A 
subsequent proton transfer followed by tautomerization of the enol produces imine VI. 
This intermediate can undergoe a second reversible tatuomerization to produce imine 
VII. The nitrogen then undergoes nucleophilic attack onto the C-2 carbonyl, resulting in 
the formation of VIII. Dehydration of VIII produces azaphilone IX. 
 The reaction conditions were first optimized using monomer 46a.  One of the main 
problems encountered was the production of uncyclized imine intermediate 50. This 
intermediate was identified through 1H NMR and mass spectrometry. In accordance with 
the mechanism previously discussed, intermediate 50 will tautomerize and cyclize to 
produce the desired product 49. Thus, this reaction required longer reaction times.  After 
screening different solvents, azaphilone 49 was obtained with 89% yield. 
 
Table 1.2.2.4.0.  Amination of monomer 46 
O
Me
O
O
OH
O
Me
O
HN
OH
46a 49
NH4OAc
solvent, rt
O
Me
O
O
OH
50
NH
 
Yield (%)b
a 1H NMR conversion based on recovered starting material. b Isolated by column 
chromatography.
94
-
85a
-
89
Entry
1
2
3
4
5
Ratio 49:50a
0:1
1:0.5
1:0.2
0:1
1:0
Time
2 h
4 d
36 h
20 h
36 h
Solvent Temperature (ºC)
0
rt
rt
rt
rt
THF
THF
THF/AcOH
MeOH
CH2Cl2
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  The amination of the dimeric azaphilone was initially attempted using the 
acetylated model system 48a to afford up to 91% 1H NMR yield of imine intermediate 52 
(Entry 1, Table 1.2.2.4.1). When dichloromethane used as solvent, the reaction yielded 
full conversion to the desired product 51 (Table 1.2.2.4.1).  
 
Table 1.2.2.4.1.  Studies towards the amination of dimers 47a and 48a. 
OR2
O
O
O
Me
O
O
O
OR2
Me
OR2
O
O
O
Me
O
HN
HN
OR2
Me
(S,S,S)- or 
(R,S,R)-51
OR2
O
O
O
Me
O
O
O
OR2
Me
(S,S,S)- or 
(R,S,R)-52
NH
NH
Yield (%)b
a 1H NMR conversion based on recovered starting material. b 1H NMR yield based on the 
recovered product 52, calculated using  an internal standard. .
90
5
0
Entry
1
2
3
Ratio 51:52a
0:1
1:0
decomp.
Time
1 h
24 h
0.5 h
SolventSubstrate
  R1 = H, R2 = OAc
  R1 = H, R2 = OH
  R1 = H, R2 = OH
THF
DCM
MeOH
NH4OAc
(S,S,S)- or 
(R,S,R)-47a, 48a
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1.2.2.5 Conclusion 
Figure 1.2.2.5.0 Chaetoglobin derivative 
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 The synthetic pathway proposed for the construction of chaetoglobin natural 
products consists in three key steps; Sonogashira cross-coupling, asymmetric phenol 
coupling, oxidative dearomatization and amination. This route was successfully 
optimized using a model diphenol with an achiral C12 group (5), which was prepared 
through a Sonogoshira cross-coupling of aryl iodine 31 with octyne. Aryl iodide 30 was 
synthesized through a four-step sequence by the combination of sterically controlled 
borylation using a hindered iridium catalyst, followed by bromination and deprotection 
of the methyl ethers. Asymmetric oxidative phenol coupling of 5 yielded biaryl 40 with 
up to 74% ee and 99% yield.  
Vilsmeier-Haack formylation of the dimeric benzyl alkyne 40 produced 3 with a 
58% yield, which was subjected to oxidative dearomatization using IBX to afford dimeric 
azaphilone 47 in up to 80% yield (dr = 1:1). Acylation of 47 yielded 48 in 82% yield. 
Alternative oxidative dearomatization using lead (IV) acetate afforded acetate 48 in 10 % 
yield. Subsequent amination generated a chaetoglobin derivative 49, which lacks the 
hydroxyl substitution on the C12 alkyl chain. Chaetoglobin analog 58 was thus proposed 
in a total of 10 steps, with these results in hand, attentions turned to synthesis of 
chaetoglobin A using a siloxy-derived alkyne. 
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1.2.3 Progress Toward the Total Synthesis of Chaetoglobin A 
  The optimized synthetic pathway was applied to the  synthesis of chaetoglobin A 
using siloxy-derived (5b-c) alkynes. These alkyne were prepared in enantiopure form 
following a reported protocol shown in Scheme 1.2.3.0. Deprotonation of 1-butyne 
followed by attack onto (S)-methyloxirane provided alkyne 53 in a 64% yield.76 An 
alkyne isomerization using metallic lithium and propylenediamine provided terminal 
alkyne 54.  Initially, alkyne 54 was protected using tert-butyldimethylsilyl chloride and 
the corresponding alkyne 5b was prepared in 69% yield by a Sonogoshira cross-coupling 
of aryl iodide 31 with 55.77  
  
Scheme 1.2.3.0 Synthesis of chiral alkyl dihydroxyphenol 
Me
OH
OH
69%   5b     R = TBS
76%   5c     R = TBDPS
ORMe
OH
OH
I
31
Pd(PPh3)2Cl2
CuI, Et2NH,DMF
60 ºC
OROH
OHO+
(S)-53
99%,    (S)-55     R = TBS
100%   (S)-56     R = TBDPS
n-BuLi, HMPA
64%
Li, H2N(CH2)3NH2
t-BuOK
100%
R3SiCl, Imidazole
DMF
55 and 56
(S)-54
(S)
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
76 Wu, Y.; Gao, J. “Total Synthesis of (+)-Brefeldin A” Org. Lett. 2008, 10, 1533–1536. 
77	  Oliveira, R. A.; Rahmeier, L. H. S.; Comasseto, J. V.; Marino, J. P.; Menezes, P. H. “Synthesis of the 
C7-C24 fragment of macrolactin F” Tetrahedron Letts. 1978, 43, 2923–2925.	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 Oxidative phenol coupling of 5b yielded biaryl 40b with up to 79% yield and a high 
diasteroselectiviy of 94:6 (Scheme 1.2.3.1). As expected the siloxy substitution on the 
C12 chain had little impact on the catalyst enantioseletive coupling. However, 
Vilsmeier-Haack formylation of the dimeric benzyl alkyne 40b produced 3b 43% yield, 
with full deprotection of the silyl ethers. Multiple attempts to optimize this reaction and 
avoid deprotection were not successful. Oxidative dearomatization using IBX to afford 
dimeric azaphilone 47b with 25% NMR yield (dr = 1:1). Alternative oxidative 
dearomatization using lead (IV) acetate afforded acetate 48b in 11% NMR yield. The 
low yields in the oxidative dearomatization are likely due the presence of a free 
hydroxyl.   
  At this point, a most robust protecting group was placed on the alkyl chain, to 
avoid deprotection during the formylation step. Alkyne 56 was protected using tert-
butyldiphenylsilyl chloride. Subsequent Sonogashira cross-coupling with aryl iodide 31 
produced the corresponding TBDPS protected alkyne 5c in a 76% yield (Scheme 
1.2.3.0). Oxidative phenol coupling of 5c yielded biaryl 40c with 71% yield and a 
diasteroselectiviy of 82:12 (Scheme 1.2.3.1) as judged by HPLC and 1HNMR. 
Vilsmeier-Haack formylation of the TBDPS protected dimeric alkyne 40c 
successfully produced 3c with up to 95% yield. Formylation was followed by oxidative 
dearomatization using IBX to afford dimeric azaphilone 47c in up to 92% yield (dr = 
1:1).  
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Ac2O, Et3N
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Scheme 1.2.3.1  Synthesis of Chaetoglobin A
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The absolute configuration of chaetoglobin A was reported as, (5R,7S)-
configuration (see Section 1.1).1 To elucidate the absolute stereochemistry of dimeric 
azaphilone 47c, circular dichroism spectroscopy was used (Figure 1.2.3.0). An (S)-chiral 
axis was assigned based on previous studies of the stereochemical outcome with 
vanadium catalyst V3. The CD spectrum of 47c showed CD absorption bands at 308 (+) 
and 361 nm (–), which is the inverse of those reported for chaetoglobin A (Figure 1.1.1). 
According to the report for chaetoglobin, the (7S)-configuration was reflected in the 249, 
354 and 302 nm bonds. The axial chirality was identified as the (5R)-configuration based 
on a negative exciton split (395 nm and 354 nm). Based on comparison to the CD 
Spectrum of Chaetoglobin A, the (5S, 7R) configuration is assigned to the symmetric 
isomer of 47c, in accord to the expected stereochemistry in the enantioselective phenol 
coupling and the model shown in Figure 1.2.2.4.0. 
  Alternative oxidative dearomatization using lead (IV) acetate afforded acetate 48 
in a 9 % yield (Scheme 1.2.3.1). Acylation of 47c provided 48c in 82% yield.   
Amination of 48c provides the corresponding N-containing azaphilone subsequent 
TBDPS deprotenction using hydrogen fluoride-pyridine would provide diasteroisomer 
58.  
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Figure 1.2.3.0  Elucidation of absolute stereochemistry of 47 
306 nm, 5.5677
254 nm, 0.2853
355 nm, –2.4918
399 nm, 0.3435
 
 
 
 
 
	   72	  
1.2.4    Applications and possible future directions 
D-tert-Leucine derivated catalyst V3 will beprepared and used for the synthesis of 
the R-40 isomer, which would lead to the reported sterechemical configuration for 
chaetoglobin A. The TBDPS-protected chaetoglobin A precursor ( n=1, R=OTBDPS) can 
be converted into chaetoglobin B (2) via selective N-alkylation.78 This synthetic route 
could be applied for the synthesis of multiple bioactive azaphilone dimers (Table 
1.2.4.0). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
78	  Pehere, A. D.; Abell, A. D. “Selective N-Acylation and N-Alkylation of Biotin” J. Org. Chem. 2011, 76, 
9514−9518.	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Table 1.2.4.0. Chaetoglobin Analogs 
OR4
O
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O
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Z
Z
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R1 R2 R3 R4
Chaetoglobin A
Chaetoglobin B
Compound 58
(-)-(S)-15183a dimer
(+)-Sclerotorin dimer
(+)-8-O-Methylsclerotiorinamine dimer
Chlorofusin  chromophore dimer
R1
R1
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Me Me
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Z
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H
H
-
-
H
H
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H
H
H
-
-
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Ac
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1.2.5 Conclusion 
OAc
O
O
O
Me
O
HN
N
OAc
MeOH
OH
R
5
5'
12
12'
7
7'
58  
 The synthetic pathway proposed for the construction of chaetoglobin natural 
products consists in three key steps; sonogashira cross-coupling, asymmetric phenol 
coupling, oxidative dearomatization, and amination. This route was successfully 
optimized using a model diphenol with an achiral C12 group (n = 2, R = H, 5). The 
optimized synthetic pathway was applied to the synthesis of chaetoglobin A 
diasteroisomer 58, proposed in a total of 11 steps. 
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1.3 Experimental Section 
General Synthetic Procedures.  All reactions were carried out under an argon 
atmosphere, unless indicated. Glassware used was oven-dried overnight, unless otherwise 
noticed. Solvents and reagents were dried prior use, when needed. THF and diethyl ether 
were distilled from sodium and benzophenone. Dioxane and CH2Cl2 were dried by 
passing through activated alumina. CH2Cl2 was distilled from CaH2. Benzene was 
distilled from sodium. Dichloroethane, Et3N, pyridine, toluene, and iPr2EtN were 
distilled from CaH2. DMF, N,N’-dimethylethylenediamine, tetramethylethylenediamine, 
and (–)-sparteine were distilled from MgSO4 under reduced pressure. (–)-Sparteine was 
use immediately after the distillation and stored at –78 ºC using dry ice.  If needed, 
HMPA was purified through vacuum distillation from CaH2. Et2NH was used without 
prior purification. When needed, DMF, THF, Et2NH, iPr2EtN, N,N’-
dimethylethylenediamine, tetramethylethylenediamine and octyne  were deoxygenated 
by pump freeze off.  Iodoxybenzoic acid (IBX) was prepared following a reported 
procedure.73 
 Thin layer chromatography was performed on EM Reagents 0.25mm silica-gel 245-
F plates and UV light was used for visualization. Column chromotagraphic purification 
was performed under air unless otherwise indicated. 
 Enantiomerical excesses were determined thought high performance liquid 
chromatography (HPLC), using a Waters 600 HPLC with UV detection at 254 nm and a 
Chiralpak IA column (0.46 cm x 25 cm) from Daicel. 1H NMR spectra were recorded on 
Bruker AM-500 (500 MHz), AM-360 (360 MHz) and AM-300 (300 MHz).  The 
chemical shifts were reported in ppm from the solvent resonance (CDCl3, 7.26 ppm).  
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Data are reported as follow: chemical shift, mitiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, dr = broad, m = multiplet), coupling constants, and number of 
protons.  13C NMR spetra was recorded on Bruker AM-500 (125 MHz) spectrometers. 
Mass spectra were taken on a high resolution VG autospect with ionization mode of ES. 
IR spectra were obtained from a Perkin-Elmer FT-IR spectrometer and JASCO FT/IR-
480 spectrometer using a thin film on NaCl plates. Melting points were determined on 
Thomas scientific Unimelt apparatus and are uncorrected. CD spectra were taken in a 
JASCO J-720 spectrometer. Specific rotations were taken in an JASCO P2000 
spectrometer. 
 
OMe
Me
MeO
Br  
1-Bromo-2,4-dimethoxy-3-methylbenzene (15).  A solution of bromine  (10 mL Br2, 
0.2 mol) in dioxane (17 mL) was diluted in ether (300 mL), stirred for 5 min and then 
added dropwise to a solution 3-dimethoxy-2-methylbenzene 14 (15.21 g, 0.1 mol) in 
ether (150 mL). The solution was stirred for 30 min.  The mixture was washed with 
water, saturated sodium carbonate, and water. The organic portion was dried over 
Na2SO4, filtered, and concentrated to afford 1-bromo-2,4-dimethoxy-3-methylbenzene in 
95 % yield as a brown oil (22.0 g, 0.0945 mol). NMR spectra matched those reported.79 
1H NMR (300 MHz, CDCl3) δ 7.32 (d, J = 8.7 Hz, 1H), 6.54 (d, J = 9.0 Hz, 1H), 3.80 (s, 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
79 Yasav, J. S.; Reddy, B. V. S.; Reddy, R. S. R.; Basak, A. S.; Nasaiah A. V. “Efficient Halogenation of 
Aromatic Systems Using N-Halosuccinimides in Ionic Liquid “Adv. Synth. Catal. 2004, 346, 77–82.  
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3H), 3.77 (s, 3H), 2.19 (s, 3H); 13C NMR (500 MHz, CDCl3) δ 158.3, 155.8, 129.9, 
122.1, 108.2, 107.6, 60.5, 55.9, 9.8.  
 
Me
MeO
CHO
OMe
 
2,4-Dimethoxy-3-methylbenzaldehyde (17). Phosphorylchloride (221 mL, 0.2 mol) was 
added dropwise to sealed flask with dry DMF (39.4 mL, 6 N) at 0 ºC. The resulting 
complex was stirred at room temperature for 30 min and added to a solution of 
dimethoxy-2-methylbenzene 14 (30 g, 0.2 mol) in DMF (39.4 mL) at 100 ºC. The 
reaction mixture heated to 110 ºC for 4 h. The mixture was quenched by pouring into 
cold water. The aqueous layer was extracted with ethyl acetate (x3). The organic layers 
were washed with brine, dried over Na2SO4, filtered, and concentrated.  The product was 
purified via chromatography (SiO2 10% Ethyl Acetate/ Hexanes) to yield 2,4-dimethoxy-
3-methylbenzaldehyde in 55% as a yellow solid (19.5 g, 0.101 mol). NMR spectra 
matched those reported. 55 1H NMR (500 MHz, CDCl3) δ 10.17 (s, 1H), 7.68 (d, J = 9.0 
Hz, 1H), 6.69 (t, J = 8.7 Hz, 1H), 3.83 (s, 3H), 3.80 (s, 3H), 2.10 (s, 3H).  
 
 
 
2-(2,4-Dimethoxy-3-methylphenyl)-1,3-dioxolane (18).  A solution of 2,4-dimethoxy-3-
methylbenzaldehyde 17  (2.47 g, 0.01 mol) and p-toluenesulfunic acid (13 mg, 0.07 
mmol) in distilled benzene (20 mL) was treated with freshly distilled ethylene glycol 
Me
MeO
OMe
O
O
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(1.67 mL, 0.03 mol). The mixture heated to reflux overnight in a flask with a Dean-Stark 
trap attached. The mixture was cooled to room temperature, washed with water, and 
saturated sodium carbonate solution and water. The organic layer was dried over Na2SO4, 
filtered and concentrated to yield 2-(2,4-dimethoxy-3-methylphenyl)-1,3-dioxolane in a 
92% yield as a light brown oil (2.28 g, 0.01 mol). 1H NMR (500 MHz, CDCl3) 7.38 (d, J 
= 8.4 Hz, 1H), 6.67 (d, J = 8.7 Hz, 1H), 6.07 (s, 1H), 4.17 (m, 2H), 4.04 (m, 2H), 3.79 (s, 
3H), 3.77 (s, 3H), 2.29 (s, 3H). 
 
Me
MeO
OMe
N
N
Me
Me
 
2-(2,4-Dimethoxy-3-methylphenyl)-1,3-dimethylimidazolidine (20). N,N’-
Dimethylethylenediamine (4.5mL, 0.061 mol) was added to a solution of 2,4-dimethoxy-
3-methylbenzaldehyde 17  (10 g,  0.056 mol)  in  distilled toluene  (98 mL) and heated to 
reflux in a flask fitted with a Dean-Stark trap. The mixture was cooled to room 
temperature, dried over Na2SO4, filtered and concentrated to give 2-(2,4-dimethoxy-3-
methylphenyl)-1,3-dimethylimidazolidine in 96% yield. Brown-red oil that crystallized 
on standing (13.34 g, 0.053 mol). NMR spectra matched those reported.43 1H NMR (300 
MHz, CDCl3) δ 7.45 (d, J = 8.7Hz, 1H), 6.68 (d, J = 8.7 Hz, 1H ), 3.81 (s, 3H), 3.72 (s, 
1H),  3.70 (s, 3H), 3.36 (m, 2H), 2.58 (m, 2H), 2.17 (s, 6H), 2.15 (s, 3H); 13C NMR (500 
MHz, CDCl3) δ 159.2, 158.5, 127.2, 124.2, 118.5, 107.0, 84.5, 61.5, 55.6, 53.4, 39.8, 9.3.  
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Me
MeO
OMe
Br
N
N
Me
Me
 
2-(6-Bromo-2,4-dimethoxy-3-methylphenyl)-1,3-dimethylimidazolidine (21).  t-BuLi  
(1.65 M in pentane, 0.57 mL, 0.92 mmol) was added dropwise at –55 ºC under inert 
atmosphere, to a solution of  aminal 20  100 mg, 10.0 mmol) in distilled ether (1.9  mL). 
The solution was stirred for 6 h at room temperature. The mixture was cooled again to –
55 ºC and a solution of 1,2-dibromotetrachloroethane (299 mg, 0.92 mmol) in ether (0.57 
mL) was added over1 h. The reaction mixture was stirred for 18 h at room temperature. 
The reaction mixture was washed with water and ether. The combined organic layers 
were dried over Na2SO4, filtered, and concentrated to give 2-(6-bromo-2,4-dimethoxy-3-
methylphenyl)-1,3-dimethylimidazolidine 21 (100% yield)  as a brown-red gummy oil 
(259 mg 0.79 mmol). The unpurified product was directly used in the next reaction. 1H 
NMR (300 MHz, CDCl3) δ 6.83 (s, 1H), 3.90 (s, 1H) 3.81 (s, 3H), 3.82 (s, 3H), 3.36 (m, 
2H), 2.59 (m, 2H), 2.29 (s, 6H), 2.09 (s, 3H).  
 
Me
HO
CHO
OMe
Br  
6-Bromo-4-hydroxy-2-methoxy-3-methylbenzaldehyde (22). Aminal 21 (100 mg, 0.30 
mmol), phenylthiol (0.03 mL, 0.30 mmol) and K2CO3 (2 mg, 0.01 mmol) were dissolved 
in N-methyl-2-pyrrolidine (0.15 mL) and heated to 190 ºC for 30 min. The reaction 
mixture was cooled to room temperature and extracted with ether. The organic layer was 
dried over Na2SO4, filtered and concentrated. The product was dissolved with 1 M NaOH 
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and extracted with ether to remove the neutral species. The aqueous layer was saturated 
with 1 M HCl and extracted with ether. The organic layer was dried over Na2SO4, 
filtered, and concentrated to yield 6-bromo-2-hydroxy-4-methoxy-3-methylbenzaldehyde 
21 in 7% yield as an oil.  1H NMR (500 MHz, CDCl3) δ 12.35 (s, 1H), 10.07 (s, 1H), 6.67 
(s, 1H), 3.84 (s, 3H), 1.98 (s, 3H). 
 
Me
MeO
OH
Br
CHO
 
6-Bromo-2-hydroxy-4-methoxy-3-methylbenzaldehyde (23).  A solution of BBr3 in 
CH2Cl2 (0.30 mL, 1 M, 0.3 mmol) was added dropwise to a solution of imidazolidine 21  
(50 mg, 0.30 mmol) at –78 ºC and stirred at room temperature for 24 h. the mixture was 
cooled to 0 ºC and quenched with water. The aqueous layer was extracted with CH2Cl2. 
The organic layer was washed with brine, dried over Na2SO4, filtered, and concentrated. 
The product was purified via chromatography (SiO2, 10 % Ethyl acetate/Hexanes) to 
yield 6-bromo-2-hydroxy-4-methoxy-3-methylbenzaldehyde 23 in a 20% yield as a white 
solid (10 mg, 0.041 mmol). mp 136–142 °C decomposition; 1H NMR (500 MHz, CDCl3) 
δ 12.43 (s, 1H), 10.22 (s, 1H), 6.73 (s, 1H), 3.91 (s, 3H), 2.05 (s, 3H); 13C NMR (500 
MHz, CDCl3) δ 196.3, 164.0, 163.1, 126.7, 113.6, 112.8, 108.4, 56.3, 7.5; HMBC (500 
MHz, CDCl3) was performed to confirm the substitution pattern; IR (film) 3438, 2900, 
1632, 1251, 756 cm-1. 
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Me
HO
CHO
OH
Br  
6-Bromo-2,4-dihydroxy-3-methylbenzaldehyde (24).  Was prepared using the same 
procedure for 6-bromo-2-hydroxy-4-methoxy-3-methylbenzaldehyde, but employing 2 
equivalents of BBr3. Compound 24 was afforded in a 36% yield as a white solid (26 mg, 
0.011 mmol). NMR spectra matched those reported.43 1H NMR (300 MHz, CDCl3) δ 
12.68 (s, 1H), 10.10 (s, 1H), 6.69 (s, 1H), 5.86 (br, 1H), 2.17 (s, 3H).  
 
Me
OH
OMe
Br  
6-Bromo-4-hydroxy-2-methoxy-3-methylbenzaldehyde (9). Was prepared using the 
same procedure for 6-bromo-2-hydroxy-4-methoxy-3-methylbenzaldehyde. The crude 
product was purified via chromatography (SiO2, 10 % Ethyl acetate/Hexanes) to yield 6-
bromo-2-hydroxy-4-methoxy-3-methylbenzaldehyde in a 90% yield (84 mg, 0.39 mmol) 
as a brown oil. mp 42-44 °C;  1H NMR (500 MHz, CDCl3) δ 6.82 (s, 1H), 6.81 (s, 1H), 
5.85 (br, 1H), 3.80 (s, 3H), 2.05 (s, 3H); 13C NMR (500 MHz, CDCl3) δ 159.2, 155.1, 
119.1, 111.8, 107.1, 56.1, 8.1; IR (film) 3429, 3002, 2934, 1587, 1299, 1111, 851, 567 
cm-1; HRMS (ES) m/z = 216.9864 calcd for C8H10BrO2 [MH]+, found 216.9721. 
 
 
	   82	  
Me
OH
OH
Br  
5-Bromo-2-methylbenzene-1,3-diol (10). Was prepared using the same procedure for 6-
bromo-2-hydroxy-4-methoxy-3-methylbenzaldehyde. The product was chromatographed 
(SiO2, CH2Cl2) to produce a white solid (872 mg, 4.32 mmol, 93%). The NMR spectra 
matched those reported.53 1H NMR (500 MHz, CDCl3) δ 6.58 (s, 2H), 4.77 (s, 2H), 2.08 
(s, 3H); 13C NMR (500 MHz, CDCl3) δ 155.4, 118.9, 111.4, 109.8, 7.9; IR (film) 3390, 
2985, 1705, 1599, 1376, 1089, 864, 567 cm-1; HRMS (ES) m/z = 201.9629 calcd for 
C7H7BrO2 [M]+, found 201.9634. 
 
Me
OH
OH
I  
5-Iodo-2-methylbenzene-1,3-diol (30). Was prepared using the same procedure for 6-
bromo-2-hydroxy-4-methoxy-3-methylbenzaldehyde 23. The product was purified 
through column chromatography (SiO2, CH2Cl2) to yield an off-white solid (1.87 g, 
90%). mp 104–105 °C; 1H NMR (500 MHz, CDCl3) δ 6.76 (s, 2H), 4.74 (s, 2H), 2.08 (s, 
3H); 13C NMR (500 MHz, CDCl3) δ 155.4, 117.3, 110.7, 89.2, 8.0; HRMS (ES) m/z = 
249.9491 calcd for C7H7IO2 [M]+, found 249.9482. 
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2-(2,4-Dimethoxy-3-methylphenyl)-1,3-dimethylimidazolidine (27). N,N’-
dimethylethylenediamine (0.02 mL, 0.22 mol) and 3 Å molecular sielves (50 mg) was 
added to a solution of 2,4-dihydroxy-3-methylbenzaldehyde  (50 mg, 0.20 mmol)  in  
distilled toluene  (0.36 mL). The mixture was heated at reflux in a sealed microwave vial. 
The mixture was cooled to room temperature, dried over Na2SO4, filtered, and 
concentrated. Compound 27 was obtained in 97% yield (58 mg, 0.13 mmol). 1H NMR 
(300 MHz, CDCl3) δ 6.52 (s, 1H), 4.24 (s, 1H), 3.38 (s, 2H), 3.36 (s, 2H), 2.64 (s, 2H), 
2.33 (s, 6H), 2.05 (s, 3H); 13C NMR (500 MHz, CDCl3) δ 159.1, 159.0, 122.1, 112.4, 
110.4, 110.1, 88.8, 52.1, 50.4, 39.0, 36.1, 8.2; IR (film) 3251, 2947, 1602, 1454, 1109, 
885 cm-1; HRMS (ES) m/z = 301.0552 calcd for C12H18BrN2O2 [MH]+, found 301.0551. 
 
Me
OMe
OMe
Br
Me
OMe
OMe
Me
OMe
OMe
PinB
B2pin2 (0.85 equiv)
[Ir(COD)(OMe)]2
(0.25 mol%)
tBu-bipy
(0.50 mol%)
THF, 80 ºC
CuBr2 (3.0 equiv)
H2O:MeOH (1:1)
80 ºC
70% two step 
one pot14 28 6  
5-Bromo-1,3-dimethoxy-2-methylbenzene (6). All glassware was oven dried. All 
solvents were distilled and deoxygenated. Arene (50 g, 328.9 mmol), [Ir(COD)OMe]2 
(567 mg, 0.85 mmol), B2Pin2 ( 71 g, 280 mmol) and 4,4'-di-tert-butylbipyridine (477 mg, 
1.78 mmol) were weighed and placed in a flask inside the glovebox. The solids were 
dissolved in dry THF (411 mL). The flask was sealed with a PTFE cap and heated at 80 
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ºC. After 40 h the solvent was removed under high vacuum and the residue dried for 2 h. 
The residue was dissolved in MeOH (2056 mL) and a solution of CuBr2 in water (221 g, 
987 mmol, 2056 mL) was added. The reaction flask was sealed and heated at 80 ºC for 48 
h. The reaction mixture was extracted with ethyl acetate (x3). The organic layers were 
combined, washed with brine, dried over sodium sulfate, filtered, and concentrated. The 
arene was purified via chromatography (SiO2, Hexanes) to yield 5-bromo-1,3-dimethoxy-
2-methylbenzene as a white solid (60.36 g, 0.202 mmol, 80%). Compound 6 was 
previously reported.80 mp 56–57 °C;  1H NMR (300 MHz, CDCl3) δ 6.67 (s, 2H), 3.80 (s, 
6H), 2.02 (s, 3H); 13C NMR (500 MHz, CDCl3) δ 158.9, 119.3, 113.7, 107.4, 56.0, 8.2; 
IR (film) 3002, 2941, 1587, 1230, 1138, 809, 618 cm-1. 
 
Me
OMe
OMe
I
Me
OMe
OMe
Me
OMe
OMe
PinB
B2pin2 = bis(pinacolato)diboron
dtbpy = 4,4'-di-tert-butylbipyridine
B2pin2 (0.85 equiv)
[Ir(COD)(OMe)]2
(0.25 mol%)
tBu-bipy
(0.50 mol %)
THF, 80 ºC
CuI, KI
phen
MeOH:H2O
air 1h14 28 31
 
5-Iodo-1,3-dimethoxy-2-methylbenzene (30). All glassware was oven dried. All 
solvents were distilled and deoxygenated. Arene (500 mg, 3.29 mmol), [Ir(COD)OMe]2 
(5.7 mg, 0.0085 mmol), B2Pin2 ( 710 mg, 280 mmol) and 4,4'-di-tert-butylbipyridine (4.8 
mg, 0.018 mmol) were weighed and placed in a flask inside the glovebox. The solids 
were dissolved in dry THF (4 mL). The flask was sealed with a PTFE cap and heated at 
80 ºC. After 40 h the solvents are removed under high vacuum and the residue was dried 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
80 Doyle, F. P.;  Nayler, H. C.; Waddington, H. R. J.; Hanson J. C.; Thomas G. R. “Derivatives of 6-
Arninopezicillanic Acid. Part VI. Analogues of 2,6-Dirnethoxyphenylpenicillin with Enhanced Stability 
towards Acids” J. Chem. Soc.1963, 0, 5838–5845. 
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for 2 h. The residue was dissolved in MeOH (26 mL).  CuI (63 mg, 0.329 mmol), KI (813 
mg, 4.9 mmol) and phenanthroline (119 mg, 0.658 mmol) were placed in as Schlenk flask 
inside the glovebox.  The methanol solution was added under air. The mixture was stirred 
at room temperature and water (6.6 mL) was added. Air was bubbled through the 
solution. The reaction mixture was heated at 80 ºC for 1 h. The mixture was cooled to 
room temperature, water (50 mL) was added, and the mixture was extracted with diethyl 
ether (x3). The organic layers were combined, washed with brine, dried over magnesium 
sulfate, filtered and concentrated. The arene was purified via chromatography (SiO2, 
Hexanes) to yield 5-iodo-1,3-dimethoxy-2-methylbenzene as a yellow solid (452 mg, 
49%).  mp 66 °C; 61  1H NMR (300 MHz, CDCl3) δ 6.85 (s, 2H), 3.80 (s, 6H), 2.04 (s, 
3H); 13C NMR (500 MHz, CDCl3) δ 158.9, 114.8, 113.4, 89.8, 56.1, 8.2; IR (film) 2937, 
1578.3, 1236, 1139, 827, 808, 557 cm-1; HRMS (ES) m/z = 277.9804 calcd for C9H11IO2 
[M]+, found 277.9805. 
 
Me
OMe
OMe
Br
Me
OMe
OMe
I
N
H
H
N
CuI, NaI
 Dioxane  
5-Iodo-1,3-dimethoxy-2-methylbenzene (30). All glassware was oven dried. All 
solvents were deoxygenated. 5-Bromo-1,3-dimethoxy-2-methylbenzene (2.00 g, 8.60 
mmol), copper iodide (80 mg, 0.42 mmol) and sodium iodide (2.60 g, 17.4 mmol) were 
weighed in an oven dried flask and dissolved in dry dioxane (7.2 mL), in the glovebox. 
Then, degassed N,N’-dimethylethylenediamine (0.10 mL, 0.86 mmol) was added. The 
reaction flask was sealed and heated to 110 ºC overnight.  The reaction was quenched 
with a saturated solution of ammonium chloride. The mixture was extracted with CH2Cl2 
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(x3) and dried over magnesium sulfate.  The product was purified via chromatography 
(SiO2, Hexanes) to yield 5-iodo-1,3-dimethoxy-2-methylbenzenein a  95%  yield (2.30 g, 
9.24 mmol) as a white solid. NMR spectra matched to those previously presented. 1H 
NMR (500 MHz, CDCl3) δ 6.84 (s, 2H), 3.79 (s, 6H), 2.02 (s, 3H). 
  
5-Iodo-2-methylbenzene-1,3-diol (31). The procedure for compound 30 above was used 
for compound 5 (704 mg, 2.82 mmol). The product was purified via chromatography 
(SiO2, CH2Cl2) and was isolated as a off-white solid (689.5 mg, 2.76 mmol, 82% crude). 
NMR spectra matched those previously presented. 
 
OH
Me
OH
 
2-Methyl-5-(oct-1-yn-1-yl)benzene-1,3-diol (5). A solution of BBr3 (1 M in CH2Cl2) 
was diluted in CH2Cl2 (0.12 mL) and stirred with K2CO3. The BBr3 solution (0.24 mL, 1 
M) was added to a solution of 1,3-dimethoxy-2-methyl-5-(oct-1-yn-1-yl)benzene (30 mg, 
0.12 mmol) and 1-methylcyclohexene (0.03 mL, 0.23 mmol) in CH2Cl2  (0.29 mL) at –78 
ºC. The mixture was stirred for 2 h and quenched with water. The reaction mixture was 
extracted with ethyl acetate (x3). The organic layers were combined, dried over sodium 
sulfate, filtered, and concentrated. The product was purified via chromatography (SiO2, 
CH2Cl2) and isolated as a light brown solid (14.8 mg, 0.064 mmol, 56%). NMR spectra 
matched those presented later. 1H NMR (500 MHz, CDCl3) δ 6.45 (s, 2H), 4.89 (br, 2H), 
2.37 (t, 2H), 2.11 (s, 3H), 1.56 (m, 2H), 1.43 (m, 2H), 1.30 (m, 4H), 0.90 (m, 3H); 13C 
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NMR (500 MHz, CDCl3) δ 154.3, 122.0, 110.9, 110.7, 89.7, 79.8, 31.3, 28.6, 28.5, 22.5, 
19.3, 13.9, 7.85.  
 
OH
Me
OMe
 
3-Methoxy-2-methyl-5-(oct-1-yn-1-yl)phenol (41). The procedure for compound 5  
above was used, using 1 equiv of BBr3. Isolated as light brown solid (189 mg, 0.765 
mmol, 40%).  1H NMR (500 MHz, CDCl3) δ 6.51 (s, 2H), 4.70 (s, 1H), 3.80 (s, 3H), 2.38 
(t, 2H), 2.09 (s, 3H), 1.59 (m, 2H), 1.45 (m, 2H), 1.32 (m, 4H), 1.25 (m, 3H). 
 
OH
 
(S)-Hept-4-yn-2-ol (53). n-BuLi (1.5 M in hexanes, 12.8 mL, 18.9 mmol) was added to a 
solution of 1-butyne (3.7 mL, 46.4 mmol) in THF (12.5 mL) at –50 ºC under argon. The 
mixture was warmed to 0 ºC. After 30 min, HMPA (3.8 mL) was added and the mixture 
was cooled to –20 ºC. (S)-Methyloxirane (1.20 mL, 17.2 mmol) was added, followed by a 
second addition of HMPA (2.5 mL) and the resultant mixture was stirred at –20 ºC for 30 
min. the reaction was warmed to room temperature over 2 h. After stirring for 12h at 
room temperature, the mixture was poured in ice water and extracted with diethyl ether 
(x3). The combined organic layers were washed with brine, dried over magnesium sulfate 
filtered, and concentrated. The product distilled to afford alcohol 54 in a 67% yield 
(1.324 g, 11.8 mmol) as colorless oil. NMR spectra matched those reported. 76 1H NMR 
(500 MHz, CDCl3) δ 3.89-3.85 (m, 1H), 2.36-2.22 (m, 2H), 2.19-2.14 (s, 2H), 2.04 (br, 
	   88	  
1H), 1.21 (d, J = 6.0 Hz, 3 H), 1.11 (t, J = 7.3 Hz, 3H). IR (film) 3450, 2979, 2214, 
16.26, 1244 cm-1; 
 
OH
 
(S)-Hept-6-yn-2-ol (54). Lithium (186 mg, 26.7 mmol) was added to H2N(CH2)3NH2 (17 
mL)  and stirred under argon at room temperature for 2-3 h till the solution turned blue.  
The mixture was warmed to 70 ºC and stirred for 30 min until the blue color disappeared, 
yielding a white solution. The mixture was cooled to room temperature and t-BuOK (1.97 
g, 17.5 mmol) was added quickly. The reaction mixture was stirred for 30 min. Alkyne        
53 (500 mg, 4.5 mmol) was added dropwise. After 30 min, the mixture was poured into 
ice water and extracted with diethyl ether (x3). The combined organic layers were 
washed with 1 N HCl, NaHCO3, and brine. The organic layers were dried over 
magnesium sulfate, filtered, and concentrated. (S)-Hept-6-yn-2-ol was isolated in 87% 
yield as yellow oil (438 mg, 0.39 mmol). No further purification was necessary. NMR 
spectra matched those reported.76 1H NMR (500 MHz, CDCl3) δ 3.85-3.82 (m, 1H), 2.22 
(m, 2H), 1.95 (m, 1H), 1.68-1.64 (m, 1H), 1.60-1.54 (m, 3H), 1.43 (br, 1H), 1.20 (d, J = 
6.0 Hz, 3H); 13C NMR (500 MHz, CDCl3) δ 84.5, 68.6, 67.7, 38.3, 24.8, 23.7, 18.5. 
 
OTBS
 
(S)-tert-Butyl(hept-6-yn-2-yloxy)dimethylsilane (55). To a solution of 54 (250 mg, 2.23 
mmol) and imidazole (470 mg, 6.92 mmol) in DMF (7.4 mL) was added TBSCl (470 mg, 
3.12 mmol). After 12 h, the mixture was diluted in diethyl ether and washed with water 
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(4x) and brine. The organic layer was dried over magnesium sulfate, filtered and 
concentrated to yield 56 as yellow oil (11.56 g, 51.20 mmol, 95%). No further 
purification was necessary. NMR spectra matched those reported.77 1H NMR (500 MHz, 
CDCl3) δ 3.83-3.79 (m, 1H), 2.22 (m, 2H), 1.94 (m, 1H), 1.61-1.50 (m, 4H), 1.21 (d, J = 
7.0, 3H), 0.91 (s, 6H), 0.88 (s, 9H); 13C NMR (500 MHz, CDCl3) δ 84.6, 68.3, 38.7, 25.8, 
24.9, 23.9, 18.6, 18.2, -2.8, -4.3, -4.5. 
 
OTBDPS
 
(S)-tert-Butyl(hept-6-yn-2-yloxy)diphenylsilane (57). The procedure for compound 5  
above was used. Conducted with alkyne 54 Isolated as light yellow oil (100%, 2.137g, 
6.10 mmol). [α]D22  –77.44 (c 3.96, 99% ee, CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 7.73-
7.67 (m, 5H), 7.42-7.37 (m, 5H), 3.89-3.85 (m, 1H), 2.13 (m, 2H), 1.91 (m, 1H), 1.57-
1.53 (m, 4H), 1.07 (m, 12H); 13C NMR (500 MHz, CDCl3) δ 136.1, 134.6, 129.7, 127.7, 
84.7, 69.2, 68.5, 38.6, 27.2, 24.4, 23.4, 19.5, 18.6; IR (film) 3071, 2930, 2118, 1472, 
1428, 1391, 1259, 823, 740, 607 cm-1; HRMS (ES) m/z = 351.2144 calcd for C23H31OSi 
[MH]+, found 351.2141. 
 
General Procedure for Sonogashira Cross-coupling 
 
All solvents and reagents were deoxygenated. Aryl halide, PdCl2(PPh3)2 (10 mol%), 
copper iodide (10 mol%) and alkyne (2 equiv) were placed in a oven-dried Schlenk flask 
and dissolved in dry DMF (0.31 M) inside the glovebox.  Triethylamine or diethyl amine  
(3.5 equiv) was added and the flask was sealed. The mixture was warmed to 60 ºC for 16-
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31 h. The reaction mixture was cooled to room temperature and treated with saturated 
aqueous NH4Cl. The mixture was extracted with ethyl acetate (x3). The organic layers 
were combined, dried over sodium sulfate, and concentrated.  
 
OMe
Me
OMe
 
1,3-Dimethoxy-2-methyl-5-(oct-1-yn-1-yl)benzene (29). Conducted with arylbromide 6 
(490 mg, 2.13 mmol). The product was purified via chromatography (SiO2, Hexanes) to 
yield 1,3-dimethoxy-2-methyl-5-(oct-1-yn-1-yl)benzene and 1-methylcyclohexene in 
88% yield (488 mg, 1.86 mmol) as a yellow oil.1H NMR (500 MHz, CDCl3) δ 6.69 (s, 
2H), 3.81 (s, 6H), 2.40 (t, J = 7.2 Hz, 2H), 2.07 (s, 3H), 1.61 (m, 2H), 1.46 (m, 2H) 1.33 
(m, 4H), 0.91 (t, J = 7.0 Hz, 3H);	   13C NMR (500 MHz, CDCl3) δ 158.1, 121.7, 115.0, 
107.0, 89.4, 81.1, 55.9, 31.6, 28.9, 28.8, 22.7, 19.6, 14.4, 8.3; IR (film) 2998, 2931, 2222, 
1728, 1601, 1575, 1182, 821, cm-1; HRMS (ES) m/z = 261.1855 calcd for C16H23O2 
[MH]+, found 261.2068. 
 
OH
Me
OH
 
2-Methyl-5-(oct-1-yn-1-yl)benzene-1,3-diol (5a) Conducted with aryl iode 31 (984 mg, 
3.94 mmol). The product was purified via chromatography (SiO2, CH2Cl2) to yield 2-
methyl-5-(oct-1-yn-1-yl)benzene-1,3-diol in  89%  yield  (813 mg, 3.50 mmol) as an 
ivory solid. 1H NMR (500 MHz, CDCl3) δ 6.45 (s, 2H), 4.89 (br, 2H), 2.37 (t, J = 7.5 Hz, 
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2H), 2.11 (s, 3H), 1.56 (m, 2H), 1.43 (m, 2H), 1.30 (m, 4H), 0.90 (t, J = 5.5 Hz, 3H); 13C 
NMR (500 MHz, CDCl3) δ 154.3, 122.0, 110.9, 110.7, 89.7, 79.8, 31.3, 28.6, 28.5, 22.5, 
19.3, 13.9, 7.85; IR (film) 3435, 3053, 2931, 2232, 1772, 1735, 1618, 1583, 1322, 1080, 
737 cm-1 HRMS (ES) m/z = 232.1463 calcd for C15H20O2 [M]+, found 232.1457. 
 
OH
Me
OH
OTBS
 
(S)-5-(6-((tert-Butyldimethylsilyl)oxy)hept-1-yn-1-yl)-2-methylbenzene-1,3-diol (5b). 
Conducted with aryl halide 31 (1.00g, 4.00 mmol). The product was purified via 
chromatography (SiO2, CH2Cl2) to yield 2-methyl-5-(oct-1-yn-1-yl)benzene-1,3-diol in a  
69%  yield  (917 mg, 2.63 mmol) as a yellow oil. [α]D22  +34.22 (c 0.82, 99% ee, 
CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 6.44 (s, 2H), 4.95 (br, 2H), 3.86-3.83 (m, 1H), 
2.37 (m, 2H), 2.11 (s, 3H), 1.58-1.55 (m, 4H), 1.15 (d, J = 7.0 Hz, 3H), 0.90 (s, 9H), 0.07 
(s, 6H); 13C NMR (500 MHz, CDCl3) δ 154.4, 122.0, 117.1, 111.0, 89.6, 81.0, 68.3, 38.8, 
25.9, 25.0, 23.8, 19.4, 18.2, 8.0, -4.4, -4.7; IR (film) 3584, 3400, 3054, 2930, 2305, 2237, 
1619, 1583, 1322, 1080, 836 cm-1; HRMS (ES) m/z = 349.2199 calcd for C20H33SiO3 
[MH]+, found 349.2298.  
 
 
OH
Me
OH
OTBDPS
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(S)-5-(6-((tert-Butyldiphenylsilyl)oxy)hept-1-yn-1-yl)-2-methylbenzene-1,3-diol (5c). 
Conducted with aryl halide 31 527 mg, 2.11 mmol). The product was purified via 
chromatography (SiO2, CH2Cl2) to yield 2-methyl-5-(oct-1-yn-1-yl)benzene-1,3-diol in a  
76%  yield  (756 mg, 1.60 mmol) as brown oil. [α]D22  +3.28  (c 0.84, 99% ee, CH2Cl2); 
1H NMR (500 MHz, CDCl3) δ 7.90-7.87 (m, 5H), 7.37-7.35 (m, 5H), 6.37 (s, 2H), 4.85 
(br, 2H), 3.90 (m, 1H), 2.27 (t, 2H), 2.11 (s, 3H), 1.84-1.56 (m, 4H), 1.08 (d, J = 5.5 Hz, 
3H), 1.06 (s, 9H); 13C NMR (500 MHz, CDCl3) δ 154.5, 136.1, 135.0, 129.6, 127.7, 
122.1, 117.2, 111.1, 89.8, 80.3, 69.3, 38.7, 29.9, 27.2, 24.5, 22.3, 19.5, 8.1; IR (film) 
3434, 3070, 2957, 1341, 1110, 1042, 820 cm-1; HRMS (ES) m/z = 473.2512 calcd for 
C24H30N4O6 [MH]+, found 473. 2480.  
 
OH
OH
 
(R)-5,5',6,6',7,7',8,8'-Octahydro-[1,1'-binaphthalene]-2,2'-diol.  (R)-BINOL (5.18 g, 
18.0 mmol) and PtO2 (0.52g, 2.1 mmol) were dissolved in acetic acid (145 mL). The 
reaction mixture was purged with H2 gas three times.  The mixture was stirred and room 
temperature. After 48 h, the reaction mixture was filtered though Celite and washed with 
chloroform. The organic layer was washed with NaHCO3, dried over sodium sulfate and 
concentrated to afford the product as a white solid. NMR spectra matched those 
reported.68 1H NMR (300 MHz, CDCl3) δ 7.06 (d, J = 8.4 Hz, 2H), 6.82 (d, J = 8.4 Hz, 
2H), 4.58 (s, 2H), 2.74 (m, 4H), 2.34-2.04 (m, 4H), 1.74-1.54 (m, 8H); 13C NMR (125 
MHz, CDCl3) δ 151.5, 137.3, 131.1, 130.2, 119.0, 113.1, 29.4, 27.3, 23.2, 23.1. 
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OMOM
OMOM
 
(R)-2,2'-Bis(methoxymethoxy)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthalene. A 
literature procedure was follow with some modifications.70 All glassware was flame 
dried. DMF (3.3 mL) was added to a suspension of NaH in THF (448 mg, 11.2 mmol, 16 
mL). After 15 min, a solution of 5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalene]-2,2'-diol 
in THF (700 mg, 2.1 mmol, 16 mL)  was added dropwise at 0 ºC. The mixture was stirred 
for 1.5 h at room temperature. MOMCl (0.49 mL, 7.0 mmol) was added at 0 ºC and the 
mixture was stirred at 0 ºC. After 1.5 h, the mixture was quenched with water and 
ammonium chloride. The organic layers were washed with aqueous ammonium chloride, 
dried over sodium sulfate, filtered, and concentrated. The product was isolated as an off-
white solid. NMR spectra matched those reported.81 1H NMR (300 MHz, CDCl3) δ 7.01 
(m, 4H), 4.99 (m, 4H), 3.29 (s, 6H), 2.78 (m, 4H), 2.28 (m, 2H), 2.13 (m, 2H), 1.73-
1.67(m, 8H). 
OMOM
OMOM
 
(R)-2,2'-Bis(methoxymethoxy)-1,1'-binaphthalene. The procedure for (R)-2,2'-
bis(methoxymethoxy)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthalene was conducted with 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
81 Takasaki, M.; Motoyama, Y.; Yoon, S.; Mochida, I.; Nagashima, H.; “Highly Efficient Synthesis of 
Optically Pure 5,5′,6,6′,7,7′,8,8′-Octahydro-1,1′-bi-2-naphthol and -naphthylamine Derivatives by Partial 
Hydrogenation of 1,1′-Binaphthyls with Carbon Nanofiber Supported Ruthenium Nanoparticles” J. Org. 
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(R)-BINOL (5.14 g, 17.5 mmol). Isolated as an off-white solid (100%, 6.83 g, 18.3 
mmol). NMR spectra matched those reported.70 1H NMR (500 MHz, CDCl3) δ 7.98 (d, J 
= 9.0 Hz, 2H), 7.91 (d, J = 8.0 Hz, 2H), 7.82 (d, J = 9.0 Hz, 2H), 7.38 (m, 2H), 7.24 (m, 
4H), 5.12 (d, J = 7.0 Hz, 2H), 5.02 (d, J = 7.0 Hz, 2H), 3.18 (s, 6H); 13C NMR (500 MHz, 
CDCl3) δ 152.6, 134.2, 130.1, 129.6, 128.1, 126.5, 125.7, 124.2, 121.5, 117.4, 95.4, 56.0.  
 
O
OMOM
O
OMOM
 
(R)-2,2'-Bis(methoxymethoxy)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthalene.  All 
glassware was flame dried. To a solution of 2,2'-bis(methoxymethoxy)-5,5',6,6',7,7',8,8'-
octahydro-1,1'-binaphthalene  in ether (200 mg, 0.54 mmol,  10.2 mL), n-BuLi (0.75 mL, 
1.8 mmol, 2.41 M) was added at room temperature and stirred for 2 h. Dry DMF was 
added at 0 ºC and the mixture was stirred overnight at room temperature.  The mixture 
was quenched with water. The mixture was extracted with ethyl acetate (x2). The organic 
layers were combined, washed with ammonium chloride, dried over sodium sulfate, 
filtered, and concentrated. The unpurified product was used directly in the next reaction. 
1H NMR (500 MHz, CDCl3) δ 10.24 (s, 2H), 7.63 (s, 2H), 4.83 (d, J = 4.5 Hz, 2H), 4.79 
(d, J = 6.0 Hz, 2H), 3.00 (s, 6H), 2.75 (m, 4H), 2.24 (m, 2H), 2.20 (m, 2H), 1.79-1.65 (m, 
8H). 
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OMOM
OMOM
CHO
CHO  
(R)-2,2'-Bis(methoxymethoxy)-[1,1'-binaphthalene]-3,3'-dicarbaldehyde.  The 
procedure for (R)-2,2'-bis(methoxymethoxy)-5,5',6,6',7,7',8,8'-octahydro-1,1'-
binaphthalene was conducted using (R)-2,2'-bis(methoxymethoxy)-1,1'-binaphthalene 
(500 mg, 1.33 mmol). The product purified via chromatography (SiO2, 20% Ethyl 
Acetate/ Hexanes) and isolated as a yellow oil (60 %, 347 mg, 0.82 mmol). NMR data 
matched those reported.70   1H NMR (300 MHz, CDCl3) δ 10.55 (s, 2H), 8.61 (s, 2H), 
8.07 (d, J = 8.1 Hz, 2H), 7.54-7.39 (m, 4H), 7.37 (t, 2H), 4.71 (q, 4H), 2.87 (s, 6H). 
 
O
OH
O
OH
 
(R)-2,2'-Dihydroxy-5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalene]-3,3'-
dicarbaldehyde.   To a solution of 2,2'-bis(methoxymethoxy)-5,5',6,6',7,7',8,8'-
octahydro-1,1'-binaphthalene (0.54 mmol) in (7.7 mL) CH2Cl2:THF (5:2)  at 0 ºC, 
concentrated HCl (1.64 mL) was added. The reaction mixture was stirred at 0 ºC.  After 
3.5 h, the mixture was warmed to room temperature and stirred for 3 h. The reaction was 
quenched with water (15 mL). The mixture was extracted with CH2Cl2 (3x 10 mL). The 
organic layers were combined, washed with NaHCO3 (10 mL), water (10 mL), brine (10 
mL), and dried over sodium sulfate. The residue was purified by column 
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chromatography.( SiO2 10% Ethyl Acetate in Hexanes) to isolate the product as a off-
white solid (64.8 mg, 0.19 mmol, 34%). 1H NMR (300 MHz, CDCl3) δ 10.93 (s, 2H), 
9.84 (s, 2H), 7.32 (s, 2H), 2.83 (m, 4H), 2.51 (m, 2H), 2.25 (m, 2H), 1.78-1.65 (m, 8H); 
13C NMR (125 MHz, CDCl3) δ 196.3, 156.4, 147.2, 133.9, 129.6, 123.4, 119.0, 29.2, 
28.0, 22.8, 22.7.  
 
OH
OH
CHO
CHO  
(R)-2,2'-Dihydroxy-[1,1'-binaphthalene]-3,3'-dicarbaldehyde. The procedure or  (R)-
2,2'-dihydroxy-5,5',6,6',7,7',8,8'-octahydro-[1,1'-binaphthalene]-3,3'-dicarbaldehyde  was 
conducted using (2,2')-bis(methoxymethoxy)-[1,1'-binaphthalene]-3,3'-dicarbaldehyde 
(107 mg, 0.25 mmol). The product purified via chromatography (SiO2, 20% Ethyl 
Acetate/ Hexanes) isolated as yellow solid (92%, 127 mg, 0.37 mmol). NMR data 
matched those reported.70  1H NMR (500 MHz, CDCl3) δ 10.59 (s, 2H), 10.19 (s, 2H), 
8.34 (s, 2H), 8.00 (d, J = 7.0 Hz, 2H), 7.41 (m, 4H), 7.21 (d, J = 8.0 Hz, 2H); 13C NMR 
(500 MHz, CDCl3) δ 196.9, 153.8, 138.7, 137.6, 130.2, 127.6, 125.0, 124.7, 122.3, 116.7. 
6.4. 
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O V
t-Bu
O
O
N
O
O V
t-Bu
O
O
OMe
 
(S,R,S)-Vanadium catalyst V2. All glassware was flame dried. A mixture of L-tert-
leucine (48.4 mg, 0.37 mmol) and ligand (65 mg, 0.18 mmol) in methanol:CH2Cl2 (2.4 
mL, 1:1)  was heated at reflux. After 1 h, the reaction mixture was cooled to room 
temperature and VO(OEt)3  (0.07 mL, 0.37 mmol) was added.  After 2 h, solvent was 
removed under reduced pressure but not to dryness. The mixture was concentrated under 
high vacuum overnight. Isolated as a green solid (100%, 139 mg, 0.19 mmol).  HRMS 
(ES) m/z = 737.1848 calcd for C35H43N2O9V2 [M]+, found 737.1843. 
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(S,R,S)-Vanadium catalyst V1. The procedure for V2 was conducted using (R)-2,2'-
dihydroxy-[1,1'-binaphthalene]-3,3'-dicarbaldehyde (104 mg, 0.14 mmol). The product 
was isolated as a green solid (83 %, 104 mg, 0.146 mmol): HRMS (ES) m/z = 729.1222 
calcd for C35H35N2O9V2 [M]+, found 729.1253. 
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(S)-Vanadium catalyst V3. All glassware was flame dried. A mixture of L-tert-leucine 
(0.34 mmol) and 3-(tert-butyl)-2-hydroxy-5-nitrobenzaldehyde (0.34 mmol) in 
methanol:CH2Cl2 (2 mL, 1:1)  was heated to reflux. After 3 h, the reaction mixture was 
cooled to room temperature and VO(OEt)3  was added.  After 3 h, solvent was removed 
under reduced pressure. Isolated as a green solid (100%, 208.6 mg, 0.484 mmol). HRMS 
(ES) m/z = 433.1180 calcd for C18H26N2O7V [MH]+, found 433.1179. 
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(+)-Vanadium catalyst V4. The procedure for V3 was conducted using (+)-phenyl 
alanine (54 mg, 0.34 mmol). The product was isolated as a dark brown solid (100%, 163 
mg, 0.34 mmol). HRMS (ES) m/z = 467.1023 calcd for C21H24N2O7V [MH]+, found 
467.1033. 
 
General Procedure for Achiral Phenol Coupling 
To a solution of phenol in chorobenzene, di-tert-butylperoxide (10 equiv) was added. The 
mixture was heated at reflux overnight.  The mixture was cooled to room temperature. 
The product was purified via chromatography (SiO2, 10 % EtOAc/Hexanes). 
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6,6'-Dibromo-4,4'-dimethoxy-3,3'-dimethyl-[1,1'-biphenyl]-2,2'-diol. Using 9 (400 
mg, 01.86 mmol), the product was isolated as a orange solid (19%, 79 mg, 0.184 mmol): 
mp 169-176 ºC decomposition; 1H NMR (500 MHz, CDCl3) δ 6.85 (s, 2H), 4.83 (s, 2H), 
3.87 (s, 6H), 2.11 (s, 3H); HPLC (Chiralpak IA, 1.0 mL/min, 90:10 hexanes:i-PrOH): 
tR(S) = 14.58 min, tR(R) =21.35 min 
 
6,6'-Dibromo-3,3'-dimethyl-[1,1'-biphenyl]-2,2',4,4'-tetraol. Prepared using the same 
procedure as for 6-bromo-2-hydroxy-4-methoxy-3-methylbenzaldehyde 23. Using 10 (75 
mg, 0.17 mmol), the product was isolated as an off-white solid (83%, 58 mg, 0.14 mmol).  
1H NMR (500 MHz, CDCl3) δ 6.83 (s, 2H), 5.52 (s, 2H), 4.95 (s, 2H), 2.13 (s, 6H); 
HPLC (Chiralpak IA, 1.0 mL/min, 80:20 hexanes:i-PrOH): tR(S) = 6.04 min, tR(R) = 8.87 
min. 
 
General Procedure for Asymmetric Phenol Coupling 
Phenol, vanadium catalyst (40-20 mol%) and the additive are placed in a oven-dried 
microwave dial and sealed. The flask is purged with oxygen three times. The solid are 
dissolved in toluene or dichloroethane (0.2 M). The mixture is stirred at 0 ºC for 3-15 h. 
The reaction mixture was purified via chromatography (SiO2, CH2Cl2). 
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(R)-6,6'-Dibromo-4,4'-dimethoxy-3,3'-dimethyl-[1,1'-biphenyl]-2,2'-diol. Using 9 (32 
mg, 0.15 mmol), catalyst V2 (21 mg, 0.03 mmol), and dichloroethane (0.30 mL) as 
solvent, the product was isolated as an off white solid (38% ee). 1H NMR (500 MHz, 
CDCl3) δ 6.85 (s, 2H), 4.83 (s, 2H), 3.87 (s, 6H), 2.11 (s, 6H); 13C NMR (500 MHz, 
CDCl3) δ 159.9, 153.7, 122.5, 114.8, 112.7, 107.8, 56.0, 8.8; IR (film) 3472, 2938, 1601, 
1572, 1394, 1305, 1104, 854, 738 cm-1; HRMS (ES) m/z = 430.9494 calcd for 
C16H17Br2O4 [MH]+, found 430.9305; HPLC (Chiralpak IA, 1.0 mL/min, 90:10 
hexanes:i-PrOH): tR(S) = 13.38 min, tR(R) = 19.34 min. 
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OH  
(R)-6,6'-Dibromo-3,3'-dimethyl-[1,1'-biphenyl]-2,2',4,4'-tetraol. Using 10 (20 mg, x 
mmol), V2 (14 mg, 0.02 mmol), and dichloroethane (0.20 mL) as solvent, the product 
was isolated as a off-white solid (28%, 5.6 mg, 0.056 mmol, 71% ee). [α]D22  +30.66 (c 
0.36, 71% ee, CH2Cl2);  1H NMR (500 MHz, CDCl3) δ 6.83 (s, 2H), 5.52 (s, 2H), 4.95 (s, 
2H), 2.13 (s, 6H); IR (film) 3691, 3055, 2987, 1639, 1612, 1477, 1422, 1330, 1266, 896 
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cm-1; HRMS (ES) m/z = 402.9181 calcd for C14H13Br4O4 [MH]+, found 402.8989; HPLC 
(Chiralpak IA, 1.0 mL/min, 80:20 hexanes:i-PrOH): tR(S) = 6.03 min, tR(R) =9.27 min. 
 
Me
OH
OH
OH
Me
OH
 
(S)-3,3'-Dimethyl-6,6'-di(oct-1-yn-1-yl)-[1,1'-biphenyl]-2,2',4,4'-tetraol (40a). Using 
5a (10 mg, 0.043 mmol) in toluene (0.21 mL) with 20 mol% V3, the product was isolated 
as an ivory sticky-solid (16.9 mg, 0.037 mmol, 99%, 70% ee). [α]D22  +56.65 (c 1.59, 12% 
ee, CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 6.57 (s, 2H), 5.83 (s, 2H), 5.03 (s, 2H), 2.15 
(s, 6H), 1.26-1.12 (m, 20H), 0.84 (t, 6H); 13C NMR (500 MHz, CDCl3) δ 154.8, 153.7, 
123.2, 115.4, 111.3, 111.0, 93.2, 78.4, 31.5, 28.5, 28.3, 22.6, 19.4, 14.3, 8.7; IR (film) 
3443, 3304, 3054, 2930, 2306, 1606, 1584, 1395, 1265, 1077, 739 cm-1; HRMS (ES) 
463.2848 calcd for C30H40O4 (MH+), found 463.2838; HPLC (Chiralpak IA, 1.0 mL/min, 
80:20 hexanes:i-PrOH): tR(S) = 6.76 min, tR(R) =15.98 min. 
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(S)-6,6'-Bis((S)-6-((tert-butyldimethylsilyl)oxy)hept-1-yn-1-yl)-3,3'-dimethyl-[1,1'-
biphenyl]-2,2',4,4'-tetraol (40b). Using 5b (25 mg, 0.072 mmol) in toluene (0.36 mL) 
with 20 mol% V3, the product was isolated as a yellow oil (19.8 mg, 0.028 mmol, 79%, 
dr = 94:6). [α]D22  +31.99  (c 3.83, dr = 94:6, CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 6.58 
(s, 2H), 5.01 (br, 4H), 3.71 (s, 2H), 2.17 (s, 6H), 1.35 (m, 4H), 1.28-1.26 (m, 8H), 1.07 
(d, J = 6.0 Hz, 6H), 0.87 (s, 18H), 0.04 (s, 3H), 0.03 (s, 3H); 13C NMR (500 MHz, 
CDCl3) δ 154.8, 153.6, 123.0, 115.4, 111.8, 111.5, 92.8, 78.6, 68.5, 38.3, 26.1, 24.8, 23.8, 
19.5, 18.3, 8.8, -4.2, -4.6; IR (film) 3526, 3053, 2930, 2305, 2228, 1609, 1582, 1398, 
1086, 730 cm-1; HRMS (ES) m/z = 695.4163 calcd for C40H63O6Si2 (MH+), found 
695.4161; HPLC (Chiralpak IA, 1.0 mL/min, 80:20 hexanes:i-PrOH): tR(S) = 4.91 min, 
tR(R) = 12.09 min. 
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(S)-6,6'-bis((S)-6-((tert-butyldiphenylsilyl)oxy)hept-1-yn-1-yl)-3,3'-dimethyl-[1,1'-
biphenyl]-2,2',4,4'-tetraol (40c). Using 5c (350 mg, 0.74 mmol) in toluene (0.74 mL) 
with 20 mol% V3, the product was isolated as a yellow oil (180 mg, 71% brsm, dr = 
82:18). Major diasteroisomer:  [α]D22  +7.27  (c 2.24, dr = 82:18, CH2Cl2); 1H NMR (500 
MHz, CDCl3) δ 7.67 (m, 10H), 7.38-7.36 (m, 10H), 6.42 (s, 2H), 4.93 (s, 2H), 4.52 (s, 
2H), 3.73 (m, 2H), 2.10 (s, 6H), 2.04 (m, 4H), 1.33-1.30 (m, 8H), 1.04 (s, 18H), 0.98 (d, J 
= 6.0 Hz, 6H); 13C NMR (500 MHz, CDCl3) δ 154.7, 153.5, 136.1, 135.0, 134.8, 129.7, 
129.6, 127.7, 127.6, 123.2, 115.3, 111.5, 111.2, 92.9, 78.7, 69.3, 38.3, 29.9, 27.2, 24.3, 
23.3, 19.5, 19.4, 8.7; IR (film) 3528, 3070, 2928, 2233, 1609, 1580, 1321, 1135, 1085, 
822, cm-1; HRMS (ES) m/z = 943.4789 calcd for C60H71O6Si2 [MH]+, found 943.4794; 
HPLC (Chiralpak IA, 1.0 mL/min, 80:20 hexanes:i-PrOH): tR(S) = 4.97 min, tR(R) 
=16.25 min. 
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3,3'',5'-Trimethyl-2',6,6''-tri(oct-1-yn-1-yl)-[1,1':3',1''-terphenyl]-2,2'',4,4',4'',6'-
hexaol. Using 5a (25 mg, 0.11 mmol) in toluene (0.54 mL) with 40 mol% V3, the 
product was isolated as a yellow oil (4.7 mg, 0.0068 mmol, 19%).  1H NMR (500 MHz, 
CDCl3) δ 6.60 (s, 2H), 5.07 (s, 2H), 5.06 (s, 2H), 4.77 (s, 2H), 2.25 (m, 4H), 2.15 (s, 9H), 
1.90 (m, 2H), 1.40-0.90 (m, 24 H), 0.88 (m, 9H); 13C NMR (500 MHz, CDCl3) δ 154.8, 
154.0, 153.5, 123.0, 115.3, 97.5, 93.5, 31.4, 28.7, 28.4, 28.3, 28.1, 22.6, 19.4, 14.2, 8.6; 
HRMS (ES) calcd for C45H57O6 (MH+) 693.4077, found 693.4081; HPLC (Chiralpak IA, 
1.0 mL/min, 80:20 hexanes:i-PrOH): tR(S) = 8.09 min, tR(R) =9.30 min. 
 
General Procedure for Vilsmeier Haack Formylation 
To a solution of dry N,N-dimethylformamide (0.02 mL) at 0 °C, phosphoryl chloride 
(0.01 mL, 0.119 mmol) was  added and stirred for 30 min. The resulting Vilsmeier 
complex was then added to a solution of alkynyl arene (0.054 mmol) in dichloroethane or 
CH2Cl2 (0.80 mL, 0.067 M). The mixture was stirred at room temperature for 1-10 h. The 
reaction mixture was quenched with water and extracted with ethyl acetate. The organic 
layers were combined, washed with brine, dried over sodium sulfate, and concentrated. 
The crude product was purified through column chromatography (SiO2, CH2Cl2).55 
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4-Hydroxy-2-methoxy-3-methyl-6-(oct-1-yn-1-yl)benzaldehyde (42b). Using 41 (50 
mg, 0.20 mmol), the product was isolated as a yellow oil (14.9 mg, 0.054 mmol, 27%).  
1H NMR (500 MHz, CDCl3) δ 8.27 (s, 1H), 6.79 (s, 1H), 6.74 (s, 1H), 3.83 (s, 3H), 2.37 
(t, 2H), 2.04 (s, 3H), 1.59-1.31 (m, 8H), 0.90 (m, 3H). 
 
OH
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OH
OHC
 
2,4-Dihydroxy-3-methyl-6-(oct-1-yn-1-yl)benzaldehyde(42a). Using 5a (50 mg, 0.22 
mmol), the product was isolated as a white solid (13.7 mg, 0.053 mmol, 24%). mp 111–
112 ºC. 1H NMR (300 MHz, CDCl3) δ 12.31 (s, 1H), 10.20 (s, 1H), 6.49 (s, 1H), 4.85 (s, 
1H), 2.44 (t, 2H), 2.10 (s, 3H), 1.60 (m, 2H), 1.45 (m, 2H), 1.31 (m, 4H), 0.90 (m, 3H); 
13C NMR (500 MHz, CDCl3) δ 195.6, 163.2, 160.9, 127.7, 114.6, 112.5, 111.7, 97.7, 
76.0, 31.4, 28.8, 28.6, 22.7, 19.7, 14.2, 7.3; IR (film) 3565, 3055, 2930, 2305, 1620, 740 
cm-1; HRMS (ES) calcd for C16H19O3 (M-H+) 259.1340, found 259.1344.  
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4,4',6,6'-Tetrahydroxy-5,5'-dimethyl-2,2'-di(oct-1-yn-1-yl)-[1,1'-biphenyl]-3,3'-
dicarbaldehyde(3a). Using 40a (25 mg, 0.054 mmol) in dichloromethane (0.80 mL), the 
product was isolated as a yellow oil (9.4 mg, 58%).  [α]D22  +31.69  (c 0.52, 12%, 
CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 12.43 (s, 2H), 10.28 (s, 2H), 2.24 (m, 4H), 2.04 
(s, 6H), 1.30-1.21 (m, 8H), 1.14 (m, 8H), 0.88 (t, 6H); 13C NMR (500 MHz, CDCl3) δ 
195.7, 163.4, 159.4, 154.7, 114.8, 114.0, 112.6, 101.5, 74.3, 31.3, 28.6, 28.5, 22.5, 19.6, 
14.2, 7.9; IR (film) 3492, 3055, 2931, 2306, 2222, 1739, 1421, 1265, 739 cm-1; HRMS 
(ES) m/z = 519.2747 calcd for C32H39O6 [MH]+, found 519.2748. 
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(S)-4,4',6,6'-Tetrahydroxy-2,2'-bis((S)-6-hydroxyhept-1-yn-1-yl)-5,5'-dimethyl-[1,1'-
biphenyl]-3,3'-dicarbaldehyde (3b). Using 40b (28 mg, 0.05 mmol), in 
dichloromenthane (0.75 mL), the product was isolated as a yellow oil (7.4 mg, 43%).  
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[α]D22  –17.94  (c 0.67, dr = 94:6, CH2Cl2);  1H NMR (500 MHz, CDCl3) δ 12.34 (s, 2H), 
10.21 (s, 2H), 8.01 (s, 2H), 5.82 (br, 2H), 4.93 (m, 2H), 2.29 (m, 4H), 2.17 (s, 6H), 1.37-
1.34 (m, 8H), 1.17 (d, J = 6.0 Hz, 6H); 13C NMR (500 MHz, CDCl3) δ 195.5, 163.5, 
160.9, 159.7, 128.4, 115.4, 113.0, 101.2, 74.3, 70.2, 34.6, 24.1, 20.0, 19.4, 7.9; IR (film) 
3414, 3058, 2933, 2223, 1717, 1622, 1325, 1104, 738 cm-1. 
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(S)-2,2'-Bis((S)-6-((tert-butyldiphenylsilyl)oxy)hept-1-yn-1-yl)-4,4',6,6'-tetrahydroxy-
5,5'-dimethyl-[1,1'-biphenyl]-3,3'-dicarbaldehyde (3c). Using 40c (235 mg, 0.24 
mmol) in dichloromethane (3.6 mL), the product was isolated as a yellow oil (236.8 mg, 
95%). [α]D22  –45.84 (c 2.26, dr = 82:18, CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 12.29 
(s, 2H), 10.15 (s, 2H), 7.75-7.66 (m, 10H), 7.42-7.38 (m, 10H), 6.14 (s, 2H), 3.77 (m, 
2H), 2.17 (s, 6H), 2.10 (m, 4H), 1.36-1.26 (m, 8H), 1.10 (s, 9H), 1.06 (s, 9H), 0.99 (d, J 
= 6.0 Hz, 6H); 13C NMR (500 MHz, CDCl3) δ 195.5, 163.4, 159.8, 136.0, 135.9, 134.9, 
129.8, 127.9, 115.4, 114.8, 112.8, 73.8, 68.9, 38.3, 32.1, 29.9, 27.2, 24.0, 23.3, 22.8, 19.6, 
19.4, 14.3, 7.9, 1.2; IR (film) 3508, 3052, 2928, 2222, 1623, 1111, 704 cm-1; HRMS (ES) 
calcd for C62H70O8Si2 (M+) 998.4609, found 998.4597. 
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(S)-2,2'-Dibromo-4,4',6,6'-tetrahydroxy-5,5'-dimethyl-[1,1'-biphenyl]-3,3'-
dicarbaldehyde.  A mixture of the dimeric phenol (10 mg, 0.025 mmol) and 
hexamethylenetetramine (14 mg, 0.100 mmol) in acetic acid (0.01mL) was heated at 110 
ºC.  After 3 h, an aqueous solution of H2SO4 (0.02 mL, 17% v/v) was added and stirred at 
100 ºC for 1 h. The reaction mixture was cooled to room temperature and extracted with 
ethyl acetate (x3). The organic layers were combined, dried over MgSO4 and 
concentrated to yield a brown solid (2.7 mg, 24%). 1H NMR (500 MHz, CDCl3) δ 12.83 
(s, 2H), 10.21 (s, 2H), 2.16 (s, 6H). 
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3-Hexyl-7-hydroxy-7-methyl-6H-isochromene-6,8(7H)-dione (46).  To 
alkynylbenzaldehyde (25 mg, 0.096 mmol) and Au(OAc)3  (2.0 mg, 0.0048 mmol) in 
DCE (0.70 mL), 50 µL trifluoroacetic acid were added, and the mixture was stirred at rt 
for 1 min. To this mixture was added IBX (60 mg, 0.22 mmol) and tetrabutylammonium 
iodide (1.8 mg). The reaction mixture was stirred at room temperature. After 1h, the 
reaction mixture was quenched with saturated Na2S2O3 and extracted three times with 
ethyl acetate. The organic layers were combined, washed with brine, dried over sodium 
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sulfate and concentrated. The residue was purified through column chromatography 
(SiO2, 40%-60% EtOAc/Hexanes) to afford the corresponding azaphilone in 95% yield 
(26.6 mg) as a brown oil. 1H NMR (500 MHz, CDCl3) δ 7.87 (s, 1H), 6. 90 (s, 1H), 5.49 
(s, 1H), 3.95 (br, 1H), 2.40 (t, J = 11.5 Hz, 2H), 1.52 (s, 3H), 1.33-1.22 (m, 8H), 0.87 (t, J 
= 6.7 Hz, 3H); 13C NMR (500 MHz, CDCl3) δ 196.5, 196.0, 163.3, 153.2, 144.4, 115.9, 
108.5, 105.1, 83.6, 33.3, 31.5, 28.7, 28.6, 26.8, 22.6, 14.1; IR (film) 3432, 3073, 3929, 
1718, 1630, 1453, 1137, 858 cm-1; HRMS (ES) calcd for C16H21O4 (MH+) 277.1440, 
found 277.1443. 
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(S)-3,3'-Dihexyl-7,7'-dihydroxy-7,7'-dimethyl-6H,6'H-[5,5'-biisochromene]-
6,6',8,8'(7H,7'H)-tetraone, (47a). Using the procedure for 46 with 3a (75 mg, 0.145 
mmol), the product was isolated as a orange oil (66.7 mg, 83%, dr = 1:1). 
RSR diasteroisomer:  [α]D22  +37.37  (c 0.23, 12 % ee, CH2Cl2); 1H NMR (500 MHz, 
CDCl3) δ 7.94 (s, 2H), 5.68 (s, 2H), 3.92 (s, 2H), 2.37 (t, J = 11.5 Hz, 4H), 1.72 (s, 6H), 
1.28-1.25 (m, 16H), 0.88 (t, 6H); 13C NMR (500 MHz, CDCl3) δ 195.7, 195.0, 163.8, 
152.6, 141.4, 116.4, 109.5, 106.7, 84.2, 33.7, 31.5, 29.8, 28.8, 27.0, 22.6, 14.1; IR (film) 
3375, 3060, 2927, 1716, 1624, 1263, 1136, 738 cm-1; HRMS (ES) calcd for C32H39O8 
(MH+) 551.2646, found 551.2625. 
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SSR diasteroisomer: [α]D22  +34.24  (c 0.21, 12 % ee, CH2Cl2)1H NMR (500 MHz, 
CDCl3) δ 8.00 (s, 1H), 7.95 (s, 1H), 5.78 (s, 1H), 5.76 (s, 1H), 3.98 (br, 1H), 3.94 (br, 
1H), 2.39 (m, 4H), 1.71 (s, 3H), 1.65 (s, 3H), 1.28-1.25 (m, 16H), 0.88 (t, 6H); IR (film) 
3439, 3054, 2929, 2686, 2306, 1717, 1633, 1428, 1111, 739 cm-1; HRMS (ES) calcd for 
C32H39O8 (M+) 551.2646, found 551.2619. 
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(S)-3,3'-Bis((S)-4-((tert-butyldiphenylsilyl)oxy)pentyl)-7,7'-dihydroxy-7,7'-dimethyl-
6H,6'H-[5,5'-biisochromene]-6,6',8,8'(7H,7'H)-tetraone (47c).  Using the procedure 
for 46 with 3c (24 mg, 0.024 mmol), the product was isolated a as a orange oil (23.2 mg, 
92%, dr = 1:1). 
RSR diasteroisomer: [α]D22  +30.94 (c 0.05, dr = 82:18, CH2Cl2); 1H NMR (500 MHz, 
CDCl3) δ 7.88 (s, 2H), 7.70 (m, 10H), 7.37-7.33 (m, 10H), 5.63 (s, 2H), 3.92 (s, 2H), 
3.85-3.82 (m, 2H), 2.24 (m, 4H), 1.71 (s, 6H), 1.56 (m, 8H), 1.04 (s, 18H), 0.87 (m, 6H): 
13C NMR (500 MHz, CDCl3) δ 195.5, 195.1, 163.1, 152.6, 141.4, 136.0, 134.6, 134.3, 
129.8, 127.7, 127.6, 116.3, 109.4, 106.8, 84.2, 68.8, 38.6, 33.7, 29.8, 28.7, 27.1, 23.3, 
22.6, 19.4. 1.2; IR (film) 3539, 2917, 2849, 2360, 1633, 1427, 1109 cm-1; HRMS (ES) 
calcd for C62H71Si2O10 (MH+) 1031.4586, found 1031.4574. 
SSR diasteroisomer:  [α]D22  +32.61 (c 0.14, dr = 82:18, CH2Cl2); 1H NMR (500 MHz, 
CDCl3) δ 7.94 (d, 1H), 7.90 (d, J = 8.0 Hz,  1H), 7.65-7.64 (m , 10H), 7.41-7.34 (m, 
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10H), 5.75 (d, J = 8.0 Hz, 1H), 5.71 (d, J = 8.0 Hz, 1H), 4.13 (br, 2H), 3.85 (m, 2H), 2.39 
(m, 4H),  1.71 (s, 6H), 1.61 (m, 8H), 1.10 (s, 18H), 0.88 (m, 6H); 13C NMR (500 MHz, 
CDCl3) δ 195.3, 195.0, 194.5, 194.4, 163.4, 153.1, 152.5, 143.5, 142.2, 141.8, 135.8, 
135.8, 129.6, 116.2, 108.2, 107.7, 107.6, 106.1, 84.1, 83.1, 68.8, 68.6, 38.5, 38.4, 33.5, 
29.7, 28.8, 27.0, 24.0, 23.2, 23.1, 19.2, 14.1, 1.0; IR (film) 3384, 3070, 2927, 1718, 1631, 
1429, 1261, 1136, 1047, 738 cm-1; HRMS (ES) calcd for C62H71Si2O10 (MH+) 1031.4586, 
found 1031.4586. 
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3-Hexyl-7-methyl-6,8-dioxo-7,8-dihydro-6H-isochromen-7-yl acetate (46b). To 
alkynylbenzaldehyde (25 mg, 0.096 mmol) and Au(OAc)3 (2.0 mg, 0.0048 mmol)  in 
DCE (0.70 mL), 50 µL trifluoroacetic acid were added, and the mixture was stirred at 
room temperature for 1 min. The resulting mixture was diluted in DCE (5.3 mL) and 
purged with argon.  Pb(OAc)4 (55 mg, 0.125 mmol) was added in three portions over 15 
min. The solution stirred for 1 hour, and was then quenched with cold water. The reaction 
mixture was extracted with dichloromethane (3x).  The organic layers were collected, 
dried over magnesium sulfate, filtered and concentrated. The product was purified 
through column chromatography (SiO2, DCM) to afford the corresponding azaphilone in 
55% yield (17.0 mg) as a brown oil. 1H NMR (500 MHz, CDCl3) δ 7.91 (s, 1H), 6.12 (s, 
1H), 5.53 (s, 1H), 2.43 (t, 2H), 1.69 (s, 3H), 1.63 (s, 3H), 1.32 (m, 8H), 0.90 (t, 3H); 13C 
NMR (500 MHz, CDCl3) δ 193.5, 192.8, 170.2, 162.6, 154.1, 142.0, 115.3, 108.7, 106.9, 
84.5, 33.2, 31.5, 28.7, 26.6, 22.6, 22.4, 20.3, 14.1. 
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(S)-3,3'-Dihexyl-7,7'-dimethyl-6,6',8,8'-tetraoxo-7,7',8,8'-tetrahydro-6H,6'H-[5,5'-
biisochromene]-7,7'-diyl diacetate, RSR Diasterosiomer (48a).   Using the procedure 
for 46b with 3a (9.0 mg, 0.016 mmol), the product was isolated as yellow oil (1.7 mg, 
5%). NMR spectra matched those presented later. 
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(S)-3,3'-bis((S)-4-((tert-butyldiphenylsilyl)oxy)pentyl)-7,7'-dimethyl-6,6',8,8'-
tetraoxo-7,7',8,8'-tetrahydro-6H,6'H-[5,5'-biisochromene]-7,7'-diyl diacetate, RSR 
diasteroisomer (48c).  Using the procedure for 46b with 3c (6.6 mg, 0.006 mmol), the 
product was isolated as yellow oil (6.6 mg, 78%). NMR spectra matched those presented 
later. 
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Preparation of Cu2L2O2 complex 
 
CuIII
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To a oven-dried microwave vial containing Cu(CH3CN)4PF6 (79 mg)  in CH2Cl2 (1.5 
mL) under argon, N,N’- tetraethylenediamine was added generating a light pink solution. 
The vial was sealed and the mixture was stirred for 30 min before being cooled to –78 ºC. 
The flask was evacuated and filled with oxygen three times producing a brown solution, 
and then stirred at –78 ºC for 1 h.41 
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(2-Hydroxy-6-(hydroxymethylene)-2-methyl-5-(oct-1-yn-1-yl)cyclohex-4-ene-1,3-
dione.  Alkynylbenzaldehyde (25 mg, 0.10 mmol) and diisopropylethylamine (0.03 mL, 
0.16 mmol) in CH2Cl2 (0.38 mL) solution were added to the Cu2L2O2 complex (0.11 
mmol, 1.5 mL). After 5 min, 4-dimethylaminopyridine (29 mg, 0.24 mmol) in CH2Cl2 
was added and the mixture was warmed and stirred at –10 ºC for 30 h. The mixture was 
quenched at –10 ºC with 1.5 mL 10% sulfuric acid and 1.5 mL brine. The mixture was 
extracted with EtOAc (x3) and concentrated. The unpurified residue was used directly in 
the next step.41 1H NMR (500 MHz, CDCl3) δ 8.25 (s, 1H), 6.12 (s, 1H), 2.50 (t, 2H), 
2.10 (s, 3H), 1.43 (m, 8H), 1.25, (t, 3H).  
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General Procedure for Acetylation. 
To a solution of azaphilone (0.047 mmol) in CH2Cl2 (2.0 mL) acetic anhydride (0.093 
mmol) was added followed by DMAP (0.047 mmol) and triethylamine (0.093 mmol).  
The mixture was stirred for 10 min at room temperature. The mixture was poured in to 
siliga-gel column (SiO2, CH2Cl2) to afford the corresponding pure azaphilone. 
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3-hexyl-7-methyl-6,8-dioxo-7,8-dihydro-6H-isochromen-7-yl acetate (46b). Using 46a 
(15.6 mg, 0.057 mmol), the product was isolated as an off-white solid (17.0 mg, 94%).  
1H NMR (500 MHz, CDCl3) δ 7.87 (s, 1H), 6.08 (s, 1H), 5.50 (s, 1H), 2.39 (m, 2H), 2.16 
(s, 3H), 1.60 (m, 2H), 1.52 (s, 3H), 1.36-1.25 (m, 6H), 0.90 (m, 3H); 13C NMR (500 
MHz, CDCl3) δ 193.5, 192.8, 170.2, 162.6, 154.1, 142.0, 115.3, 108.7, 106.9, 84.5, 33.2, 
31.5, 28.7, 26.6, 22.6, 22.4, 20.3, 14.1; IR (film) 3060, 2927, 1718, 1641, 1257, 1089 cm-
1; 1HRMS (ES) calcd for C18H23O5 (MH+) 319.1545, found 319.1546. 
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3,3'-Dihexyl-7,7'-dimethyl-6,6',8,8'-tetraoxo-7,7',8,8'-tetrahydro-6H,6'H-[5,5'-
biisochromene]-7,7'-diyl diacetate, RSR Diasterosiomer (48a). Using (RSR)-47a 
(9.0mg, 0.016 mmol), the product was isolated as a yellow oil (8.0 mg, 82%).   1H NMR 
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(500 MHz, CDCl3) δ 7.92 (s, 2H), 5.93 (s, 2H), 2.34 (m, 4H), 2.16 (s, 6H), 1.62 (s, 6H), 
1.40-1.20 (m, 16H), 0.90 (t, 6H); 13C NMR (500 MHz, CDCl3) δ 193.6, 190.8, 170.5, 
163.2, 153.8, 141.8, 115.6, 110.6, 107.5, 85.0, 33.5, 32.1, 31.5, 28.8, 26.6, 22.8, 20.4, 
14.3; HRMS (ES) calcd for C36H42O10 (MH+) 635.2856, found 635.2855. 
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3-Hexyl-7-hydroxy-7-methylisoquinoline-6,8(2H,7H)-dione (50). To a solution 
azaphilone 46 (8.1 mg, 0.029 mmol) in CH2Cl2 (1.8 mL), ammonium acetate (3.0 mg) 
was added. The mixture was stirred at room temperature for 36 h. The solvent was 
removed. The product was purified through column chromatography (SiO2, 80%-100% 
EtOAc/Hexanes) to afford 50 in 89% yield (7.3 mg) as a red-orange oil. 1H NMR (500 
MHz, CDCl3) δ 8.79 (s, 1H), 6.64 (s, 1H), 5.26 (s, 1H), 4.75 (br, 1H), 2.71 (t, 2H), 1.68 
(m, 3H), 1.31-1.25 (m, 8H), 0.88 (m, 3H); 13C NMR (500 MHz, CDCl3) δ 202.3, 195.5, 
169.3, 150.3, 121.9, 117.2, 90.2, 38.9, 31.7, 30.7, 30.1, 29.8, 29.7, 29.2, 22.8, 14.3; IR 
(film) 3355, 3151, 2926, 1705, 1596, 1171, 738 cm-1; HRMS (ES) calcd for C16H22NO3 
(M+) 463.1600, found 463.285. 
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2-Hydroxy-6-(iminomethyl)-2-methyl-5-(2-oxooctyl)cyclohex-4-ene-1,3-dione (51). 
Using the procedure for 50. Isolated as a red oil (17.3 mg, 98%): 1H NMR (500 MHz, 
CDCl3) δ 9.19 (s, 1H), 7.13 (s, 1H), 4.17 (d, J = 20.0 Hz, 1H), 3.88 (d, J = 20.5, 1H), 
3.69 (s, 1H), 2.87 (m, 3H), 1.77 (s, 3H), 1.35 (m, 8H), 0.73 (m, 3H). 
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CHAPTER 2  
 
SELECTIVE OXIDATIVE HOMO- AND CROSS-COUPLING OF PHENOLS USING 
AEROBIC CATALYSTS 
 
2.1 Background: Importance and Applications of Chiral Biaryl Compounds. 
Optically active biphenols are important scaffolds in the synthesis of chiral 
catalysts and natural products. Many highly bioactive natural products contain biphenols 
in their skeleton (Figure 2.1.0). The biphenolic scaffold is found in different 
arrangements such as homocoupled phenols with ortho-ortho (1-8),82, 83, 84, 85 ortho-para 
(11-12),83 and para-para (9)86 connetctions, heterophenols (10),87 oxidized derivatives (8), 
and bridged phenols (11-12).88 
 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
82 Nunez-Montoya, S C.; Agnese, A. M.; Cabrera, J. L. “Anthraquinone Derivatives from Heterophyllaea 
Pustulata” J. Nat. Prod. 2006, 69, 801–803 
83 Bringmann, G.; Gulder, T.; Gulder, T. A. M.; Breuning, M.; “Atroposelective Total Synthesis of Axially 
Chiral Biaryl Natural Products” Chem. Rev. 2011, 111, 563–639. 
84 Kobayashi, E.; Ando, K.; Nakano, H.; Ilda, T.; Morimoto, M.; Tamaki, T. “Calphostins (UCN-1028), 
Novel and Specific Inhibitors of Protein Kinase C. I. Fermentation, Isolation, physico-chemical Properties 
and Biological Activities.” J. Antibiot. 1989, 10, 1470–1474. 
85 Ge, H. M.; Zhang, W. Y.; Ding, G.; Saparpakon, P.; Song, Y. C. Hannongbua, S.; Tan, R. X.; 
“Chaetoglobins A and B, two Unusual Alkaloids from Endophytic Chaetomium globosum Culture” Chem. 
Commun. 2008, 5978-5980. 
86 Maestri D. M.; Nepote V.; Lamarque A. L.; Zygadlo J. A. “Natural Products as Antioxidants” 
Phytochemistry: Advances in Research, 1st; Research Signpost: Kerala, India, 2006: pp105–135	  
87 Jossang, A.; Fodor, P; Bodo, B. “A New Structural Class of Bisindole Alkaloids from the Seeds of 
Catharanthus roseus: Vingramine and Methylvingramine” J. Org. Chem., 1998, 63, 7162–7167. 
88 Kosenkova, Y. S.; Polovinka, M. P.; Komarova, D. V.; Korchagina, N. Y.; Kurochkina, N. Y.; 
Cheremushkina, V. A.; Salakhutdinov, N. F.; “Riccardin C, a Bisbibenzyl Compound from Primula 
Macrocalyx” Chem. Nat. Comp. 2007, 43, 712–713.	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Figure 2.1.0  Biphenolic Natural Products 
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Numerous biphenolic natural products have been reported with a broad range of 
biological applications such as: cancer cell growth and proliferation inhibition, anti-
HIV,83 antioxidant,86 and antibacterial activities.83 Skyrin (1), a well-studied 
disanthaquinone, inhibits the growth of HeLa, Vero, K562, and other tumor cells.89  
Michellanime B shows high anti-HIV activity in vitro.83 Chaetoglobin A (8) is considered 
a potential platform for the development of antibacterial90–91 and anti-cancerous drugs. 
This molecule inhibits the tumor-related genes bcl-2, c-myc and β-catenin, which are 
common in human and animal cancers.85  Riccardin C (11)92 functions as a liver receptor 
agonist, which is an essential regulator of cholesterol homeostasis.  
Chiral biphenols are important scaffolds in the synthesis of chiral catalysts (Figure 
2.1.1). Rosseta et al. synthesized and characterized a series of phosphoramidite ligands 
(13)93 and used them in copper-catalyzed 1,4-addition with up to 99.5% ee. Ojima et al. 
reported a new library of phosphoramidite ligands (13 and 14) that show high 
enantioselectivities in palladium catalyzed allylic alkylation and Rhodium catalyzed 
hydrogenation.94 Tanaka et al. (15)95 synthesized a series of chiral biaryl diphosphine 
ligands through a rhodium-catalyzed intramolecular [2+2+2] cycloaddition of alkynes 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
89 Lin, L.; Chou, C.; Kuo, Y. "Cytotoxic Principles from Ventilago Leiocarpa" J. Nat. Prod. 2001, 64, 674–
676. 
90 Ayer, W. A.; Craw, P.A.; Nozawa, K. “Two 1H-naphtho[2,3-clpyran-1-onemetabolites from the Fungus 
Paecilomyces Variotii” Can. J. Chem., 1991, 69,189–191.  
91 Mukhopadhyay, T.; Roy, K.; Coutinho, L.; Rupp, R. H.; Ganguli, B. N. “Fumifungin, a new antifungal 
antibiotic from Aspergillus Fumigatus Fresenius 1863 ” J. Antibiot., 1987, 40, 1050-1052. 
92	  Tamehiro, N.; Sato, Y.; Suzuki, T.; Hashimoto, T.; Asakawa, Y.; Yokoyama, S.  Kawanishi T.; Ohno, 
Y.; Inoue, K.; Nagao, T.; Nichimaki-Mogami, T. “Riccardin C: A Natural Product that Functions as a liver 
X Receptor (LXR)a Agonist and an LXRb Antagonist” FEBS Lett. 2005, 579, 5299–5304.	  
93	  Alexakis,	  A.;	  Poleta,	  D.;	  Benhaimb,	  C.;	  Rosseta,	  S.	  “Biphenol-­‐based	  Ligands	  for	  Cu-­‐catalyzed	  
Asymmetric	  Conjugate	  Addition”	  Tetrahedron:	  Asymmetry	  2004,	  15,	  2199–2203.	  
94 Chapsal B. D.; Hua Z.; Ojima, I. “Catalytic Asymmetric Transformations with Fine-tunable Biphenol-
based Monodentate Ligands” Tetrahedron: Asymmetry 2006, 17, 642–657. 
95	  Mori, F.; Fukawa, N.; Noguchi, K.; Tanaka, K. “Asymmetric Synthesis of Axially Chiral Biaryl 
Diphosphine Ligands by Rhodium-Catalyzed Enantioselective Intramolecular Double [2 + 2 + 2] 
Cycloaddition” Org. Lett. 2011, 13, 362–365. 
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and employed them for the rhodium-catalyzed enantioselective hydrogenation of 
disubstituted alkenes. Sugar-based phosphite and phosphoroamidite ligands were 
designed by Alexkis and coworkers, and used for Cu-catalyzed 1,4-addition to enones.96 
Wulff designed an efficient synthetic route for the preparation of valuates biaryl 17 and 
evaluated their copper-mediated deracemization.97 These types of ligands are highly 
efficient in a number of asymmetric reactions such as: Diels-Alder reactions, 
aziridination reactions, Mannich reactions, Baeyer-Villiger reactions, asymmetric 
reduction of imines, desymmetrization of aziridines, the Petasis reaction, and the 
hydroarylation of alkenes97. 
 
 
 
 
 
 
 
 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
96 Raluy, E.; Pamies, O.; Dieguez, M.; Rosset, S.; Alexkis, A. “Sugar-based Phosphite and 
Phosphoroamidite Ligands for the Cu-catalyzed Asymmetric 1,4-addition to Enones” Tetrahedron: 
Asymmetry, 2009, 20, 2167–2172. 
97 Hu, G.; Holmes, D.; Gendhar, F. B.; Wolff, W. D. “Optically Active (aR)- and (aS)-Linear and Vaulted 
Biaryl Ligands: Deracemization versus Oxidative Dimerization” J. Am. Chem. Soc. 2009, 131, 14355–
14364.	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Figure 2.1.1  Biphenolic Ligands. 
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2.1.1  Studies Toward the Oxidative Coupling of Naphthols 
  Chiral biphenols are important building blocks in the construction of widely used 
ligands and highly active natural products. For years, scientists have investigated ways to 
prepare these compounds in a regio- and enantioselective way. Oxidative coupling of 
naphthols is a straightforward strategy for the preparation of binaphtols. This section 
presents the most relevant methods developed for oxidative coupling of naphthols. 
 Nakajima and coworkers developed an enantioseletive method for the oxidative 
coupling of 2-naphthols using copper-proline derived diamine catalyst (Scheme 
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2.1.1.0).98 Oxidative coupling of naphthols was afforded with up to 78% ee by employing 
only 10 mol % of chiral catalyst with oxygen as the oxidant 
 
Scheme 2.1.1.0. Enantioselective Synthesis of Binaphthols Using Chiral Diamine Copper 
Complexes  
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Kozlowski’s research group investigated 1,5-diaza-cis-decalins as ligands in the 
asymmetric oxidative coupling of 2-naphthols derivatives (Scheme 2.1.1.1).99,100,101  
These ligands were applied to the coupling of 3-substituted 2-naphthols including 3-ester, 
ketone, phosphonyl, and sulfonyl derivatives to afford the corresponding binaphthols in 
44–96% ee.  This method was used for the synthesis of a number of  
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
98 Nakajima, M.; Miyoshi, I.;  Kanayama, K.; Hashimoto, S. “Enantioselective Synthesis of Binaphthol 
Derivatives by Oxidative Coupling of Naphthol Derivatives Catalyzed by Chiral Diamine‚Copper 
Complexes” J. Org. Chem. 1999, 64, 2264–2271. 
99	  Li, X.; Yang, J.; Kozlowski, M. C.; “Enantioselective Oxidative Biaryl Coupling Reactions Catalyzed by 
1,5-Diazadecalin Metal Complexes” Org. Lett. 2001, 3, 1137–1140. 
100	  Li, X.; Hewgley, J. B.; Mulrooney, C. A.; Yang, J.; Kozlowski, M. C. “Enantioselective Oxidative 
Biaryl Coupling Reactions Catalyzed by 1,5-Diazadecalin Metal Complexes: Efficient Formation of Chiral 
Functionalized BINOL Derivatives” J. Org. Chem. 2003, 68, 5500–5511.	  
101	  Hewgley, J. B.; Stahl, S. S.; Kozlowski, M. C.; “Mechanistic Study of Asymmetric Oxidative Biaryl 
Coupling: Evidence for Self-Processing of the Copper Catalyst to Achieve Control of Oxidase vs. 
Oxygenase Activity” J. Am. Chem. Soc. 2008, 130, 12232–12233. 
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Scheme 2.1.1.1.  Enantioselective Oxidative Biaryl Coupling of Highly Hindered 
Naphthols 
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natural products such as: (S)-bisoranjidiol (18),102,103 nigerone (19),104 Hipocrelin A 
(20),105 and perylenequinone (21).106 This strategy was also applied to the asymmetric 
synthesis of binaphthyl polymers.107 
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  Podlesny E. E.; Kozlowski, M. C.; “Divergent Approach to the Bisanthraquinone Natural Products: 
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78, 466−476. 
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 Katsuki used a series of metal-salen catalysts for the enantioselective aerobic 
oxidative coupling of naphthols (Scheme 2.1.1.2). 108  Katsuki initially developed a 
photopromoted oxidative coupling of naphthols using a chiral (NO)Ru(II)-salen 26 as 
catalyst to afford the respective binaphthols in moderate to good enantioselectivities.109 
Years later, Katsuki used Fe-(salen) catalysts (22–25, 27) to afford  chiral 3,3′-
disubstituted binaphthols with moderate enantioselectivities.110,111 
Gong designed a series of chiral oxovanadium complexes (28 and 29, Scheme 
2.1.1.3) from the asymmetric coupling of naphthol derivatives.112,113 The coupling of 
naphthols using oxygen as the oxidant was carried out using 5 mol % of  an oxovanadium 
complex derived from tert-leucine to produce the corresponding binaphthols in good 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
103	  Podlesny, E. E.; Kozlowski, M. C. “Enantioselective Total Synthesis of (S)-Bisoranjidiol, an Axially 
Chiral Bisanthraquinone” Org. Lett. 2012, 14, 1408-1411. 
104	  Kozlowski, M. C.; Dugan, E. C.;  DiVirgilio, E. S.; Maksimenka K.; Bringmann G. “Asymmetric Total 
Synthesis of Nigerone and ent-Nigerone:Enantioselective Oxidative Biaryl Coupling of Highly Hindered 
Naphthols” Adv. Synth. Catal. 2007, 349, 583 – 594. 
105	  O’Brien, E. M.; Morgan, B. J; Mulrooney, C. A.; Carroll, P.; Kozlowski, M. C. “Perylenequinone 
Natural Products: Total Synthesis of Hypocrellin A” J. Org. Chem. 2010, 75, 57–68. 
106	  Mulrooney; C. A.; Li, X.; DiVirgilio, E. S.; Kozlowski, M. C. “General Approach for the Synthesis of 
Chiral Perylenequinones via Catalytic Enantioselective Oxidative Biaryl Coupling” J. Am. Chem. Soc. 
2003, 125, 6856–6857. 
107	  Morgan, B. J.; Xie, X.; Phuan, P.; Kozlowski, M. C. “Enantioselective Synthesis of Binaphthyl 
Polymers Using Chiral Asymmetric Phenolic Coupling Catalysts: Oxidative Coupling and Tandem 
Glaser/Oxidative Coupling” J. Org. Chem. 2007, 72, 6171–6182. 
108	  Uchida, T.; Katsuki, T. “Green Asymmetric Oxidation Using Air as Oxidant” J. Synth. Org. Chem., 
Jpn.  2013, 71, 1126–1135. 
109 Irie R.; Masutani K.; Katsuki T.; “Asymmetric aeroboc oxidative coupling of 2-naphthol derivatives 
catalyzed by photoactivated chira (O)Ru(II)-Salen complex” Synlett 2000, 10, 1433–1436.	  
110	  Egami, H.;  Katsuki, T. “Iron-Catalyzed Asymmetric Aerobic Oxidation: Oxidative Coupling of 2-
Naphthols” J. Am. Chem. Soc. 2009, 131, 6082–6083. 
111	  Egami, H.; Matsumoto, K.; Oguma, T.; Kunisu ,T.; Katsuki, T. “Enantioenriched Synthesis of C1-
Symmetric BINOLs: Iron-Catalyzed Cross-Coupling of 2-Naphthols and Some Mechanistic Insight” J. Am. 
Chem. Soc., 2010, 132, 19633–19635. 
112	  Guo, Q.; Wu, Z.; Luo, Z.;  Liu, Q.; Ye, J.; Luo, S.;  Cun, L.; Gong, L. “Highly Enantioselective 
Oxidative Couplings of 2-Naphthols Catalyzed by Chiral Bimetallic Oxovanadium Complexes with Either 
Oxygen or Air as Oxidant” J. Am. Chem. Soc. 2007, 129, 13927–13938. 
113	  Liu, Q.; Xie, N.; Luo, Z.; Cui, X.; Cun, L.; Gong, L.; Mi ,A.; Jiang, Y. “Facile Preparation of Optically 
Pure 7,7¢-Disubstituted BINOLs and Their Application in Asymmetric Catalysis” J. Org. Chem. 2003, 68, 
7921–7924. 
	  
	   125	  
yields and high enantioselectivities. The tert-butyl group was found to be the mayor 
control element in the stereochemistry of the biaryl product. Further, the presence of two 
centers was much more effective and a coupling involving two naphthols binding to the 
catalyst is support by kinetic studies. High-resolution mass spectroscopy on the reaction 
revealed an intramolecular radical mechanism. 
 
Scheme 2.1.1.2. Asymmetric Aerobic Oxidative Coupling of 2-Naphthols 
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Chen and coworkers also synthesized a number of oxovanadium-N-ketopinidene-
r-amino acids complexes (30) and used them for naphthol coupling to afford biaryls with 
up to 84% ee.114,115 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
114	  Hon, S.; Li, C.; Kuo, J.;  Barhate, N. B.; Liu, Y.; Wang, Y.; Chen, C. “Catalytic Asymmetric Coupling 
of 2-Naphthols by Chiral Tridentate Oxovanadium(IV) Complexes” Org. Lett., 2001, 3, 869–872. 
115	  Barhate, N. B.; Chen, C. “Catalytic Asymmetric Oxidative Couplings of 2-Naphthols by Tridentate N-
Ketopinidene-Based Vanadyl Dicarboxylates” Org. Lett. 2002, 4, 2529–2532. 
	  
	   126	  
Scheme 2.1.1.3.  Vanadium-Catalyzed Enantioselective Coupling of Naphthols 
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2.1.2 Studies Toward the Oxidative Coupling of Phenols 
Oxidative phenol coupling is a useful but challenging strategy for the construction of 
biaryls. The mechanism for naphthol and phenol coupling is believed to undergo a single 
electron transfer (Figure 2.1.2.0 and Figure 2.1.2..1).116 First, the naphthol coordinates to 
a metal complex and becomes oxidized to keto radical II.  The produced radical may 
react with another metal bound radical in bimetallic complexes or with another species in 
monometallic systems. Due to benzylic stabilization, the indicated resonance form of the 
radical dominates the reactivity. 
 On the other hand, the corresponding phenolic radical can be delocalized to the 
ortho and para carbons (VI, VII and VIII, Figure 2.1.2.1) and can produce three 
different products (X, XI, XII). The regioselectivity depends on the phenol substituents 
and how these substituents stabilize or destabilize the phenolic radical, resulting in a 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
116 Cao, T. “Part A: Palladium(II)-catalyzed enantioselective Saucy-Marbet Claisen rearrangement of 
propargyloxy indoles to quaternary oxindoles and spirocyclic lactones. Part B: The regioselective oxidative 
coupling of phenols” Ph.D. Dissertation, University of Pennsylvania, Philadelphia, PA, 2013.	  
	   127	  
substrate-dependent and limited in scope strategy. In addition, loss of aromaticity in an 
isolated aromatic system is higher in energy than loss of aromaticity in one ring of a 
naphthyl system  rendering phenol coupling more difficult than naphthol coupling. 
 
Figure 2.1.2.0. Mechanism for Oxidative Naphthol Coupling 
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Figure 2.1.2.1. Mechanism for Oxidative Phenol Coupling 
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Oxidative phenol coupling of phenols has been a subject of study for decades. In 
this section we present a summary of the most relevant studies toward oxidative phenol 
coupling. Nonhebel investigated the oxidative coupling of phenols using different 
stoichiometric oxidants to study the role of spin density on the product composition.117 
Nonhebel proposed a sandwich-like transition state (Figure 2.1.2.2).  The phenolic 
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radicals approach each other as shown in Figure 2.1.2.2 to maximize single occupied 
molecular orbital (SOMO) interactions. Nonhebel suggested two probable transitions 
states (A and B). Transitions state A possesses the strongest SOMO-SOMO interactions 
since the sites of highest spin density (para-position) are above each other. However, 
transition state A has a strong electrostatic interatcion between the two electronegative 
atoms (oxygen). Transition state A would lead to the formation of para-para and ortho-
ortho products, while TS B affords ortho-ortho and ortho-para products.  The 
experimental results revealed that at higher temperatures ortho-ortho product is 
predominant and at lower temperatures ortho-para product is favored. However, the 
results were not consistent with the proposed spin density distribution in the phenolic 
radical intermediate. Steric effects between the substituents do not appear to play a 
mayor role in the products distribution.  
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Figure 2.1.2.2. Sandwich-like Transition Ttate 
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Due to the limited-scope of this strategy, chemists have investigated different 
ways to produce each possible product for different types of substrates.118  Uang used 
catalytic VO(acac)2 for the oxidative coupling of naphthols and phenols to produce 
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regioselectively ortho-ortho coupling products 31 and 32.119,120 Mizuno studied oxidative 
coupling of naphthols and substituted phenols using catalytic Ru(OH)x /Al2O3 in water 
(33). 121   Wyreb investigated aryl oxidative coupling using stoichiometric copper 
complexes and selectively afforded the para-para dimer 34 in a system where only one 
coupling regioisomer is possible.122,123 
 
Scheme 2.2.0. Oxidative coupling of phenols 
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2.1.3 Salen-type Catalysts and Oxidation Reactions. 
Metal-salen complexes are versatile catalysts for a number of oxidation reactions.124 
Barch showed that manganese-salen catalysts are effective for the enantioselective 
oxidation of sulfides containing a lactam-binding motif to yield the corresponding 
sulfoxide 36 in a 63% yield and 47% ee (Scheme 2.1.3.0).125 The enantioselectivity is 
induced on the sulfide through hydrogen bonding with the salen catalyst. Iron-(salan) 
complexes, were also used  for the asymmetric oxidation of sulfides (37) to their 
respective sulfoxide (36) with a high enantioselectivities  using hydrogen peroxide in 
water.126 
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Scheme 2.1.3.0.  Manganese(salen)-Catalyzed Sulfoxidation Reaction. 
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Scheme 2.1.3.1. Iron(salan)-Catalyzed Oxidation of Sulfides 
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Enantioselective aerobic cyclization of stilbene 39 to produce benzofuran 40 was 
afforded in an enantioselective way (up to 72% ee) through oxygen cationonic radical 
catalyzed by (NO)Ru(salen). Photo-irradiation is essential for this transformation since 
light dissociates the nitosyl ligand to produce a free coordination site on the ruthenium, 
which is oxidized to Ru(IV) by oxygen.127 
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Scheme 2.1.3.2. Ruthenium(salen)-Catalyzed Asymmetric Cyclization  
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 Coates and coworkers reported the stereoselective synthesis of polyethers and 
kinetic resolution of epoxides using bimetallic cobalt complex (Scheme 2.1.3.3)128, 129.  
The fact that this particular ligand can hold two metals may make it attractive for 
bimetalic phenol coupling reactions. 
 
Scheme 2.1.3.3. Enantioselective Polymerization of Epoxides. 
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Recently, Katsuki reported oxidative binaphthol coupling using an iron salen 
catalyst with up to 93% yield and 94% ee (Scheme 2.1.3.2).108,109,110 This work suggests 
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that salen complexes could be an efficient set of catalysts for oxidative coupling of 
phenols. 
 
2.1.4 N,N-dimethylbis(pyridyl)ethylenediamine Catalysts. 
 
Jacobsen reported a method for the epoxidation of olefins 43 using a N,N’-
dimethylbis(pyridyl) ethilenediamine iron catalyst  and  50% H2O2 in water to afford  the 
corresponding epoxide in up to 90% yield in short reaction times (Scheme 2.1.4.0)130,131. 
 
Scheme 2.1.4.0. Epoxidation of 1-decene using iron N,N-
dimethylbis(pyridyl)ethylenediamine catalysts. 
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The oxidation of alkenes by iron enzymes generally produces epoxides, with the 
exception of Rieske dioxygenases, where the mayor product is cis-diols. Que designed a 
synthetic iron catalyst to afford the enantioselective dihydroxilation of alkenes in up to 
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82% yield and 76% ee (Scheme 2.1.4.1).132, 133 These complexes were also used for the 
study of regioselectivity in biomimetic extradiol cleavage of catechols.134 
 
Scheme 2.1.4.1. Iron(N,N-dimethylbis(pyridyl)ethylenediamine)-catalyzed Alkene 
Hydroxylation 
N N
N N
n-C4H9
0.1 mol% cat.
CH3CN,
H2O2 (20 equiv)
30 ºC,30 min
82% yield, 76% ee
n-C4H9
OH
OH
R R
R= 6-Me2-BPMCN
-FeII(CF3SO3)2
45 46
 
 
 
 
 
 
 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
132	  Chen, K.; Costas, M.; Kim, J.; Tipton, A. K.; Que, L. “Olefin Cis-Dihydroxylation versus Epoxidation 
by Non-Heme Iron Catalysts: Two Faces of an FeIII-OOH Coin” J. Am. Chem. Soc. 2002, 124, 3026–3035.	  
133	  Costas, M.; Tipton, A. K.; Chen, Jo, K. D.; Que, Jr. L; “Modeling Rieske Dioxygenases: The First 
Example of Iron-Catalyzed Asymmetric cis-Dihydroxylation of Olefins” J. Am. Chem. Soc. 2001, 123, 
6722–6723.	  
134	  Mayilmurugan, R.; Stoeckli-Evans, H.;  Palaniandavar, M.; “Novel Iron(III) Complexes of Sterically 
Hindered 4N Ligands: Regioselectivity in Biomimetic Extradiol Cleavage of Catechols” Inorg. Chem. 
2008, 47, 6645–6658.	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2.1.5 Summary of Prior Oxidative Coupling 
Chiral biaryls are important scaffolds in the preparation of wide range of chiral 
ligands and bioactive natural products. For years, scientists have investigated ways to 
synthesize these compounds in a regio- and enantioselective way. Oxidative coupling of 
naphthols is one of the most straightforward strategies for the enantioselective synthesis 
of binaphthols reported to date.  
The corresponding oxidative phenol coupling is a challenging strategy for the 
synthesis of biphenols. Achiral phenol coupling has been studied for many years with a 
variety of stoichiometric oxidants; however, the regioselective methods reported to date 
are substrate-dependent and limited in scope. Also, there is no report in literature of 
enantioselective oxidative phenol coupling.  
Metal-salen complexes have been used for a number of oxidation reactions. 
Recently, Katsuki reported oxidative binaphthol coupling using an iron salen catalyst 
with good yield and high enatioselectivity. This work suggests that salen complexes 
could be an efficient set of catalysts for oxidative coupling of phenols. 
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2.1.6 Aim of This Study 
The goal of this project is to develop a regioselective method for oxidative coupling 
of phenols. First, we synthesized a library of catalysts. Salen catalysts were first chosen 
based on success of reported oxidation reactions catalyzed by metal-salen complexes, 
especially the oxidative binaphthol coupling using an iron salen catalyst reported by 
Katsuki. Salen catalysts are flexible, easy to prepare, easy to derivatize, and interact well 
with a wide range of metals. Also, a series of N,N’-dimethylbis(pyridyl) ethylenediamine 
metal catalysts were synthesized, based on their reported success in oxidation reactions. 
In collaboration with Trung Cao, high-throughput experimentation (HTE) was 
used to screen a series of substrates and 58 catalysts in oxidative phenol coupling in order 
to explore the reactivity of these catalysts.  The substrates employed in the screening 
provide different reactivity modes and some exhibit chirality. Each substrate screen was 
compared with as many standards of the ortho-ortho, para-para, and ortho-para (or 
Pummerer ketone) coupling products as were available from conventional oxidants. Hits 
from each screening were validated in a larger scale and isolated yield were obtained. 
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2.2 Studies Towards the Synthesis of Unsymmetrical Salen-type Ligands  
In 2001, Nguyen and coworkers reported the synthesis of unsymmetrical salen-type 
ligands from cyclohexyldiamine and different benzaldehydes.135,136,8 The synthetic route 
reported allows the variation of steric and electronic properties of different metal binding 
sites.   
Initially, the synthesis of unsymmetrical salen-type ligands was attempted with 
the goal of creating a set of bimetallic catalyst for the oxidative coupling of phenols. The 
synthesis of this ligand was carried out in a divergent way (Scheme 2.2.0). First, the 
binaphtol scaffold was synthesized starting from commercially available binaphthol 1. 
Potection of the hydroxyl groups with MOMCl afforded biaryl 2. Ortho-directed 
lithiation followed by formylation using dimethyl formamide provided the corresponding 
di-aldehyde, which was then deprotected to yield compound 3.  
Benzaldeyde 5 was prepared from the readily available aryl 4 through a Duff 
reaction.137  
The unsymmetrical cyclohexenyldiamine backbone was synthesized from 
cyclohexyldiamine 6, which was isolated from the respective tartrate salt by selective 
reaction of one amino group (7). The produced mono-imino ammonium salt 7 was treated 
with one equivalent of salicylaldehyde 5 to yield 8.  Finally, condensation of two 
equivalent of mono-imino amminoum 8 and formylated binaphthol 3 should afford ligand 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
135	  Campbell, E. J.; Nguyen, S. T. “Unsymmetrical Salen-type Ligands: High Yield Synthesis of Salen-
Type Schiff Bases Containing Two Different Benzaldehyde Moieties” Tetrahedron Lett. 2001, 42, 1221–
1225.	  
136	  Garcia Velazquez D., Diaz Diaz D., Gutierrez Ravelo A. Marrero Tellado J. J., “Instantaneous Low 
Temperature Gelation by a Multicomponent Organogelator Liquid System Based on Ammonium Salts” J. 
Am. Chem. Soc. 2008, 130, 7967-7973.	  
137 Kurahashi, T.; Hada, M.; Fujii, H. “Critical Role of External Axial Ligands in Chirality Amplification of 
trans-Cyclohexane-1,2-diamine in Salen Complexes” J. Am. Chem. Soc. 2009, 131, 12394–12405. 
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9. Unfortunately, the efforts for to produce mono-imino ammonioum 8 were 
unsuccessful; instead the corresponding salen was formed. 
 
Scheme 2.2.0 
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2.3 Regioselective Phenol Coupling Using Salen/Salan Catalysts 
Salen ligands were applied to a selected group of metals with redox phenols. Salen 
ligands were chosen because of their flexibility and ready complextion with these metals. 
Recently, Katsuki reported oxidative binaphthol coupling using an iron salen catalyst 
with up to 93% yield and 94% ee.108,109,110,111 These results confirm that salen complexes 
will catalyze oxidative coupling reactions. 
 
2.3.1 Synthesis of Salen/Salan Ligands 
After many unsuccessful attempts for making the unsymmetrical ligand 9, we 
decided to employ symmetrical salen catalysts. Salen/salan catalysts were synthesized in 
2-3 steps using several metals. Fist, condensation of benzaldehyde 5 and diamines 
afforded three different salen ligands.135 Salan ligands were prepared by reduction of 
salen ligands using sodium borohydride. 138  This set of salen/salan ligands were 
complexed to 7 metals to afford 38 catalysts (Scheme 2.3.1.0).126,139 The catalysts where 
characterized by LC-MS and NMR spectroscopy. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
138 Li, B.; Wu, G. P.; Ren, W. M.; Wang, Y. M.; Rao, D. Y.; Lu, X. B. “Asymmetric, Regio- and Stereo-
Selective Alternating Copolymerization of CO2 and Propylene Oxide Catalyzed by Chiral Chromium Salan 
Complexes” J. Polym. Sci. Polym. Chem. 2008, 46, 6102-6113.        
139 (a) Adano, P.; Costa-Pessoa, J.; Henriques, J.T.; Kuznetsov, M. L.; Avecilla, F.; Maurya, M.R;  Kumar, 
U.; Correa, I.; “Synthesis, Characterization, and Application of Vanadium-Salan Complexes in Oxygen 
Transfer Reactions” Inorg. Chem. 2009, 48, 3542-3561. (b) Sauve, A. A.; Grove, J. T. “Synthesis of 
Trithiolanes and Tetrathianes from Thiiranes Catalyzed by Ruthenium Salen Nitrosyl Complexes” J. Am. 
Chem. Soc. 2002, 126, 4770-4778 (c) Pratt R. C.; Stack, T. D. P. “Intramolecular Charge Transfer and 
Biomimetic Reaction Kinetics in Galactose Oxidase Model Complexes” J. Am. Chem. Soc. 2003, 125, 
8716–8717. (d) Senanayake, C. H.; Liu, J.; Shinkai, I. “(R,R)-N,N'-bis(3,5-di-tert-butylsalicylidiene)-1,2-
cyclohexanediamino Manganese (III) Chloride,; A Highly Enantioselective epoxidation catalyst” Org. 
Synth. 1998, 75. (e) Senanayake C. H.; Liu J.; Shinkai I.; “(R,R)-N,N'-bis(3,5-di-tert-butylsalicylidiene)-
1,2-cyclohexanediamino Manganese (III) Chloride,; A Highly Enantioselective Epoxidation Eatalyst” Org. 
Synth. 2004, 10, 96. (f) Shimazaki Y., Yajima T., Tani F., Karasawa S., Fukui K., Naruta Y., Yamauchi O. 
“Syntheses and Electronic Structures of One-Electron-Oxidized Group 10 
Metal(II)−(Disalicylidene)diamine Complexes (Metal = Ni, Pd, Pt)” J. Am. Chem. Soc 2007, 129, 2559-
2568. 
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Scheme 2.3.1.0. Preparation of Salen/Salan Catalyst129,135,138,139 
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2.3.2 High-Throughput Screening 
In collaboration with Trung Cao,116 high-throughput experimentation (HTE) was 
used to screen a series of substrates and 38 salen/salan catalysts in oxidative phenol 
coupling in order to explore the reactivity of these catalysts (Scheme 2.3.2.0).  The 
substrates employed in the screening provide different reactivity modes and some exhibit 
chirality (Scheme 2.3.2.1).  Each substrate screen was compared with as many standards 
of the ortho-ortho, para-para, and ortho-para (or Pummerer ketone) coupling products 
as were available from conventional oxidants.  
 
Scheme 2.3.2.0. Oxidative Phenol Coupling 
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Scheme 2.3.2.1. Substrate Scope 
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   Figure 2.3.2.0 shows a summary of the best results from the HTE screening for the 
oxidative coupling of phenols using the catalyst array. 2-Naphthol 20 was screened to test 
the reactivity of the catalysts towards the oxidative coupling. The HTE result revealed 
that 2,3,5-trimethylphenol (12) was selective for the para-para products with copper and 
chromium catalysts; the ortho-ortho product was observed with the iron catalyst.  Even 
though 3,5-dimethoxy-4-methylphenol (17) showed a preference for Pummerer ketone, it 
also showed a relatively high selectivity for ortho-ortho coupling product with copper, 
chromium and ruthenium catalysts. 
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Figure 2.3.2.0.  Preliminary HTE screening results. 
 
 
2.3.3 Scale-up and Validation of the HTE Results 
The coupling of 12 was carried out on a larger scale using six of the catalysts that 
showed some selectivity in the screen and with oxygen and tert-butyl hydroperoxide as 
oxidants (Table 2.3.3.0).  The reactions carried out with tert-butyl hydroperoxide gave 
primarily the oxygenation product (Entry 3-6).   During this initial validation, a new 
product identified from ortho-para coupling. Based on these preliminary results, my 
focus turned to identifying reaction conditions that selectively couple 2,3,5-
trimethylphenol (12) to the ortho-para product. 
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Table 2.3.3.0. Validation of HTE hits. 
OH
 [O]
DCE
65 – 70 °C, 29 h
OH
OH
OH
OH
++
OH
OHMe
Me
Me
Me
Me
Me
Me
Me
Me
Me
Me
MeMe
Me
Me
Me
Me
Me
Me
Me
ortho-ortho (o-o) para-para (p-p) ortho-para (o-p)
Me +
Me
Me
O
O
Me
Quinone (Q)  
0
0
33
40
41
39
Q  (%)ao-o (%)a p-p (%)aCatalyst
0
0
13
13
-
15
0
0
0
0
0
0
0
0
12
0
0
0
o-p  (%)a
Fe Cy Salan
Fe Ph Salan
Fe Cy Salan
V Cy Salan
V Ph Salen
Mn Ph Salan
Conversion (%)a
0
29
73
100
78
-
Entry
1
2
3
4
5
6
[O]
O2
O2
TBHP
TBHP
TBHP
TBHP
a Purified by silica gel column chromatography.  
 
 A wider set of catalysts was then evaluated on a larger scale using oxygen as 
oxidant. Initially, we tested a selected number of catalysts that showed high reactivity in 
the HTE screening (Entries 1-5). The results showed that copper-Ph-salan produce the 
ortho-ortho coupling product in a moderate yield and with a selectivity of 2:1 ortho-
ortho:ortho-para (Entry 3). The ruthenium catalyst produces the ortho-ortho and ortho-
para product in a 1:1 ratio.  Even though chromium showed a higher selectivity of para-
para product, it generally yields the ortho-para over the ortho-ortho product (Entry 4). 
Based	  on	  these	  preliminary	  results,	  my	  focus	  turned	  to	  identifying	  reaction	  conditions	  that	  
selectively	   couple	   2,3,5-­‐trimethylphenol	   (5)	   to	   the	  ortho-­‐para	   product. Testing of all the 
chromium and ruthenium catalysts (Entries 6-16), showed that chromium cyclohexenyl 
salen produced the ortho-para product with high selectivity (6:1) and moderate yield of 
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58% (Entry 7).  Ruthenium phenyl salan, on the other had produced ortho-para coupling 
with moderate yield and lower selectivity (Entry 16). We also found that ruthenium 
cyclohexyl salan produced ortho-ortho dimer with a moderate yield of 57% and 6:1 
selectivity (Entry 14). Though we are not exploring enantioselectivity yet, it is 
encouraging that some level of enantioselectivity was produced. 
 
Table 2.3.3.1. Validation of HTE hits using oxygen as oxidant. 
OH
20 mol% catalyst
DCE, O2
65 – 70 °C, 24 h
OH
OH
OH
OH
+
+
OH
OHMe
Me
Me
Me
Me
Me
Me
Me
Me
Me
Me
MeMe
Me
Me
Me
Me
Me
Me
Me
ortho-ortho (o-o) para-para (p-p) ortho-para (o-p)
Me
 
24
44
24
24
24
24
24
24
24
24
48
48
48
48
48
48
Time (h) o-o (%)a p-p (%)a
ee
o-o (%)Catalyst
a Purified by silica gel column chromatography.
8
62
14
-
26
-
8
5
NR
NR
18
46
12
57
19
31
-
-
-
34
-
-
-
-
-
-
-
-
-
-
-
-
-
35
14
16
8
8
58
6
-
-
26
27
16
10
39
46
0
8
4
-
19
-
20
-
-
-
-
-
-
-15
-
0
o-p  (%)a ee o-p (%)
Cu Cy Salan
Cu Ph Salan
Ru Ph Salen
Cr H Salen
Mn Ph Salan
Cr H Salan
Cr Cy Salen
Cr Cy Salan
Cr Ph Salen
Cr Ph Salan
Ru H Salen 
Ru H Salan
Ru Cy Salen
Ru Cy Salan
Ru Ph Salen
Ru Ph Salan
-
-4
-
-
-
-9
-
-
-
-
-
-
2
-
2
0
Entry
1
2
3
4
5
6
7
8
9
10
11
12
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2.3.4  Studies Towards the Selective formation of o-p Coupling Product  
We attempted the further optimization of the reaction conditions for the selective 
production of ortho-para dimer using ruthenium phenyl salan catalyst.  In order to 
accomplish better results we screened a number of solvents, drying agents and additives.  
 
Table 2.3.4.0. Solvent Screening 
20 mol% Ru Ph Salan
Solvent, O2
65 – 70 °C
OH
OH
OHMe
Me
Me
Me
Me
Me
Me
Me
ortho-para (o-p)
Me
 
Solvent Time (h) Conversion (%)a o-p (%)a
a Purified by silica gel column chromatography.
bPercent conversion was calculated from the recovered starting material.
1,2-dichloroethane
Benzene
Toluene
Chlorobenzene
m-Dichlorobenzene
1,1,2-Trichloroethane
1,1,2,2-Tetrachloroethane
Chloroform
Dichloromethane
Carbon tetrachloride
`5 days
72 h
5 days
5 days
5 days
72 h
72 h
24 h
72 h
72 h
72 h
72 h
67
54
59
51
60
52
-
79
80
36
0
0
27
18
14
13
19
18
-
18
18
15
0
0
Entry
1
2
3
4
5
6
7
8
9
10
 
 
The solvent effect in the selectivity and reactivity of the oxidative coupling of 2,3,5-
trimethylphenol (12) using ruthenium-Ph-salan catalyst was first studied (Table 2.3.4.0). 
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Adding chlorines to the aromatic ring  increased the percentage of ortho-para (Entries 2-
5). Since none of the aromatic solvents showed a significant improvement from  the 
standard solvent, dichloroethane, others chloninated alkanes were tested. 1,1,2-
Trichloroethane and 1,1,2,2,-tetrachloroethane were selective for the ortho-para coupling 
product but the reaction was incomplete and a significant decomposition was observed 
(Entries 6 and 7). Solvents  containing one carbon such chloroform, dichloromentane and 
carbon tetrachloride gave low or no conversion. 
Low yields is one of the main problems in oxidative phenol coupling reactions, 
which was reflected in Table 2.3.4.1. Since water is a side product in this reaction, it may 
coordinate to ruthenium and slow down the reaction.  Based on this hypothesis, several 
drying agent were screened to see if this accelerates the reaction.  The reaction using 
powdered molecular sieves showed a rate of the reaction with 98 % conversion in only 24 
h.  However, the product yield still low, suggesting competing reaction pathways.  
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Table 2.3.4.1. Screening of drying agents 
OH
OH
OH
OH
OH
++
OH
OHMe
Me
Me
Me
Me
Me
Me
Me
Me
Me
Me
MeMe
Me
Me
Me
Me
Me
Me
Me
ortho-ortho (o-o) para-para (p-p) ortho-para (o-p)
Me
20 mol% Ru Ph Salan
 Additive, DCE, O2
65 – 70 °C
 
Drying Agent Time (h) Conversion (%)a o-p (%)a
No additive
MgSO4
Na2SO4
mol sieves 3 Å
mol sieves powder
5 days
5 days
5 days
5 days
5 days 
24 h
54
64
54
75
-
98
17
<23
18
19
-
16
Entry
1
2
3
4
5
6
aYields calculated from HPLC using biphenyl as internal standard.  
 
In order to assess the regioselectivity with more accuracy, the screenings were 
analyzed via HPLC using biphenyl as an internal standard. The reactions were conducted 
under oxygen. For analysis, the mixtures were out in the bench. diluted, placed in a 96-
well plate, and analyzed by HPLC.   
A series of additives were thus screened (Table 2.3.4.2). The results showed that 
ytterbium triflate yielded the o–p product with higher selectivity (2:1) in comparison to 
the control after 47 h (Entry 3).  Reactions were analyzed at different time points to 
monitor the progress (Entries 3 and 5). These results showed that the reaction stopped 
after 48 h.  
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Table 2.3.4.2. Additive Screening 
OH
OH
OH
OH
OH
++
OH
OHMe
Me
Me
Me
Me
Me
Me
Me
Me
Me
Me
MeMe
Me
Me
Me
Me
Me
Me
Me
ortho-ortho (o-o) para-para (p-p) ortho-para (o-p)
Me
20 mol% Ru Ph Salan
 Additive, DCE, O2
65 – 70 °C
 
72
72
47
72
72
47
72
72
72
72
72
Time (h) o-o (%)a p-p (%)bAdditive
5
7
5
5
6
7
7
1
1
1
2
0
0
0
0
0
0
0
0
0
0
0
o-p  (%b
Control
TFA
Yb(OTf)3a
DIEA
Tartatic acid
TBSOTf
AgOTf
AgBF4
AgBr
Entry
1
2
3
4
5
6
7
8
9
a 3 equiv were added. bHPLC yield
6
6
10
9
6
6
5
1
1
2
5
 
 
A further experiment investigated the effect of the equivalents of ytterbium 
triflate (Table 2.3.4.3). However, greater amounts did affect the selectivity or the 
efficiency of the reaction.  
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Table 2.3.4.3. Additive and Equivalents Screening 
OH
OH
OH
OH
OH
++
OH
OHMe
Me
Me
Me
Me
Me
Me
Me
Me
Me
Me
MeMe
Me
Me
Me
Me
Me
Me
Me
ortho-ortho (o-o) para-para (p-p) ortho-para (o-p)
Me
20 mol% Ru Ph Salan
 Additive, DCE, O2
65 – 70 °C, 24 h
 
Time (h) o-o (%)a p-p (%)bAdditive
12
6
4
4
3
0
3
4
4
3
o-p  (%)b
Control
Yb(OTf)3 
Yb(OTf)3 
Yb(OTf)3
Entry
1
2
3
4
10
10
9
9
8
72
48
72
72
72
a Equivalent to the catalyst. bHPLC yield
Equiva
-
1.5
3
9
 
 
Since, we were unable to further optimize the oxidative coupling of 2,3,5-
trimethylphenol (12) to selectively produce ortho-para dimer using ruthenium phenyl 
salan, we decided to investigate chromium cyclohexenyl salen catalyst at 40 ºC (Table 
2.3.2.1, entry 7). For the study of oxidative phenol coupling of trimethylphenol using 
chromium cyclohexenyl salen, solvent screening was carried out (Table 2.3.4.4).  The 
solvents chosen fell on two classes; the hydrocarbons (Entries 1-4) and aromatics 
(Entries 5-9). The number of halogen substituents in the alkylchains and arenes were 
increased to investigate how an inductive effect may promote or disfavor the selectivity. 
The result of the screening showed that dichloroethane, chloroform and trifluorotoluene 
produced ortho-para biphenol with the highest selectivity (Entries 1, 4 and 9). However, 
no trend could be deduced from this screening. 
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Table 2.3.4.4. Solvent Screening for Cr(salen)-Catalyzed Phenol Coupling 
OH
OH
OH
OH
OH
++
OH
OHMe
Me
Me
Me
Me
Me
Me
Me
Me
Me
Me
MeMe
Me
Me
Me
Me
Me
Me
Me
ortho-ortho (o-o) para-para (p-p) ortho-para (o-p)
Me
20 mol%Cr Cy Salen
Solvent, O2
40 °C
 
96
96
96
96
96
96
96
96
96
Time (h) o-o (%)a p-p (%)aSolvent
3
3
1
3
2
2
4
2
3
8
4
2
8
7
0
1
7
8
26
14
2
20
19
0
3
16
23
o-p  (%)a
DCE
4Cl Ethane
DCM
CDCl3
Benzene
chlorobenzene
1,3-Dichlorobenzene
Toluene
PhCF3
Entry
1
2
3
4
5
6
7
8
9
 
 
An additive screening was carried out using DCE as solvent (Table 2.3.4.5). The 
results show that ytterbium triflate and silver bromide provided ortho-para dimer with 
higher selectivity (Entries 3 and 9). Decomposition of the desired o–p product over the 
course of reaction, decreased yield (Entry 3). 
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Table 2.3.4.5. Additive Screening for Cr(salen)-Catalyzed Phenol Coupling 
OH
OH
OH
OH
OH
++
OH
OHMe
Me
Me
Me
Me
Me
Me
Me
Me
Me
Me
MeMe
Me
Me
Me
Me
Me
Me
Me
ortho-ortho (o-o) para-para (p-p) ortho-para (o-p)
Me
20 mol%Cr Cy Salen
DCE, Additive, O2
40 °C
 
72
96
72
96
50
96
96
96
96
96
96
96
Time (h) o-o (%)a p-p (%)aAdditive
2
3
2
2
1
1
0
0
0
0
1
1
5
3
20
17
8
0
0
7
1
2
5
4
o-p  (%)a
Control
TFA
Yb(OTf)3
DIEA
Tartatic acid
TBSOTf
AgOTf
AgBF4
AgBr
Entry
1
2
3
4
5
6
7
8
9
aHPLC yield
15
11
14
15
17
2
0
3
0
1
3
9
 
 
Scheme 2.3.4.0. Final Results for o-p Coupling Product 
Cr Cy Salen 20 mol% 
DCE, O2
60 °C, 24 h
58%
OH
Me
OH
Me
Me
Me
Me
Me
Me
Me
Me
OH
ortho-para (o-p)  
 
In summary, the oxidative coupling of phenol 12 produces ortho-para dimer 
selectively using chromium cylohexenyl salen catalyst, in moderate yield (Scheme 
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2.3.4.0 and Table 2.3.3.1, entry 7). However, we were unable to further optimize the 
initial results to produce ortho-para dimer from the coupling of 2,3,5-trimethylphenol 
(Table 2.3.3.1, enties 7 and 16). Multiple solvents, drying agents and additives were 
screened with no success. The primary problems with these catalysts was the low 
catalytic turnover and decomposition of starting material and products.  
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2.3.5  Studies Towards the Selective Formation of o-o and p-p Coupling Products 
Next interest turned to develop a regioselective entry to the ortho-ortho and para-
para coupling products for the oxidative coupling of 2,3,5-trimethylphenol. Catalysts that 
showed high selectivity for ortho-ortho and para-para dimers respectively in the initial 
high throughput screening were selected for further study. These results were validated in 
bench scale reactions that were monitored by thin layer chromatography (Tables 2.3.5.0 
and 2.3.5.1). Entries 1 from Table 2.3.5.0 and Table 2.3.5.1 showed a good reaction 
progress, and higher selectivity toward para-para and ortho-ortho dimers respectively. 
The reaction from Table 2.3.5.0, entry 1 was purified and the isolated yield of each 
product was obtained. 	   
 
Table 2.3.5.0  Studies Toward para-para Coupling of 2,3,5-Trimethyl Phenol 
OH
20 mol% catalyst
DCE, O2 OH
OH
OH
OH
++
OH
OHMe
Me
Me
Me
Me
Me
Me
Me
Me
Me
Me
MeMe
Me
Me
Me
Me
Me
Me
Me
ortho-ortho (o-o) para-para (p-p) ortho-para (o-p)
Me
 
Time (h) Ratio (SM:o-o : o-p :p-p)aCatalyst
40
28
28
28
28
28
0:1:1:0
decomp.
decomp.
NR
0:0:1:0
NR
Cu Ph Salan
Mn Ph Salan
Mn Ph Salan
Cu Cy Salan
V Cy Salan
Cu Cy Salan
Temperature (ºC)
40
55
55
55
55
55
Entry
1
2
3
4
5
6
[O]
O2
O2
TBHP
O2
TBHP
O2/AcOH
a The reaction was monitored by TLC  
 
	   157	  
Table 2.3.5.1  Studies Toward ortho-ortho Coupling of 2,3,5-Trimethyl Phenol. 
OH
20 mol% catalyst
DCE, O2 OH
OH
OH
OH
++
OH
OHMe
Me
Me
Me
Me
Me
Me
Me
Me
Me
Me
MeMe
Me
Me
Me
Me
Me
Me
Me
ortho-ortho (o-o) para-para (p-p) ortho-para (o-p)
Me
 
Time (h) Ratio (SM:o-o : o-p :p-p)aCatalyst
29
24
24
24
24
2:0:1:2
NR
NR
NR
1:1:0:0
Cr H Salen
Cu H Salan
Fe H Salan
Mn H Salan
Mn H Salan
Temperature (ºC)
50
115
115
115
115
Entry
1
2
3
4
5
[O]
O2
O2/AcOH
O2
O2/AcOH
O2/Yb(OTf)3
a The reaction was monitored by TLC  
 
In summary, the oxidative coupling of phenol 12 using chromium salen catalyst 
produces para-para dimer selectively with up to 62% yield based on the recovered 
starting material (Scheme 2.3.5.0) and copper phenyl salan produces ortho-ortho in up to 
62% isolated yield. 
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Scheme 3.5.0. Final results 
OH
Cr H Salen 20 mol%
DCE, O2
55 °C, 29 h
OH
OH
+
OH
OHMe
Me
Me
Me
Me
MeMe
Me
Me
Me
Me
Me
Me
Me
para-para (p-p)
62% brsm
ortho-para (o-p)
40% brsm
Me
Cu Ph Salan 20 mol%
DCE, O2
60 °C, 44 h
OH
OH
OH
Me
Me
Me
Me
Me
Me
Me
Me
Me
ortho-ortho (o-o)
62%
Me
OH
+
Me
OH
MeMe
Me
Me
ortho-para (o-p)
35%  
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2.3.6 Oxidative Phenol Coupling Using NO2 Substituted Salen/Salan Catalysts. 
One of the major problems encountered with the salen/salan catalyst previously 
presented was the low reactivity toward some of the substrates screened.  Recently, 
Young Lee demonstrated that the reactivity of a monomeric vanadium ligand V3 is 
enhanced when an electronwithdrawing group is incorporated in the arene ligand 
(Scheme 2.3.6.0). Based on these results, we decided to incorporate a nitro group in the 
salen ligand. 
 
Scheme 2.3.6.0.  Asymmetric oxidative phenol coupling 
O2N
tBu
N
O
t-Bu
O
O
V
O
V3
OR
Me
Me
Me OH
Me
Me
Me OH
Me
Me
Me OH
40 mol% catalyst
AcOH (6.25 equiv)
O2, 0 ºC–rt
Toluene
ortho-ortho
(o-o)
100% conversion
 83% ee
12
 
 
Nitro-salen catalysts were synthesized in 3-4 steps. The nitro substituted aldehyde 
was synthesized from the commercially available tert-butyphenol 25. Formylation of 25 
afforded benzaldehyde 26 in up to 33% yield. The nitro group was incorporated through 
an electrophilic aromatic substitution with HNO3 to afford aldehyde 27.140 Condensation 
of benzaldehyde 27 and three different diamines provided the salen ligands 28.135 Nitro 
salan ligands were prepared from the reduction of salen ligands using sodium 
borohydride.138 The nitro-salen/salan ligands were complexed to selected metals to afford 
a total of 8 catalysts (Scheme 2.3.6.1).139 The catalysts were characterized by LC-MS. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
140	  Gisch, N.; Balzarini, J.; Meier, C. “Enzymatically Activated cycloSal-d4T-monophosphates:   The Third 
Generation of cycloSal-Pronucleotides” J. Med. Chem., 2007, 50, 1658–1667. 
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Scheme 2.3.6.1. Synthesis of NO2 substituted salen/salan catalysts 
CHO
OH
tBu
HNO3
AcOH
60% yield
CHO
OH
tBu
O2NCHO
OH
tBu
(CH2O)n, MgCl2
THF, 70 ºC 3 d
33% yield
25 26 27
+
H2N
R
NH2
R
N
R
N
R
O2N
tBu
OH HO
tBu
NO2
1. MeOH:EtOH 
rt, 25 h
43-49 % yield
2. NaBH4 (10 equiv)
MeOH:THF, rt. 2 h
84-99% yield
[M] N
R
N
R
O2N
tBu
O O
tBu
NO2
R = H, -(CH2)4-, Ph
M
10
28 Cat.
27
M L1 L2
V
Mn
Cu (salan)
Cr
Ru
F
Cl
H2O
H2O
-
NO
NO
NO
O
-
-
-
-
H2O
H2O
H2O
R
Cy
Ph(salan)
H 
Cy
Cy (salen)
Ph (salan)
H ( salen)
Cy (salan)
 
 
Trung Cao screened these catalysts towards oxidative phenol coupling of 9 
substrates.141 Ruthenium-nitro-H-salen catalyst selectively produced the ortho-ortho 
coupling product for phenols 29 and 30 with 73% and 72% respectively (Figure 
2.3.6.0).  
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Figure 2.3.6.0.   
OH
OMe
MeO
Et
OH
OMe
MeO
Ph
Ru-Salen-H-NO2
73% o-o
Ru-Salen-H-NO2
72% o-o
29 30
 
 
2.3.7 Conclusion 
A library of salen catalysts were successfully synthesized and in collaboration with 
Trung Cao, high-throughput experimentation (HTE) was used to screen a series of 
substrates and 44 salen catalysts in oxidative phenol coupling. We successfully identified 
catalysts that give high reactivity and selectivity toward different substrates (Figure 
3.7.0). 
 
Figure 2.3.7.0 Phenol coupling final results 
OH
Me
Me
Me
OH
OMe
MeO
Me
OH
OMe
MeO
Et
OH
OMe
MeO
Ph
OH
Me
Me OH
tBu
MeO
MeO
Cu-Salan-Ph
72% o-o
Mn-Salan-Ph
65% PK
Ru-Salen-H-NO2
73% o-o
Cr-Salen-H
55% PK
Ru-Salen-H-NO2
72% o-o
V-Salen-Cy
74% o-o
Cr-Salen-Cy
58% o-p
Cr-Salen-H
62% p-p
Cu-Salan-Ph
62% o-o
Ru-Salen-Ph
85% o-o
31 29 30
34 35 36
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This strategy was further expanded and applied to the selective cross-coupling of 
phenols, which is currently being conducted by Young Lee (Figure 3.7.1).141 
 
Figure 3.7.1. Phenol hetero-coupling 
OH
R1 R2
OH
R
5 mol% Cr-Salen-Cy
O2, DCE, 
50-85 °C, 18-48 h
OH
R1 R2
R OH
+
1.2-2.0 equiv 1 equiv
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
141	  Lee, Y.; Cao, T.; Torruellas, C.; Kozlowski, M. C. “Selective Oxidative Homo- and Cross-Coupling of 
Phenols with Aerobic Catalysts” J. Am. Chem. Soc. 2014 submitted. 
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2.4 Regioselective Phenol Coupling using N,N-dimethylbis(pyridyl)ethylenediamine 
N,N’-dimethylbis(pyridyl)ethylenediamine complexes have been reported in 
catalytic oxidation of alkenes to selectively produce cis-diol and epoxides.130–134 Based 
on their oxidation activity, we undertook a study of these tetradentate pyridyl complexes 
in oxidative phenol coupling 
 
2.4.1 Synthesis of N,N-dimethylbis(pyridyl)ethylenediamine 
The tetradentate pyridyl complexes were synthesized as shown in Scheme 2.4.1.0 
with a variety of metals to get a total of 12 catalysts.135,58a,142,143 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
142 (a) Icke, R. N.; Wisegarver, B. B.; Alles, G. A. “β-phenylethydimethylamine” Org. Synth. 1955, 3. 723. 
(b) Icke, R. N.; Wisegarver, B. B.; Alles, G. A. “β-phenylethydimethylamine” Org. Synth. 1945, 25, 89 
143 (a) Egdal, R. K.; Bond, A. D.; McKenzie, C. J. “Chloro[N,N’-dimethy-N,N’-bis(2-
pyridylmetheyl)ethane-1,2-diamine]oxovanadium(IV) perchlorate” Acta. Cryst, 2005, 61, 412–413.  (b) 
Pandiyan, T.; Guadalupe, H. J.; Cruz, J.; Bernès, S; Ugalde-Salvdivar V. M.; González, I. “DFT and 
Experimental Studies of Perchlorate Ion Coordination in cis/trans-Copper(II) Complexes of Tetradentate 
Pyridyl Ligands” Eur. J. Inorg. Chem. 2008, 3274–3285. (c) Hureau, C.; Blondin, G.; Charlot, M.; 
Philouze, C.; Nierlich, M.; Ce´sario, M.; Anxolabe´he`re-Mallart, E.; “Synthesis, Structure, and 
Characterization of New Mononuclear Mn(II) Complexes. Electrochemical Conversion into New Oxo-
Bridged Mn2(III,IV) Complexes. Role of Chloride Ions” Inorg. Chem. 2005, 44, 3669–3683. (d) Li, C. K.; 
Tong-Tang, W.; Che, C.; Wong, K. Y.; Wang, R., Mak, T.; “Synthesis, Electrochemistry and X-ray Crystal 
Structure cis-[RuIIIL1(Cl)(H2O)][ClO4]2·2H2O [L1=N,N′-dimethyl-N,N′-bis(2-
pyridylmethyl)ethylenediamine]; Electrochemical Oxidation of Alcohols and Tetrahydrofuran by cis-
[RuVL1(Cl)O]2” J. Chem. Soc. Dalton Trans., 1991, 1909–1914. (e) Coates, C.; Hagan, K.; Mitchell, C. 
A.; Gorden, J. D.; Goldsmith, C. R.  “Structural characterization of manganese and iron complexes with 
methylated derivatives of bis(2-pyridylmethyl)-1,2-ethanediaminereveals unanticipated conformational 
flexibility” Dalton Trans., 2011, 40, 4048–4058. (f) Hazell, R.; Jensen, K. B.; McKenzie, C. J.; Toftlund, 
H.  “Properties and Reactivity of Unusual Diiron Complexes of a Linear Tetradentate Ligand. Crystal 
structures of Diiron-(II) and -(III) Complexes” J. Chem. Soc., Dalton Trans., 1995, 707–717. 
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Scheme 2.4.1.0 Synthesis of N,N-dimethylbis(pyridyl)ethylenediamine catalysts. 
N
Cl
HCl
N
Cl
K2CO3 (2 equiv)
CH2Cl2 NaOH (aq. 2 equiv)
CH2Cl2, rt, 24 h
75 –81% yield
n
37 38 39
H2N NH2
N N
N N
n
1. MeOH:EtOH 
rt, overnight
37 % yield
2. NaBH4 (10 equiv)
MeOH:THF, rt. 2 h
95% yield
41
N
CHO
40 42
(CH2O)n, HCO2H
100 º,C 8 h
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NH2H2N
NH HN
N N
N N
N N
N
R
N
R
n
N N
n= 0  R =  -(CH2)4-
n= 0  R= H
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N
R
N
R
n
N N
[M]
Cat.
M
X
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Cu 
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Cl
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-
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Trung Cao used high-throughput experimentation to screen these catalysts in the 
oxidative coupling of 2,3,5-trimethylphenol 12. Unfortunately, these catalysts gave low 
conversion. 
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2.5 Experimental Section 
 
H2N NH2
S S
 
(1S,2S)-Cyclohexane-1,2-diamine (6). Two procedures were used; (1) The tartrate salt 
(1.6314, 6.2 mmol) was treated with a solution of HCl in methanol (11 mL, 1:9 ratio).  
Ether was added dropwise until a white precipitate appeared. The solid was collected 
through vacuum filtration, washed with ether and dried under vacuum. The resulting solid 
was dissolved in a saturated solution of sodium hydroxide. The solution was extracted 
with ether (x2). The combined organic layers were dried over MgSO4 and concentrated to 
yield (1S,2S)-cyclohexane-1,2-diamine in a 54% yield as a yellow oil (305 mg mg, 2.67 
mmol). Spectral data matched with those reported.144 
(2) The tartrate salt (9.08 g, 0.097 mol) was placed in a separation funnel and a 
concentrated solution of potassium hydroxide ( 10 mL, 15.5 N) was added. The mixture 
was swirled. The layers were separated and the diamine was dried over Na2SO4 and 
isolate as yellow oil in 100% yield (4.68 g, 0.041mol). 1H NMR (300 MHz, CDCl3) δ 
204 (m, 2H), 1.79 (m, 3H), 1.64 (m, 3H), 1.24 (m, 4H). 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
144	  Garcia-Velazquez, D.; Diaz-Diaz, D.; Gutierrez-Ravelo, A.; Marrero-Tellado J. J. “Instantaneous Low 
Temperature Gelation by a Multicomponent Organogelator Liquid System Based on Ammonium Salts ” J. 
Am. Soc. 2008, 130, 7967–7973.	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H2N NH3 Cl  
(1S,2S)-2-Aminocyclohexanaminium chloride (7).  To a solution of  (1S,2S)-
cyclohexane-1,2-diamine (2.04 g, 17.5 mmol)  in ether (61.9 mL)  4 N HCl in dioxane 
(4.08 mL, 17.5 mmol) was added dropwise. After the addition a precipitate appeared. The 
reaction mixture was stirred overnight. The precipitate was collected through vacuum 
filtration and washed with ether. (1S,2S)-2-Aminocyclohexanaminium chloride  was 
afforded in a 91% yield as a white solid (2.41 g, 16.07 mmol). 1H NMR match with the 
reported spectra.135  
 
CHO
OH
 
3,5-di-tert-butyl-2-hydroxybenzaldehyde (5).  A solution of 2,4-di-tert-butylphenol (10 
g, 48 mmol) and hexamethyltetramine  (13.4 g, 95 mol) in acetic acid (24.0 mL) was 
heated to 120 ºC for 3 h. An aqueous solution of sulfuric acid (24.0 mL, 17.9% v/v) was 
added at 100 ºC and stirred for 1 h. the reaction mixture was washed cooled to room 
temperature and extracted with ether (3 x 400 mL). The organic layer was washed with 
brine (3 x 100 mL) dried with Mg2SO4, filtered and concentrated. The product was 
purified via chromatography (SiO2, 20% Ethyl Acetate/Hexanes) to yield 3,5-di-tert-
butyl-2-hydroxybenzaldehyde in 38% yield as a yellow solid (4.3 g, x mmol). Spectral 
data matched those reported.137 1H NMR (300 MHz, CDCl3) δ 11.64 (s, 1H), 9.87 (s, 
1H), 7.59 (d, J = 2.5 Hz, 1H), 7.34 (d, J = 2.1 Hz, 1H), 1.43 (s, 9H), 1.33 (s, 9H); 13C 
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NMR (500 MHz, CDCl3) δ 197.5, 159.2, 141.8, 137.7, 132.0, 128.0, 120.1, 35.2, 34.4, 
31.5, 29.4.  
N
R
N
R
OH HO
 
To a solution of the diamine (1 equiv) in MeOH:EtOH (1:1) solution (0.10 M) 3,5-di-tert-
butyl-2-hydroxybenzaldehyde (2 equiv) was added quickly. The solution was stirred for 
24 h under an Ar atmosphere. The solvents were removed through rotatory evaporation.  
The resultant product was recrystallized using a 1:1 mixture of methanol and ethyl 
acetate.  
6,6'-((1E,1'E)-(Ethane-1,2-diylbis(azanylylidene))bis(methanylylidene))bis(2,4-di-
tert-butylphenol). Long yellow crystals (159 mg, 85% yield). 1H NMR (300 MHz, 
CDCl3) δ 13.63 (s, 2H), 8.39 (s, 2H), 7.43 (d, J = 2.5 Hz, 2H), 7.07 (d, J = 2.5 Hz, 2H), 
4.00 (s, 4H), 1.54 (s, 18H), 1.39 (s, 18H). 13C NMR (500 MHz, CDCl3) δ 167.8, 158.2, 
140.2, 136.7, 127.2, 126.2, 117.9, 59.8, 35.2, 34.3, 31.4, 29.6.  Spectral data matches 
those reported.116 
 
6,6'-((1E,1'E)-((1S,2S)-Cyclohexane-1,2-
diylbis(azanylylidene))bis(methanylylidene))bis (2,4-di-tert-butylphenol). Yellow 
crystals (159 mg, 85% yield). 1H NMR (300 MHz, CDCl3) δ 13.70 (s, 2H), 8.29 (s, 2H), 
7.30 (d, J = 2.5 Hz, 2H), 6.98 (d, J = 2.5 Hz, 2H), 3.33 (d, J = 3.9 Hz, 2H), 1.97-1.37 (m, 
4H), 1.75 (m, 2H), 1.61 (m, 2H), 1.54(s, 18H), 1.41 (s, 18H). 13C NMR (500 MHz, 
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CDCl3) δ 166.0, 158.1, 140.0, 136.5, 126.9, 126.2, 118.0, 72.6, 35.1, 34.2, 33.4, 31.6, 
29.6, 24.5. Spectral data matches those reported.116 
6,6'-((1E,1'E)-(((1S,2S)-1,2-Diphenylethane-1,2-
diyl)bis(azanylylidene))bis(methanylyli dene))bis(2,4-di-tert-butylphenol). Isolated as 
yellow crystals (159 mg, 85% yield). 1H NMR (300 MHz, CDCl3) δ 13.58 (s, 2H), 8.29 
(s, 2H), 7.31 (d, J = 2.5 Hz, 2H), 7.17 (s, 10H), 6.98 (d, J = 2.5 Hz, 2H), 4.72 (s, 2H), 
1.42 (s, 18H), 1.22 (s, 18H); 13C NMR (500 MHz, CDCl3) δ 167.28, 158.01, 140.06, 
139.85, 136.44, 128.30, 128.07, 127.44, 127.27, 126.37, 117.92, 80.17, 35.03, 34.16, 
31.45, 29.49. Spectral data matches those reported.116 
 
N
R
N
R
O2N
tBu
OH HO
tBu
NO2
R = H, -(CH2)4-, Ph  
6,6'-((1E,1'E)-(Ethane-1,2-diylbis(azanylylidene))bis(methanylylidene))bis(2-(tert-
butyl)-4-nitrophenol).  Isolated as a yellow solid (829 mg, 83%). mp: 230-231 ºC: 1H 
NMR (500 MHz, CDCl3) δ 15.01 (s, 2H), 8.47 (s, 2H), 8.22 (s, 2H), 8.10 (s, 2H), 4.05 (s, 
4H), 1.45 (s, 18H); 13C NMR (500 MHz, CDCl3) δ 167.2, 166.5, 139.9, 139.0, 126.4, 
125.3, 117.2, 58.4, 35.4, 29.0; IR (film) 3691, 3055, 2987, 1639, 1612, 1477, 1422, 1330, 
1266, 896 cm-1; HRMS (ES) m/z = 471.2244 calcd for C24H31N4O6 [MH]+, found 471. 
2229. 
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6,6'-((1E,1'E)-(((1S,2S)-Cyclohexane-1,2-
diyl)bis(azanylylidene))bis(methanylylidene))bis(2-(tert-butyl)-4-nitrophenol.  
Isolated as a yellow solid (985 mg, 99%). mp: 104-110 ºC: 1H NMR (500 MHz, CDCl3) δ 
15.02 (s, 2H), 8.35 (s, 2H), 8.15 (s, 2H), 7.99 (s, 2H), 3.47 (m, 2H), 2.09 (m, 2H), 1.95 
(m, 2H), 1.80 (m, 2H), 157 (m, 2H), 1.40 (s, 18H); 13C NMR (500 MHz, CDCl3) δ 157.2, 
154.7, 138.8 138.6, 126.3, 125.2, 117.0, 71.5, 35.3, 32.5, 29.0, 24.2 IR (film) 3500, 3055, 
2987, 1639, 1612, 1500, 1330, cm-1; HRMS (ES) m/z = 525.22713 calcd for C28H37N4O6 
[MH]+, found 525.2659.	  
6,6'-((1E,1'E)-(((1S,2S)-1,2-Diphenylethane-1,2-
diyl)bis(azanylylidene))bis(methanylylidene))bis(2-(tert-butyl)-4-nitrophenol).  
Isolated as a yellow solid (556 mg, 56%). 1H NMR (500 MHz, CDCl3) δ 8.33 (s, 2H), 
8.19 (s, 2H), 7.99 (s, 2H), 7.30-7.22 (m, 10H), 4.88 (s, 2H), 3.49 (s, 2H), 1.43 (s, 18H).  
 
N N
N N
 
(1E,1'E)-N,N'-((1S,2S)-Cyclohexane-1,2-diyl)bis(1-(pyridin-2-yl)methanimine). 
Isolated as a yellow solid (747 mg, 37%). 1H NMR (500 MHz, CDCl3) δ 8.54 (d, J = 5.5 
Hz, 2H), 8.31 (s, 2H), 7.88 (d, J = 9.0 Hz, 2H), 7.64 (t, 2H), 7.22 (t, J = 12.0 Hz, 2H), 
3.53 (m, J = 10.0 Hz, 2H), 1.89-1.84 (m, 6H), 1.51 (m, 2H); 13C NMR (500 MHz, 
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CDCl3) δ 160.5, 149.1, 136.6, 122.0, 64.4, 61.3, 52.4, 31.5, 25.0. Spectral data matches 
those reported.145  
 
 
 
From the salen: To a solution of the salen in THF:MeOH (1:1), sodium borohydride (10 
equiv) was slowly added. The solution was stirred for 2 h and it turned clear. The mixture 
was quenched with water and extracted with dichloromethane. The combined organic 
layers were washed with brine, dried over Na2SO4, filtered, and concentrated. 
Salen formation and reduction: To a solution of the diamine (1 equiv) in MeOH:EtOH 
(1:1), 3,5-di-tert-butyl-2-hydroxybenzaldehyde (2 equiv)  was added quickly. The 
solution was stirred overnight under an Ar atmosphere. THF was added to dissolve the 
precipitate formed and sodium borohydride (10 equiv) was slowly added. The solution 
was stirred for 2 h and it turned clear. The mixture was quenched with water and 
extracted with dichloromethane. The combined organic layers were washed with brine, 
dried over Na2SO4, filtered, and concentrated.. 
6,6'-((Ethane-1,2-diylbis(azanediyl))bis(methylene))bis(2,4-di-tert-butylphenol). 
White solid (440 mg, 88% yield): 1H NMR (500 MHz, CDCl3) δ 7.23 (d, J = 2.5 Hz, 2H), 
6.85 (d, J = 2.1 Hz, 2H), 3.98 (s, 4H) 2.87 (s, 4H), 1.41 (s, 18H), 1.28 (s, 18H); 13C NMR 
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  Cristau, H. J.; Ouali, A.; Spindler, J. F.; Taillefer, M. “Mild  and Efficient Copper-Catalyzed Cyanation 
of Aryl Iodides and Bromides” Chem. Eur. J. 2005, 11, 2483 – 2492.	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(500 MHz, CDCl3) δ 154.6, 140.8, 136.1, 123.4, 123.3, 121.5, 53.6, 48.1, 35.0, 34.3, 
31.8, 29.8. Spectral data matches those reported.116	  
6,6'-(((1S,2S)-Cyclohexane-1,2-diylbis(azanediyl))bis(methylene))bis(2,4-di-tert-butyl 
phenol). Slight yellow solid (90 mg, 85% yield): 1H NMR (500 MHz, CDCl3) δ 7.25 (d, 
J = 2.5 Hz, 2H), 6.87 (d, J = 2.1 Hz, 2H), 4.03 (d, J = 13.0 Hz, 2H), 3.93 (d, J = 13.0 Hz, 
2H), 2.49 (m, 2H), 2.19 (m, 2H), 1.86 (m, 2H), 1), 1.70 (m, 2H), 1.39 (s, 18H), 1.30 (s, 
18H); 13C NMR (500 MHz, CDCl3) δ 154.4, 140.8, 136.1, 123.3, 123.2, 122.5, 60.0, 
51.0, 35.0, 34.3, 31.8, 30.8, 29.8, 24.3. Spectral data matches those reported.116	  
6,6'-((((1S,2S)-1,2-diphenylethane-1,2-diyl)bis(azanediyl))bis(methylene))bis(2,4-di-
tert-butylphenol). White solid (200 mg, 67% yield): 1H NMR (500 MHz, CDCl3) δ 7.26 
(10H), 6.98 (s, 2H), 6.97 (d, J = 3.0 Hz, 2H), 6.65 (d, J = 2.0 Hz, 2H), 4.07 (s, 2H), 3.81 
(d, J = 13.5 Hz, 2H), 3.65 (d, J = 13.5 Hz, 2H), 1.46 (s, 18H), 1.25 (s, 18H). Spectral data 
matches those reported.116	  
 
NH
R
HN
R
O2N
tBu
OH HO
tBu
NO2
R = H, -(CH2)4-, Ph  
6,6'-((Ethane-1,2-diylbis(azanediyl))bis(methylene))bis(2-(tert-butyl)-4-nitrophenol).  
Isolated as a yellow solid (182 mg, 91%). 1H NMR (500 MHz, CDCl3) δ 8.14 (s, 2H), 
7.83 (s, 2H), 4.10 (s, 4H), 2.90 (s, 4H), 1.41 (s, 18H).  
6,6'-((((1S,2S)-Cyclohexane-1,2-diyl)bis(azanediyl))bis(methylene))bis(2-(tert-butyl)-
4-nitrophenol).   Isolated as a yellow solid (168 g, 84%). mp: 99-104 ºC: 1H NMR (500 
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MHz, CDCl3) δ 8.12 (s, 2H), 7.83 (s, 2H), 4.18 (d, J = 14 Hz, 2H), 4.04 (d, J = 14 Hz, 
2H), 2.44 (m, 2H), 2.24 (m, 2H), 2.85 (m, 2H), 1.46 (s, 18H), 1.25 (m, 2H), 1.15 (m, 2H); 
13C NMR (500 MHz, CDCl3) δ 163.7, 139.7, 138.1, 122.7, 122.6(2), 60.0, 49.8, 35.1, 
30.8, 29.1, 24.3; IR (film) 3309, 3056, 2938, 1590, 1469, 1333, 1266, 1104, 907, 738 cm-
1; HRMS (ES) m/z = 529.3026 calcd for C28H41N4O6 [MH]+, found 529.3010. 
6,6'-((((1S,2S)-1,2-Diphenylethane-1,2-diyl)bis(azanediyl))bis(methylene))bis(2-(tert-
butyl)-4-nitrophenol).   Isolated as a yellow solid (205 mg, 99%). 1H NMR (500 MHz, 
CDCl3) δ 12.00 (br, 2H), 8.12 (s, 2H), 7.60 (s, 2H), 7.25 (m, 6H), 6.92 (m, 4H), 3.95 (m, 
4H), 2.35 (s, 2H), 1.42 (s, 18H).  
 
NH HN
N N
 
(1S,2S)-N1,N2-Bis(pyridin-2-ylmethyl)cyclohexane-1,2-diamine (41).  To a solution of 
the salen (747 mg, 2.60 mmol) in THF:MeOH (15.6 mL), NaBH4 (947 mg, 26.0 mmol) 
was added slowly. The mixture was stirred at room temperature. After 2 h, the reaction 
mixture was quenched with water and extracted CH2Cl2 (3 x 15 mL). The organic layers 
were combined, dried over sodium sulfate and concentrated. The product was purified via 
chromatography (SiO2, 5% Et3N, 10% MeOH/CH2Cl2) to afford the salan as a dark 
brown oil (717 mg, 95%). 1H NMR (500 MHz, CDCl3) δ 8.52 (s, J = 6.5 Hz, 2H), 7.62 (t, 
2H), 7.39 (d, J = 8.0 Hz, 2H), 7.13 (m, 2H), 3.94 (d, J = 14 Hz, 2H), 3.74 (d, J = 14.0 Hz, 
2H), 2.26-224 (m, 2H), 2.06 (m, 2H), 1.85 (m, 2H), 1.16m, 2H), 1.09 (m, 2H); 13C NMR 
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(500 MHz, CDCl3) δ 160.5, 149.1, 136.6, 122.0, 64.4, 61.3, 52.4, 31.5, 25.0. Spectral 
data matches those reported.146  
 
N
R
N
R
O O
V
O
F
 
A solution of the salen in dichloromethane (0.16 M) was added to a suspension VOF3 (1 
equiv) in dichloromethane (0.14 M).  The solution changed color right after the addition. 
The reaction mixture was stirred for 2 h at rt, filtered and concentrated.124b 
Ethylene Salen Vanadium Complex.  Dark green solid. 1H NMR matches the reported 
spectrum.124b 
Ethylene Salan Vanadium Complex  Dark green solid. LCMS (ES) calcd for 
C32H49FN3O2V (M-O)+ 563.32, found 563.34.  
Cyclohexenyl Salen Vanadium Complex. Dark green solid. LCMS (ES) calcd for 
C36H52N2O3V (M-F)+  611.34 found 611.30. 
Cyclohexenyl Salan Vanadium Complex. Dark green solid.  
Diphenyl Ethylene Salen Vanadium Complex l.  Dark green solid. LCMS (ES) calcd 
for C44H52N2O3VNa (M-F+Na)+ 732.35, found 732.48. 
Diphenyl Ethylene Salan Vanadium Complex. Dark green solid. LCMS (ES) calcd for 
C44H58N2O3V (M-F)+ 713.39, found 713.50. 
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  Schoumacker, S.; Hamelin, O.; Pecaut, J.; Fontecave, M. “Catalytic Asymmetric Sulfoxidation by 
Chiral Manganese Complexes: Acetylacetonate Anions as Chiral Swtiches” Inorg. Chem. 2003, 42, 8110–
8116.	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A solution of salen/salan in THF (0.36 M) was added to a to a suspension of NaH (2 
equiv) at 0 ºC. The solution was heated at reflux for 2 h. A solution of FeCl3 (1.1 equiv) 
in THF (0.72 M) was then added at room temperature and mixture was heated at reflux 
for 4 h. The reaction mixture was cooled, filtered, and concentrated.110  
Ethylene Salen Iron Complex.  Purple solid. LCMS (ES) calcd for C32H44N2O2Fe (M+-
Cl,-2H)+ 545.28, found 545.35. 
Ethylene Salan Iron Complex Purple solid. LCMS (ES) calcd for C32H50N2O2FeCl (M-
Cl)+ 585.20 found 585.29. 
Cyclohexenyl Salen Iron Complex. Red solid. LCMS (ES) calcd for C32H52N2O2Fe (M-
Cl)+ 600.33, found 600.44.   
Cyclohexenyl Salan Iron Complex. Violet solid. LCMS (ES) calcd for C36H56N2O2Fe 
(M-Cl)+ 604.37, found 604.45. 
Diphenyl Ethylene Salen Iron Complex. Light brown solid. LCMS (ES) calcd for 
C44H54N2O2Fe (M-Cl)+ 698.35, found 698.48. 
Diphenyl Ethylene Salan Iron Complex. Violet solid. LCMS (ES) calcd for 
C44H58N2O2Fe (M-Cl)+ 702.38, found 702.50.  
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A solution of salen/salan in dry DMF (0.00817 M) was added to a suspension of NaH (2 
equiv) and stirred for 1 h at room temperature. Then a solution of Ru(NO)(H2O)Cl3 (1 
equiv) in DMF (0.05 M) was added and the mixture was stirred for 18 h at 130 ºC.  The 
solvents were removed through rotatory evaporation and heating.58b  
Ethylene Salen Ruthenium Complex.  Brown-red solid. LCMS (ES) calcd for 
C32H46N2O2Ru (M-Cl, -NO)+ 592.26, found 592.20. 
Ethylene Salan Ruthenium Complex Brown-red solid. LCMS (ES) calcd for 
C32H49N2O2Ru (M-Cl, -NO, +H)+ 595.28, found 595.40. 
Cyclohexenyl Salen Ruthenium Complex. Brown-red solid. 
Cyclohexenyl Salan Ruthenium Complex. Brown-red solid. LCMS (ES) calcd for 
C36H56N3O3Ru (M-Cl)+ 680.33, found 680.40.  
Diphenyl Ethylene Ruthenium Complex. Brown-red solid.  
Diphenyl Ethylene Ruthenium Complex. Brown-red solid. LCMS (ES) calcd for 
C44H58N3O3Ru (M-Cl+) 778.35, found 778.30.  
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R = H, -(CH2)4-, Ph
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Cyclohexenyl Salan Ruthenium Complex. Brown-red solid.  
Diphenyl Ethylene Ruthenium Complex. Brown-red solid.  
 
N
R
N
R
O O
Cu
 
A solution of CuCl2 (1 equiv) in dry ethanol (0.12 M) was added to a solution of salen in 
toluene (0.12 M). The reaction mixture was heated to reflux until a precipitate appeared. 
The precipitates was collected and dried under vacuum.58c  
Ethylene Salen Copper Complex.  Orange solid. LCMS (ES) calcd for C32H47N2O2Cu 
(MH+) 554.29, found 554.30.   
Cyclohexenyl Salen Copper Complex. Orange solid.  LCMS (ES) calcd for 
C32H53N2O2Cu (MH+) 608.24, found 608.20. 
Diphenyl Ethylene Salen Copper Complex l. Orange solid. 
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To a solution of salan in methanol (0.0312 M), Cu(Ac)2H2O (1 equiv) and powdered 
NaOH (2 equiv) were added. As soon as the salt dissolved the solvent was removed and 
the solid was dissolved in dichloromethane and washed with water. The organic layer 
was dried over Na2SO4, filtered and concentrated. 58c 
Ethylene Salan  Copper Complex Orange solid. LCMS (ES) calcd for C32H48N2O2Cu 
(M-H2O)+ 555.30, found 555.80.   
Cyclohexenyl Salan Copper Complex. Orange solid.  LCMS (ES) calcd for 
C36H57N2O2Cu (M-H2O)+ 612.37, found 612.40.   
Diphenyl Ethylene Salan Copper Complex. Orange solid. LCMS (ES) calcd for 
C44H58N2O2Cu (M-H2O)+ 710.39, found 710.50.  
 
N
R
N
R
O2N
tBu
O O
tBu
NO2
Cu
OH2
R = H, -(CH2)4- .  
Ethylene Salan Copper Complex Orange solid. LCMS (ES) calcd for C24H32CuN4O7 
(M-H)+ 550.15, found 550.80.  
Cyclohexenyl Salan Copper Complex.  Orange solid. LCMS (ES) calcd for 
C28H34CuN4O6 (M-H2O)+ 585.18, found 585.20. 
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A solution of CrCl2 (1.1 equiv) in THF was added to a solution of the salen/salan in THF 
and stirred under argon. After 24h the solvent was removed by exposing the mixture to 
air.138 
Ethylene Salen Chromium Complex.  Orange solid. LCMS (ES) calcd for 
C32H46N2O2Cr (M-Cl)+ 544.31, found 544.41.  
Ethylene Salan  Chromium Complex Silver-Violet solid. LCMS (ES) calcd for 
C32H51N2O2Cr (M-Cl)+ 547.33, found 547.51. 
Cyclohexenyl Salen Chromium Complex. Orange solid.  LCMS (ES) calcd for 
C36H52N2O2Cr (M-Cl)+ 596.81, found 596.40 . 
Cyclohexenyl Salan Chromium Complex. Violet solid.  LCMS (ES) calcd for 
C36H56N2O2Cr (M-Cl)+ 600.84, found 598.4 (-2H) 
Diphenyl Ethylene Salen Chromium Complex. Dark-Orange solid.  LCMS (ES) calcd 
for C36H58N2O2Cr (M-Cl, +2H)+ 698.39, found 698.40 . 
Diphenyl Ethylene Salan Chromium Complex. Green solid LCMS (ES) calcd for 
C44H56N2O2Cr (M-Cl)+ 696.37, found 696.40. 
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Cyclohexenyl Salen Chromium Complex.  Orange solid. LCMS (ES) calcd for 
C28H34ClCrN4O6 (M)+ 609.16, found 609.30.  
 
N
R
N
R
O O
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Cl
 
A solution of salen/salan in toluene (0.36 N) was added to a solution of Mn(OAc)2•4H2O  
(3 equiv) in ethanol at 75 ºC. The mixture was heated at reflux for 2 h and then air was 
bubbled through for 1 h at reflux. The mixture was cooled to room temperature, the 
airflow was discontinued, and the mixture was extracted with water. The organic layer 
was dried over Na2SO4, filtered and concentrated.58d-e 
 Ethylene Salen Manganese Complex.  Brown solid. LCMS (ES) calcd for 
C32H47N2O2MnCl (M-Cl,+H)+ 546.30, found 546.44.  
Ethylene Salan  Manganese Complex Brown solid. LCMS (ES) calcd for 
C32H50N2O2Mn (M-Cl)+ 549.32, found 549.54.  
Cyclohexenyl Manganese Iron Complex. Brown solid. LCMS (ES) calcd for 
C32H52N2O2Mn (M-Cl)+ 599.34, found 599.45.  
Cyclohexenyl Salan Manganese Complex. Brown solid. LCMS (ES) calcd for 
C36H56N2O2Mn (M-Cl)+ 603.37, found 603.44.  
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Diphenyl Ethylene Salen Manganese Complex l. Brown solid.  LCMS (ES) calcd for 
C44H54N2O2Mn (M-Cl)+ 697.36, found 697.47.  
Diphenyl Ethylene Salan Manganese Complex. Brown solid.  LCMS (ES) calcd for 
C44H57N2O2Mn (M-Cl,-H)+ 700.38, found 700.50. 
 
N
R
N
R
O O
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A solution of Pd(OAc)2 (1 equiv) in ethanol (0.1 M) was added to a warm solution of the 
salen in ethanol (0.1 M). The reaction mixture was heated to reflux for few minutes. After 
cooling to room temperature, the precipitate was collected through vacuum filtration.58f  
Ethylene Salen Palladium Complex.  Silver-green solid. LCMS (ES) calcd for 
C32H46N2O2Pd (M+) 597.14, found 597.30.  
Ethylene Salan Palladium Complex Silver-green solid. LCMS (ES) calcd for 
C32H50N2O2Pd (M+) 601.17, found 601.30.  
 
OH
20 mol% cat. 
DCE, O2  
65 – 70 °C, 24 h
OH
OH
OH
OH
+
+
OH
OHMe
Me
Me
Me
Me
Me
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Me
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To a microwave vial was added 2,3,5-dimethylphenol (50 mg, 0.37 mmol) and 
salen/salan catalyst (0.072 mmol), The vial was sealed with a crimping cap and 
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dichloroethane (1.8 mL) was added. Oxygen was added though a balloon. The reaction 
mixture was stirred for 1-5 days at 60-70 ºC. The mixture was concentrated and purified 
via chromatography (10 % Ethyl Acetate/ Hexanes).  
3,3',4,4',6,6'-Hexamethyl-[1,1'-biphenyl]-2,2'-diol (ortho-ortho). White solid. 1H NMR 
(360 MHz, CDCl3) δ 6.74 (s, 2H), 4.73 (s, 2H), 2.29 (s, 6H), 2.17 (s, 6H), 1.92 (s, 6H); 
13C NMR (500 MHz, CDCl3) δ 151.7, 138.6, 135.2, 123.9, 120.4, 117.0, 20.1, 19.3, 11.9; 
IR (film) 3509, 3460, 2922, 2359, 1560, 1458, 1298, 1079 cm-1; HPLC (Chiralpak AD, 
1.0 mL/min, 99:1 hexanes:i-PrOH, λ = 254 nm): tR= 5.03 min, tR=6.96 min. 
2,2',3,3',6,6'-Hexamethyl-[1,1'-biphenyl]-4,4'-diol (para-para).  Yellow oil. 1H NMR 
(360 MHz, CDCl3) δ 6.56 (s, 2H), 4.50 (s, 2H), 2.18 (s, 6H), 1.80 (s, 6H), 1.78 (s, 6H); 
13C NMR (500 MHz, CDCl3) δ 151.9, 136.2, 134.2, 133.3, 119.6, 113.9, 19.9, 16.5, 11.9; 
IR (film) 3434, 2916, 1633, 1285, 1280 12191, 12191, 1086 cm-1. 
2',3,3',4,6,6'-Hexamethyl-[1,1'-biphenyl]-2,4'-diol (ortho-para). Yellow oil. 1H NMR 
(500 MHz, CDCl3) δ 6.62 (s, 1H), 6.58 (s, 1H), 4.71 (s, 1H), 4.48 (s, 1H), 2.22 (s,1H), 
2.12(t, J = 11.5 Hz, 6H), 1.84 (d J = 8.5 Hz, 6H), 1.77 (s, 3H).; ); 13C NMR (125 MHz, 
CDCl3) δ 153.4, 150.6, 138.5, 136.6, 136.4, 133.7, 126.5, 123.8, 123.1, 120.8, 119.4, 
114.8, 20.1, 20.0, 19.4, 16.8, 12.1, 11.9; (ES) calcd for C18H22O2 (M+) 270.17, found 
271.10; HPLC (Chiralpak AD, 1.0 mL/min, 90:10 hexanes:i-PrOH, λ = 254 nm): tR= 
7.10 min, tR=8.54 min. 
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3-(tert-butyl)-2-Hydroxybenzaldehyde (26).  2-(tert-Butyl)phenol (10.3 g, 66.6 mmol), 
para-formaldehyde (18 g, 266.4 mmol), magnesium chloride (12.7g, 33.2 mmol) and 
triethylamine (18 ml, 133.2 mmol) were dissolved in THF (100 mL) and the reaction 
flask was sealed. After heating at reflux overnight, the mixture was acidified with 1 M 
HCl.  The aqueous layer was extracted with ethyl acetate three times. The organic layers 
were combined, dried over sodium sulfate and concentrated.  The product was purified by 
chromatography (SiO2, Hexanes) to yield the product as a orange-red oil (7.08 g, 33%). 
Spectral data matches those reported.140 1H NMR (300 MHz, CDCl3) δ 11.82 (s, 1H), 
9.87 (s, 1H), 7.53 (d, J = 7.8 Hz, 1H), 7.39 (d, J = 9.3 Hz, 1H), 6.95 (t, 1H), 1.44(s, 9H). 
 
CHO
OH
tBu
O2N
 
(3-(tert-Butyl)-2-hydroxy-5-nitrobenzaldehyde (27).  To a solution of 3-(tert-butyl)-2-
hydroxybenzaldehyde (4.08, 22.9 mmol) in acetic acid (62 mL), HNO3 (22.7 mL, 549.8 
mmol) was added slowly to at 0 ºC. The mixture was stirred at room temperature. After 
1h the reaction mixture was poured into water with rapid stirring. After 30 min stirring at 
0 ºC, the yellow solid was collected and dried in vacuo (3.10 g, 60%). Spectral data 
matches those reported.147 1H NMR (500 MHz, CDCl3) δ 12.44 (s, 1H), 9.97 (s, 1H), 8.41 
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  Chen, C. T.; Kao, J. Q.; Salunke, S. B.; Lin, Y. H. “Enantioselective Aerobic Oxidation of α-Hydroxy-
Ketones Catalyzed by Oxidovanadium(V) Methoxides Bearing Chiral, N-Salicylidene-tert-
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(s, 2 H), 1.46 (s, 9H); 13C NMR (500 MHz, CDCl3) δ 196.4, 166.0, 140.8, 128.8, 128.0, 
119.8, 119.5, 35.5, 29.0. 
 
N N
N N
 
N,N-Dimethylbis(pyridyl)ethylenediamine (39). Picolyl chloride-HCl (2.428 g, 14.8 
mmol) was treated with an aqueous solution of potassium carbonate (6.381 g, 29.6 mmol, 
35 mL), extracted with CH2Cl2 and dried over MgSO4. To a solution of diamine (0.81 
mL, 7.40 mmol) in CH2Cl2 (21 mL), a solution of picolyl chloride in CH2Cl2 (21 mL) and 
1 M NaOH (17.2 mL, 17.2 mmol) were added. After 60 h, the reaction mixture was 
diluted in 1 M NaOH and extracted with CH2Cl2 (15 mL x 3). The organic layers were 
combined, dried over sodium sulfate and concentrated. Spectral data matches those 
reported.130 
N1,N2-Dimethyl-N1,N2-bis(pyridin-2-ylmethyl)ethane-1,2-diamine.  Isolated as a 
orange-red oil (1.503 g, 75%). 1H NMR (500 MHz, CDCl3) δ 8.42 (m, 2H), 7.53 (m, 2H), 
7.33 (m, 2H), 7.04 (m, 2H), 3.60 (s, 4H), 2.56 (s, 4H), 2.18 (s, 6H); 13C NMR (500 MHz, 
CDCl3) δ 159.1, 148.9, 136.3, 123.1, 121.9, 64.0, 55.3, 42.7.  
N1,N3-Dimethyl-N1,N3-bis(pyridin-2-ylmethyl)propane-1,3-diamine.  Isolated as a 
brown oil (1.627 g, 81%). 1H NMR (500 MHz, CDCl3) δ 8.44 (m, 2H), 7.35 (m, 2H), 
7.30 (m, 2H ), 7.06 (m, 2H), 3.56 (s, 4H), 2.40 (m, 4H), 2.15 (s, 6H), 1.26 (m, 2H); 13C 
NMR (500 MHz, CDCl3) δ 159.6, 149.1, 136.5, 123.1, 122.0, 64.0, 55.9, 42.6, 25.3. 
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NH HN
N N
PhPh
 
(1S,2S)-1,2-Diphenyl-N1,N2-bis(pyridin-2-ylmethyl)ethane-1,2-diamine.  To a 
solution of the diamine (1.8 g, 5.07 mmol) in MeOH:EtOH (1:1, 34 mL), picolyl 
aldehyde (0.96 mL, 10.15 mmol)  was added quickly. The solution was stirred under an 
Argon atmosphere at room temperature for 2 h. NaBH4 (1.876 g, 50.7 mmol) was added 
slowly and stirred at room temperature. After 2 h, the reaction mixture was quenched 
with water and extracted CH2Cl2 (3 x 50 mL). The organic layers were dried over sodium 
sulfate, and concentrated to yield the product (255 mg, 13%). 1H NMR (300 MHz, 
CDCl3) δ 1H NMR (300 MHz, CDCl3) δ 8.27 (s, 2H), 7.65 (m, 6H), 7.32-7.13 (m, 10H), 
4.72 (s, 2H), 1.55 (s, 4H). 
 
N N
N N
 
(1S,2S)-N1,N2-Dimethyl-N1,N2-bis(pyridin-2-ylmethyl)cyclohexane-1,2-diamine (42).   
(1S,2S)-N1,N2-Bis(pyridin-2-ylmethyl)cyclohexane-1,2-diamine (100 mg, 0.34 mmol) 
was added to a flask  with formic acid (87 mg, 1.71 mmol) at 0 ºC followed by 
formaldehyde (0.082 mL, 1.01 mmol, 37%) was added. The reaction flask was sealed and 
heated for 8 h at 100 ºC. The resultant mixture was treated with 4 N HCl and evaporated 
under reduced pressure.  The residue was dissolved in water, treated with 15 N KOH and 
extracted with benzene (x3). The organic layers were dried over Na2SO4 and K2CO3. 
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Concentration yielded an orange oil (85.7 mg, 79%). Spectroscopic data matches those 
reported.142 1H NMR (500 MHz, CDCl3) δ 8.44 (s, 2H), 7.55 (m, 4H), 7.09 (m, 2H), 3.88 
(d, J = 14.5 Hz, 2H), 3.76 (d, J = 14.5 Hz, 2H), 2.63 (m, 2H), 2.25 (s, 6H), 1.95 (m, 2H), 
1.73 (m, 2H) 1.25 (m, 2H), 1.13 (m, 2H); 13C NMR (500 MHz, CDCl3) δ 161.39, 148.72, 
136.40, 123.00, 121.72, 64.52, 60.56, 36.75, 25.95, 25.90.  
 
N
R
N
R
n
N NV
ClO4
Cl
O
n= 0  R =  -(CH2)4-
n= 0  R= H
n= 1 R= H  
A solution of the perchlorate salt of the ligand (0.37 mmol) and VCl3 (0.37 mmol) in 
methanol (6.2 mL) was prepared. The mixture was heated to reflux and 6 N NaOH (01.8 
mmol) was slowly added to dissolve the salt. The resulting mixture heated at reflux. After 
1 h,  crystals were collected.62a  
Vanadium ethylene complex.  Violet crystals  
Vanadium propylene complex.  Olive crystals  
Vanadium cyclohexyl complex.  Brown crystals  
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N
R
N
R
N NMn
Cl
Cl
n= 0  R =  -(CH2)4-
n= 0  R= H
n= 1 R= H  
Manganese ethylene complex MnCl2 (0.37 mmol) and the ligand were dissolved in 
acetonitrile (0.74 mL) and heated at 90 ºC overnight. The solvent was removed to yield a 
solid.62c  
Manganese ethylene complex.  White solid  
Manganese propylene complex.  Brown crystals  
Manganese cyclohexyl complex.  White crystals  
 
N
R
N
R
n
N NCu
2ClO4
n= 0  R =  -(CH2)4-
n= 0  R= H
n= 1 R= H
+2
 
To a solution of the ligand in methanol (0.37 mmol, 3.7 mL), a methanolic solution of 
Cu(ClO4)2-6H2O (0.37 mmol, 1.9 mL) was added. The solvent was slowly evaporated at 
room temperature to yield the complex.62b 
Copper ethylene complex.  Blueviolet solid  
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Copper propylene complex.  Dark violet crystals  
Copper cyclohexyl complex.  Violet crystals  
 
N
R
N
R
n
N NFe
ClO4
Cl
Cl
n= 0  R =  -(CH2)4-
n= 0  R= H
n= 1 R= H  
To a solution of of the ligand (0.37 mmol) in CH2Cl2, a solution of FeCl3 in acetonitrile 
(0.37 mmol, 2 mL) was added. After stirring 3 d the solvent was removed under reduced 
pressure.62e 
Iron ethylene complex.  Yellow solid  
Iron propylene complex.  Black crystals  
Iron cyclohexyl complex.  Ivory solid 
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Appendix B. High Performance Liquid Chromatography 
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Figure B.1 Racemic (S)-6,6'-dibromo-4,4'-dimethoxy-3,3'-dimethyl-[1,1'-biphenyl]-2,2'-
diol. 
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Figure B.2 Phenol Coupling of 6,6'-dibromo-4,4'-dimethoxy-3,3'-dimethyl-[1,1'-
biphenyl]-2,2'-diol Using V1. 
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Figure B.3 Phenol Coupling of 6,6'-dibromo-4,4'-dimethoxy-3,3'-dimethyl-[1,1'-
biphenyl]-2,2'-diol Using V2. 
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Figure B.4 Racemic (S)-6,6'-dibromo-3,3'-dimethyl-[1,1'-biphenyl]-2,2',4,4'-tetraol. 
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Figure B.5 Phenol Coupling of (S)-6,6'-dibromo-3,3'-dimethyl-[1,1'-biphenyl]-2,2',4,4'-
tetraol Using V1. 
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Figure B.6 Phenol Coupling of (S)-6,6'-dibromo-3,3'-dimethyl-[1,1'-biphenyl]-2,2',4,4'-
tetraol Using V2. 
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Figure B.7 Phenol Coupling of (S)-6,6'-dibromo-3,3'-dimethyl-[1,1'-biphenyl]-2,2',4,4'-
tetraol Using V3. 
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Figure B.8 Racemic 40a.  
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Figure B.9 Phenol Coupling of 40a Using V2. 
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Figure B.10 Phenol Coupling of 40a Using V3. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure B.11 Racemic 40b.  
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Figure B.12 Phenol Coupling of 40b Using V3. 
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Figure B.13 Racemic 40c.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Me
OH
OH
OH
Me
OH
OTBDPS
OTBDPS
	   330	  
Figure B.14 Phenol Coupling of 40c Using V3. 
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Appendix C. Circular Dichroism Spectroscopy 
 
 
Figure B.1 CD Spectrum of RSR 47c 
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DATA TYPE  
 
ORIGIN JASCO 
 
OWNER  
 
DATE 14/02/20 
 
TIME 15:31:08 
 
SPECTROMETER/DATA SYSTEM JASCO Corp., J-715, Rev. 1.00 
 
RESOLUTION  
DELTAX -0.5 
XUNITS NANOMETERS 
YUNITS CD[mdeg] 
Y2UNITS ABSORBANCE 
FIRSTX 500.0000 
 
LASTX 250.0000 
 
NPOINTS 501 
 
FIRSTY 1.10406 
 
MAXY 6.08058 
 
MINY -2.57049 
 
XYDATA 
 
500.0000 1.10406 -0.384433 
 
499.5000 1.08845 -0.384414 
 
499.0000 1.08081 -0.384319 
 
498.5000 1.08039 -0.384692 
 
498.0000 1.0732  -0.385376 
 
497.5000 1.06691 -0.386463 
 
497.0000 1.07759 -0.38734 
 
496.5000 1.07193 -0.388321 
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496.0000 1.07547 -0.389648 
 
495.5000 1.07297 -0.391174 
 
495.0000 1.05918 -0.392548 
 
494.5000 1.06747 -0.393917 
 
494.0000 1.07  -0.395322 
 
493.5000 1.07815 -0.396888 
 
493.0000 1.08824 -0.399006 
 
492.5000 1.07755 -0.401129 
 
492.0000 1.06986 -0.402884 
 
491.5000 1.07472 -0.404367 
 
491.0000 1.07113 -0.404856 
 
490.5000 1.08382 -0.404234 
 
490.0000 1.08439 -0.40264 
 
489.5000 1.07972 -0.399852 
 
489.0000 1.06971 -0.396421 
 
488.5000 1.06703 -0.392671 
 
488.0000 1.06846 -0.388542 
 
487.5000 1.05749 -0.385032 
 
487.0000 1.04641 -0.382467 
 
486.5000 1.04287 -0.380433 
 
486.0000 1.05355 -0.379746 
 
485.5000 1.07418 -0.380608 
 
485.0000 1.07862 -0.382367 
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484.5000 1.07155 -0.385128 
 
484.0000 1.06735 -0.388105 
 
483.5000 1.0588 -0.391004 
 
483.0000 1.05442 -0.394429 
 
482.5000 1.04652 -0.396949 
 
482.0000 1.04674 -0.398135 
 
481.5000 1.03882 -0.398613 
 
481.0000 1.03948 -0.397973 
 
480.5000 1.03572 -0.396343 
 
480.0000 1.0329  -0.394568 
 
479.5000 1.01308 -0.391348 
 
479.0000 1.00582 -0.387572 
 
478.5000 0.983705 -0.383353 
 
478.0000 0.984803 -0.379072 
 
477.5000 0.980793 -0.375452 
 
477.0000 0.973941 -0.372626 
 
476.5000 0.982301 -0.370461 
 
476.0000 0.987214 -0.369988 
 
475.5000 0.979673 -0.371231 
 
475.0000 0.981258 -0.374097 
 
474.5000 0.978744 -0.378499 
 
474.0000 0.986284 -0.384358 
 
473.5000 0.996546 -0.390901 
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473.0000 0.9953  -0.397452 
 
472.5000 0.987879 -0.403138 
 
472.0000 0.990604 -0.407389 
 
471.5000 0.997436 -0.410223 
 
471.0000 0.997942 -0.411685 
 
470.5000 0.997732 -0.411691 
 
470.0000 0.997848 -0.411239 
 
469.5000 0.985323 -0.410661 
 
469.0000 0.98686 -0.410834 
 
468.5000 0.978144 -0.411785 
 
468.0000 0.968462 -0.413207 
 
467.5000 0.952668 -0.414383 
 
467.0000 0.938532 -0.414884 
 
466.5000 0.924573 -0.413766 
 
466.0000 0.92307 -0.411321 
 
465.5000 0.924104 -0.407433 
 
465.0000 0.930654 -0.402393 
 
464.5000 0.939744 -0.396744 
 
464.0000 0.956974 -0.391023 
 
463.5000 0.953916 -0.385864 
 
463.0000 0.954908 -0.381387 
 
462.5000 0.952502 -0.377341 
 
462.0000 0.953305 -0.373711 
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461.5000 0.954371 -0.370023 
 
461.0000 0.964065 -0.366627 
 
460.5000 0.963253 -0.363506 
 
460.0000 0.967357 -0.360314 
 
459.5000 0.975193 -0.357361 
 
459.0000 0.986171 -0.354187 
 
458.5000 0.999316 -0.351267 
 
458.0000 0.995268 -0.348851 
 
457.5000 0.989612 -0.346263 
 
457.0000 0.992526 -0.343505 
 
456.5000 0.999548 -0.340531 
 
456.0000 1.00494 -0.337211 
 
455.5000 1.00021 -0.333792 
 
455.0000 0.978168 -0.329939 
 
454.5000 0.966226 -0.326403 
 
454.0000 0.933649 -0.323342 
 
453.5000 0.929177 -0.320554 
 
453.0000 0.941279 -0.318545 
 
452.5000 0.939897 -0.317617 
 
452.0000 0.94336 -0.317998 
 
451.5000 0.935814 -0.319094 
 
451.0000 0.951474 -0.320424 
 
450.5000 0.970656 -0.322093 
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450.0000 0.954567 -0.322815 
 
449.5000 0.934201 -0.322464 
 
449.0000 0.920911 -0.320375 
 
448.5000 0.917993 -0.316999 
 
448.0000 0.922137 -0.311784 
 
447.5000 0.9076  -0.305359 
 
447.0000 0.911601 -0.298926 
 
446.5000 0.916059 -0.293098 
 
446.0000 0.924967 -0.287769 
 
445.5000 0.927794 -0.283489 
 
445.0000 0.929516 -0.279637 
 
444.5000 0.938994 -0.276927 
 
444.0000 0.954198 -0.274496 
 
443.5000 0.940992 -0.2719 
 
443.0000 0.928417 -0.269472 
 
442.5000 0.917596 -0.267531 
 
442.0000 0.916693 -0.265266 
 
441.5000 0.916877 -0.263358 
 
441.0000 0.914361 -0.26147 
 
440.5000 0.899878 -0.259317 
 
440.0000 0.905864 -0.256915 
 
439.5000 0.905026 -0.254176 
 
439.0000 0.889489 -0.251078 
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438.5000 0.878052 -0.247945 
 
438.0000 0.859329 -0.244711 
 
437.5000 0.846694 -0.241288 
 
437.0000 0.856335 -0.237845 
 
436.5000 0.872092 -0.234131 
 
436.0000 0.896769 -0.230243 
 
435.5000 0.909911 -0.225969 
 
435.0000 0.905757 -0.221628 
 
434.5000 0.902584 -0.21745 
 
434.0000 0.891528 -0.213495 
 
433.5000 0.883031 -0.209858 
 
433.0000 0.866356 -0.206808 
 
432.5000 0.831494 -0.203754 
 
432.0000 0.821702 -0.200878 
 
431.5000 0.822942 -0.19857 
 
431.0000 0.821711 -0.196542 
 
430.5000 0.822951 -0.194357 
 
430.0000 0.813113 -0.192103 
 
429.5000 0.820801 -0.18979 
 
429.0000 0.830357 -0.187821 
 
428.5000 0.825738 -0.185828 
 
428.0000 0.821966 -0.183421 
 
427.5000 0.814355 -0.180747 
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427.0000 0.815818 -0.178407 
 
426.5000 0.800123 -0.175768 
 
426.0000 0.789794 -0.172837 
 
425.5000 0.786247 -0.169991 
 
425.0000 0.801751 -0.167095 
 
424.5000 0.803491 -0.164174 
 
424.0000 0.789249 -0.161639 
 
423.5000 0.787935 -0.159074 
 
423.0000 0.785643 -0.15659 
 
422.5000 0.795136 -0.154446 
 
422.0000 0.792859 -0.152452 
 
421.5000 0.79227 -0.151008 
 
421.0000 0.801101 -0.149785 
 
420.5000 0.795946 -0.148402 
 
420.0000 0.772982 -0.147448 
 
419.5000 0.774188 -0.146474 
 
419.0000 0.764754 -0.144861 
 
418.5000 0.765468 -0.142711 
 
418.0000 0.759431 -0.139915 
 
417.5000 0.756921 -0.136047 
 
417.0000 0.745785 -0.131701 
 
416.5000 0.741859 -0.127565 
 
416.0000 0.728328 -0.123273 
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415.5000 0.706546 -0.119554 
 
415.0000 0.682358 -0.116846 
 
414.5000 0.658813 -0.114584 
 
414.0000 0.657004 -0.113074 
 
413.5000 0.672573 -0.112529 
 
413.0000 0.685167 -0.111292 
 
412.5000 0.687301 -0.109856 
 
412.0000 0.67273 -0.108284 
 
411.5000 0.666698 -0.105598 
 
411.0000 0.666543 -0.102388 
 
410.5000 0.649823 -0.0992901 
 
410.0000 0.646267 -0.0955667 
 
409.5000 0.634175 -0.0916841 
 
409.0000 0.627505 -0.0880537 
 
408.5000 0.631918 -0.0839745 
 
408.0000 0.612153 -0.0798984 
 
407.5000 0.577159 -0.0756715 
 
407.0000 0.540287 -0.0711199 
 
406.5000 0.501749 -0.0667101 
 
406.0000 0.476787 -0.0621369 
 
405.5000 0.452351 -0.0575245 
 
405.0000 0.442006 -0.0530124 
 
404.5000 0.435092 -0.0487836 
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404.0000 0.413111 -0.0448515 
 
403.5000 0.41919 -0.0406797 
 
403.0000 0.415414 -0.0365642 
 
402.5000 0.420866 -0.0326706 
 
402.0000 0.419022 -0.0293385 
 
401.5000 0.41742 -0.0259907 
 
401.0000 0.411622 -0.0228521 
 
400.5000 0.421515 -0.0203535 
 
400.0000 0.40094 -0.0178413 
 
399.5000 0.389388 -0.0152689 
 
399.0000 0.343511 -0.0126072 
 
398.5000 0.29341 -0.00987019 
 
398.0000 0.269395 -0.00721527 
 
397.5000 0.262696 -0.00422135 
 
397.0000 0.240032 -0.000158325 
 
396.5000 0.203093 0.00426449 
 
396.0000 0.175246 0.00896794 
 
395.5000 0.132528 0.0134555 
 
395.0000 0.0868539 0.0184103 
 
394.5000 0.0324716 0.0228493 
 
394.0000 -0.00175238 0.0267172 
 
393.5000 -0.0211825 0.0303042 
 
393.0000 -0.0249147 0.0340589 
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392.5000 -0.0774403 0.0379535 
 
392.0000 -0.102374 0.0421127 
 
391.5000 -0.124208 0.0463675 
 
391.0000 -0.164684 0.0514591 
 
390.5000 -0.238781 0.0571126 
 
390.0000 -0.287199 0.0626404 
 
389.5000 -0.346073 0.0673102 
 
389.0000 -0.368315 0.0718876 
 
388.5000 -0.384055 0.0767794 
 
388.0000 -0.431476 0.0820241 
 
387.5000 -0.460349 0.0875091 
 
387.0000 -0.484051 0.0927473 
 
386.5000 -0.534977 0.0981216 
 
386.0000 -0.589367 0.104277 
 
385.5000 -0.642236 0.110311 
 
385.0000 -0.708539 0.115597 
 
384.5000 -0.741359 0.120253 
 
384.0000 -0.783611 0.124876 
 
383.5000 -0.843734 0.129609 
 
383.0000 -0.893193 0.134341 
 
382.5000 -0.934757 0.138672 
 
382.0000 -0.99403 0.143217 
 
381.5000 -1.03944 0.147993 
	   343	  
 
381.0000 -1.11077 0.152814 
 
380.5000 -1.1628 0.15764 
 
380.0000 -1.21062 0.162639 
 
379.5000 -1.25382 0.167235 
 
379.0000 -1.3009 0.172063 
 
378.5000 -1.3397 0.176641 
 
378.0000 -1.40767 0.181469 
 
377.5000 -1.45828 0.186233 
 
377.0000 -1.51247 0.190559 
 
376.5000 -1.55832 0.19486 
 
376.0000 -1.60627 0.199537 
 
375.5000 -1.67054 0.20387 
 
375.0000 -1.69797 0.207695 
 
374.5000 -1.71682 0.211319 
 
374.0000 -1.73196 0.214782 
 
373.5000 -1.78145 0.218566 
 
373.0000 -1.84779 0.222093 
 
372.5000 -1.9284 0.225706 
 
372.0000 -1.97831 0.229744 
 
371.5000 -2.01905 0.234564 
 
371.0000 -2.05465 0.239591 
 
370.5000 -2.0964 0.244508 
 
370.0000 -2.10653 0.249369 
	   344	  
 
369.5000 -2.09858 0.25463 
 
369.0000 -2.1079 0.259683 
 
368.5000 -2.14004 0.264649 
 
368.0000 -2.1849 0.269819 
 
367.5000 -2.22269 0.274829 
 
367.0000 -2.26175 0.279781 
 
366.5000 -2.32235 0.284369 
 
366.0000 -2.36406 0.288652 
 
365.5000 -2.38528 0.293488 
 
365.0000 -2.39608 0.298281 
 
364.5000 -2.43497 0.303066 
 
364.0000 -2.48742 0.308494 
 
363.5000 -2.52143 0.314222 
 
363.0000 -2.54415 0.320258 
 
362.5000 -2.56143 0.326076 
 
362.0000 -2.5649 0.331584 
 
361.5000 -2.57049 0.336984 
 
361.0000 -2.54527 0.34193 
 
360.5000 -2.51003 0.346934 
 
360.0000 -2.49046 0.352156 
 
359.5000 -2.48  0.357658 
 
359.0000 -2.49352 0.363263 
 
358.5000 -2.49315 0.369093 
	   345	  
 
358.0000 -2.51907 0.375294 
 
357.5000 -2.49675 0.381845 
 
357.0000 -2.49384 0.388117 
 
356.5000 -2.49099 0.393985 
 
356.0000 -2.51291 0.39979 
 
355.5000 -2.51739 0.405605 
 
355.0000 -2.5184 0.411633 
 
354.5000 -2.49176 0.417231 
 
354.0000 -2.54489 0.42285 
 
353.5000 -2.53634 0.428873 
 
353.0000 -2.54409 0.435046 
 
352.5000 -2.5035 0.441355 
 
352.0000 -2.47926 0.447934 
 
351.5000 -2.48087 0.454463 
 
351.0000 -2.44713 0.461438 
 
350.5000 -2.39262 0.468159 
 
350.0000 -2.35056 0.47482 
 
349.5000 -2.27944 0.481919 
 
349.0000 -2.20345 0.488664 
 
348.5000 -2.09641 0.49513 
 
348.0000 -2.01004 0.501447 
 
347.5000 -1.93783 0.507212 
 
347.0000 -1.88387 0.51242 
	   346	  
 
346.5000 -1.84857 0.51709 
 
346.0000 -1.78025 0.521297 
 
345.5000 -1.70116 0.525039 
 
345.0000 -1.68238 0.528207 
 
344.5000 -1.62887 0.53142 
 
344.0000 -1.56094 0.534962 
 
343.5000 -1.45924 0.538777 
 
343.0000 -1.35319 0.542844 
 
342.5000 -1.27814 0.547253 
 
342.0000 -1.21445 0.552023 
 
341.5000 -1.10572 0.557031 
 
341.0000 -1.03141 0.561411 
 
340.5000 -0.930005 0.564857 
 
340.0000 -0.81677 0.56822 
 
339.5000 -0.705292 0.571415 
 
339.0000 -0.600768 0.573289 
 
338.5000 -0.528528 0.575123 
 
338.0000 -0.416586 0.577336 
 
337.5000 -0.273135 0.580321 
 
337.0000 -0.174845 0.584219 
 
336.5000 -0.108782 0.588728 
 
336.0000 -0.0143091 0.593665 
 
335.5000 0.149057 0.59985 
	   347	  
 
335.0000 0.329116 0.605831 
 
334.5000 0.466815 0.611466 
 
334.0000 0.613666 0.616628 
 
333.5000 0.753735 0.621758 
 
333.0000 0.89874 0.626244 
 
332.5000 1.04449 0.630254 
 
332.0000 1.13075 0.633715 
 
331.5000 1.26635 0.637438 
 
331.0000 1.40899 0.641299 
 
330.5000 1.53275 0.645525 
 
330.0000 1.68334 0.649085 
 
329.5000 1.82375 0.653208 
 
329.0000 1.96759 0.657191 
 
328.5000 2.12534 0.661123 
 
328.0000 2.28116 0.664951 
 
327.5000 2.46329 0.668556 
 
327.0000 2.63656 0.671582 
 
326.5000 2.807  0.675168 
 
326.0000 3.01269 0.67864 
 
325.5000 3.15966 0.682885 
 
325.0000 3.3605  0.687792 
 
324.5000 3.52741 0.692459 
 
324.0000 3.72383 0.697633 
	   348	  
 
323.5000 3.88574 0.702761 
 
323.0000 4.0656  0.707452 
 
322.5000 4.23283 0.712055 
 
322.0000 4.41559 0.716534 
 
321.5000 4.55648 0.720555 
 
321.0000 4.65734 0.724118 
 
320.5000 4.74772 0.727469 
 
320.0000 4.85619 0.731899 
 
319.5000 4.98469 0.736691 
 
319.0000 5.08671 0.741671 
 
318.5000 5.15018 0.746612 
 
318.0000 5.25776 0.751816 
 
317.5000 5.38451 0.757391 
 
317.0000 5.50571 0.762118 
 
316.5000 5.65756 0.765904 
 
316.0000 5.77964 0.769511 
 
315.5000 5.88597 0.773024 
 
315.0000 6.01834 0.775906 
 
314.5000 6.05003 0.778042 
 
314.0000 6.08058 0.780229 
 
313.5000 6.0641  0.782992 
 
313.0000 6.01135 0.78547 
 
312.5000 5.94769 0.788045 
	   349	  
 
312.0000 5.89521 0.790156 
 
311.5000 5.87594 0.793031 
 
311.0000 5.89012 0.796716 
 
310.5000 5.90973 0.799978 
 
310.0000 5.94392 0.802956 
 
309.5000 5.95057 0.805858 
 
309.0000 5.94959 0.808393 
 
308.5000 5.97637 0.810155 
 
308.0000 5.96679 0.810925 
 
307.5000 5.92638 0.81143 
 
307.0000 5.82679 0.81241 
 
306.5000 5.69313 0.813683 
 
306.0000 5.56771 0.815038 
 
305.5000 5.46098 0.816288 
 
305.0000 5.3353  0.818331 
 
304.5000 5.15737 0.820856 
 
304.0000 5.05854 0.82305 
 
303.5000 4.95241 0.824885 
 
303.0000 4.89214 0.826563 
 
302.5000 4.79008 0.827904 
 
302.0000 4.66189 0.828596 
 
301.5000 4.5461  0.82921 
 
301.0000 4.43467 0.829951 
	   350	  
 
300.5000 4.33922 0.830874 
 
300.0000 4.23823 0.831356 
 
299.5000 4.10883 0.831724 
 
299.0000 4.03033 0.832446 
 
298.5000 3.86024 0.833961 
 
298.0000 3.7246  0.835171 
 
297.5000 3.52847 0.836807 
 
297.0000 3.36334 0.838758 
 
296.5000 3.21411 0.841468 
 
296.0000 3.03211 0.844586 
 
295.5000 2.83609 0.847916 
 
295.0000 2.71005 0.850645 
 
294.5000 2.59483 0.853302 
 
294.0000 2.55465 0.85576 
 
293.5000 2.39782 0.857854 
 
293.0000 2.26274 0.860081 
 
292.5000 2.15585 0.862362 
 
292.0000 2.09849 0.864546 
 
291.5000 1.99286 0.867697 
 
291.0000 1.90471 0.87129 
 
290.5000 1.77508 0.875341 
 
290.0000 1.68455 0.880168 
 
289.5000 1.61381 0.884834 
	   351	  
 
289.0000 1.45791 0.889481 
 
288.5000 1.30265 0.894146 
 
288.0000 1.2042             0.89769 
 
287.5000 1.01832 0.900826 
 
287.0000 0.864088 0.903507 
 
286.5000 0.755703 0.906018 
 
286.0000 0.615755 0.908603 
 
285.5000 0.594052 0.911327 
 
285.0000 0.508797 0.914939 
 
284.5000 0.383137 0.919287 
 
284.0000 0.332244 0.924024 
 
283.5000 0.332196 0.929488 
 
283.0000 0.260559 0.934903 
 
282.5000 0.17801 0.94107 
 
282.0000 0.0708183 0.947318 
 
281.5000 -0.00515779 0.953335 
 
281.0000 -0.0605176 0.959826 
 
280.5000 -0.104416 0.966088 
 
280.0000 -0.211399 0.973038 
 
279.5000 -0.249698 0.980894 
 
279.0000 -0.20855 0.988703 
 
278.5000 -0.22264 0.997638 
 
278.0000 -0.244293 1.00832 
	   352	  
 
277.5000 -0.306396 1.01928 
 
277.0000 -0.405215 1.03079 
 
276.5000 -0.487074 1.04323 
 
276.0000 -0.531809 1.05615 
 
275.5000 -0.65105 1.06979 
 
275.0000 -0.639924 1.08381 
 
274.5000 -0.718187 1.09677 
 
274.0000 -0.802561 1.10968 
 
273.5000 -0.796498 1.12203 
 
273.0000 -0.783457 1.13287 
 
272.5000 -0.789346 1.14277 
 
272.0000 -0.763672 1.15195 
 
271.5000 -0.739637 1.16131 
 
271.0000 -0.633581 1.17136 
 
270.5000 -0.542275 1.18176 
 
270.0000 -0.485673 1.19255 
 
269.5000 -0.401083 1.20389 
 
269.0000 -0.373154 1.21507 
 
268.5000 -0.395962 1.22666 
 
268.0000 -0.34649 1.23815 
 
267.5000 -0.32401 1.25012 
 
267.0000 -0.278885 1.26227 
 
266.5000 -0.261407 1.27357 
	   353	  
 
266.0000 -0.266649 1.285 
 
265.5000 -0.22379 1.29672 
 
265.0000 -0.178662 1.30803 
 
264.5000 -0.189051 1.3189 
 
264.0000 -0.141139 1.32858 
 
263.5000 -0.060158 1.3365 
 
263.0000 0.0387837 1.34485 
 
262.5000 0.154535 1.35316 
 
262.0000 0.346366 1.36137 
 
261.5000 0.363631 1.36931 
 
261.0000 0.380705 1.37806 
 
260.5000 0.388752 1.38775 
 
260.0000 0.378053 1.3984 
 
259.5000 0.417813 1.40938 
 
259.0000 0.386054 1.42118 
 
258.5000 0.367447 1.4338 
 
258.0000 0.347341 1.44689 
 
257.5000 0.400234 1.45959 
 
257.0000 0.558323 1.47282 
 
256.5000 0.457892 1.48693 
 
256.0000 0.375568 1.50159 
 
255.5000 0.399254 1.51668 
 
255.0000 0.318739 1.53269 
	   354	  
 
254.5000 0.360642 1.54948 
 
254.0000 0.287312 1.5668 
 
253.5000 0.100863 1.58511 
 
253.0000 0.175661 1.60448 
 
252.5000 0.131028 1.62478 
 
252.0000 0.0911842 1.64635 
 
251.5000 0.0428836 1.66987 
 
251.0000 0.11409 1.69593 
 
250.5000 0.148663 1.72441 
 
250.0000 0.0588596 1.7548 
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